Ryman Healthcare Limited 2019 Annual Report
All about people
RYMAN HEALTHCARE ANNUAL REPORT 2019
We see it as a privilege
to look after older people.
RYMAN HEALTHCARE
2
Chair’s report
04
Chief executive’s report
Our senior executives
Our directors
How we create value over time
Enhancing the resident experience
Our people are our greatest resource
12
18
20
23
35
47
55
65
We are in a strong financial position
75
We value strong corporate governance
123
The long-term opportunities are significant
Serving our communities
ANNUAL REPORT 2019
3
CHAIR’S REPORT
We continue
to create value
RYMAN HEALTHCARE
4
RYMAN HEALTHCARE CHAIR
Dr David Kerr
Ryman has been a care company since it started 35 years ago.
As we continue to grow, we continue to create value for our
residents and their families, our staff, and our shareholders by
putting care at the heart of everything we do.
We’re a company with a purpose – to look after older people.
We know that if we get our care and resident experience right,
and have happy staff, the financial results take care of themselves.
I believe purpose and profitability are comfortable companions.
Integrating the two supports us in creating value over time.
This year, we continue to use the Integrated Reporting <IR> Framework*
to share the wider story of how we create that value.
*For more information on the <IR> Framework, visit integratedreporting.org
ANNUAL REPORT 2019
5
Producing strong financial results
I’m pleased to report a solid year that included
challenging market conditions. Our underlying
profit rose 11.5 percent to $227 million. Our
reported profit, which includes unrealised
valuations, declined 16 percent to $326 million.
The 2018 full-year reported profit was boosted
by changes to the independent valuation
assumptions. There were no significant changes
to the assumptions in the 2019 year. The full-year
dividend lifted to 22.7 cents per share, in line with
the growth in underlying profit.
Our net assets reached $2.17 billion, up from
$1.94 billion. Our operating cashflows rose
15 percent to $401.4 million, with cash receipts
from residents exceeding $1 billion for the
first time. This has allowed us to invest a record
$552 million in new and existing villages during
the year, up from $478 million last year.
Our medium-term target is to continue to
double our underlying profit every 5 years.
To achieve this, we aim to increase underlying
profit by around 15 percent each year, over the
medium term.
We fell short of this 15 percent increase this
year, for two reasons. Firstly, we made some
longer-term strategic decisions to reinvest
in the business, which we believe will help
performance in the coming years. Secondly,
resale volumes were flat. It’s hard to predict
the number of resales we get in the short term,
but we would expect volumes to grow in the
medium term in line with portfolio growth.
As a company we’re very focused on growth,
but we will not compromise our core value of
putting our residents first.
We think it’s a solid result given the decline in the
Melbourne housing market and a cooling-off in
the New Zealand market, particularly in Auckland.
It has not dented our plans to invest further.
Our villages remained in demand during the year.
Occupancy at our established care centres was
97 percent. While resales were flat, we sold almost
all of our stock that came up, which we take as a
positive sign that our villages are hitting the mark.
At 31 March, only 1 percent of our resale stock
was unsold.
Our build rate during the year lifted by
42 percent, and we have 20 new villages either
in development or in our land bank, giving us a
strong platform for growth in the years ahead.
Building sustainably
Our villages are built to be sustainable. It’s in
everyone’s long-term interests that we build
them to the highest standards.
Our villages are an extraordinarily
efficient use of land when compared to a
conventional subdivision. We are committed
to a programme of work to make them even
more environmentally sustainable.
We’ve measured our carbon footprint, and we
are working on ways to reduce our impact
by saving on energy consumption and waste
within each village.
We will be trialling solar-powered townhouses,
and we’ve installed an electric car-charging
network in Auckland.
We’ve introduced electric cars into our fleet,
and we’re trialling an eCab service at three
villages, using low-emission vehicles.
“I believe purpose
and profitability are
comfortable companions.”
RYMAN HEALTHCARE
6
Managing risk to create value over time
As a board, we are constantly focused on the
risk involved in everything we do.
The safety of our people is our top priority.
We’re committed to doing everything we can
to make sure our people are happy and healthy
in their work and get home safe each day.
A risk for us is not having the right people to
meet the demand that lies ahead. Long term,
we’re focused on succession planning and
attracting the talent we need. I’m pleased to see
the significant progress that’s been made to add
strength and depth to the teams. Our new learning
and development initiatives are creating Ryman’s
future leaders.
Investing in our people
During the year, we made a strategic decision
to act quickly on a pay increase for registered
nurses in New Zealand, to maintain our leadership
position in the industry. We immediately matched
the increased pay rates for District Health
Board nurses.
That decision, worth $5 million a year, has kept
us ahead of the curve, and I believe we have a
team that remains extremely loyal.
We have decided to increase pay again for all
of our team. On top of this general pay increase,
from July 2019 the minimum adult hourly rate at
our New Zealand villages will lift to $20.
We also invested in developing our people, by
establishing the Ryman Academy. With several
excellent education providers, including the
Melbourne Business School, we will provide
world-class development courses and support
for our senior leaders.
We are working with other training establishments
and universities to provide more courses for other
members of the team.
Our Lead, Energise and Perform (LEAP)
leadership programme is now well into its
second year, with 280 of our leaders participating.
We’ve refined and developed the programme
and will launch the next version, LEAP 2.0,
in the coming year.
Initiatives such as the LEAP programme and the
Ryman Academy recognise that we value our
people. We know our team want to build their
careers and gain expertise with us.
Having a career path at a company with purpose
and a strong future makes for a highly engaged
workforce. Our latest team survey shows that
engagement levels are at a record high.
Our aim is to be the employer of choice in a
competitive market. Our residents will continue to
benefit from being cared for by a highly engaged,
stable, and well-prepared team.
Ryman is successful because of our team.
We were delighted to learn recently that we’d
been named Most Trusted Brand in the aged
care and retirement sector in New Zealand.
“We will not compromise
our core value of putting
our residents first.”
“The safety of our people
is our top priority.”
ANNUAL REPORT 2019
7
Pursuing clinical excellence
Over the year, our pursuit of clinical excellence
continued. We’ve created a new Medications
Advisory Committee, which includes respected
geriatricians, a specialist pharmacist, researchers,
and a representative from the Health, Quality
& Safety Commission. The aim is to better
understand how medications affect the people
they’re designed to help and to make sure
medications are appropriately prescribed.
We’ve also engaged a specialist health researcher
to analyse the data we gather in myRyman. As a
clinician, I’m fascinated by the valuable insights
this innovation is delivering.
The secure data provides insights into the health
challenges of our residents, directly linking visiting
doctors with clinical health outcomes. We could
never have done this without the significant
investment we made in myRyman.
In May 2019, myRyman achieved international
recognition when it was named Innovation of the
Year – Care Model at the Asia Pacific Eldercare
Innovation Awards in Singapore.
During the year, we refreshed our approach
to dementia care. Ryman has been providing
dementia care for more than 20 years, and it
is a core part of our care offering. We currently
have 841 dementia beds and 665 more to come
from our land bank.
We will be introducing myRyman Life, a new
approach to dementia care, during the coming
year. The approach supports the resident living
with dementia to be happy in the moment, in the
best environment possible.
We also introduced our first telehealth clinics
during the year, which use technology to connect
our clinical teams in New Zealand and Victoria.
Bringing them together online makes efficient
use of time and resources to improve care.
Achieving the ‘gold standard’ in care
Achieving excellence in care is critical for us.
I’m delighted to report that 81 percent of our
care centres have now achieved ‘gold standard’
Ministry of Health 4-year certification.
Our investment in myRyman has helped,
as has our constant focus on improvement and
on building an internal audit team to work with
our village teams. When you treat every day as
audit day, excellent outcomes follow.
Ryman delivers more than 7 million hours of
care each year. We’re confident in our team, our
systems, and in our ability to constantly improve.
If we make mistakes, we learn from them so that
we can deliver the best possible care.
Investing in Ryman Delight
Our operations team has been busy working on
initiatives to enhance the quality of life of our
7,500 independent residents. The initiatives
are collectively known as Ryman Delight. For
many of our residents, cooking can sometimes
be a bit of a chore, so we’ve taken our Delicious
recipes and turned them into ready-to-eat meals.
Independent residents can buy them from us, and
heat and eat them at home.
We’ve introduced a new hosting service to make
our village centres more of a destination in the
evenings. Residents, their families, and friends can
enjoy a drink and bar snacks in our village lounge.
We’re also showing more films and adding later
session times so that after meeting for a drink and
snacks, they can enjoy a night out at the movies.
Our Ryman Benefits card provides discounts
for our team with more than 50 of our suppliers.
We wanted our residents to share the same
benefits, so we’ve now extended the benefits
card to them. Our residents and team can
make the most of our buying power, and our
suppliers are more than happy to be part of
the Ryman community.
RYMAN HEALTHCARE
8
Strengthening our corporate
governance structure
During the year, we welcomed two new
directors to the board – Geoff Cumming and
Anthony Leighs.
Geoff, an economist and world-class business
thinker, was one of our directors when we listed
in 1999. Geoff sees his long-term shareholding
in Ryman as an investment in a company with
purpose and with strong growth prospects.
Anthony is a successful construction entrepreneur
with expertise in commercial building. Ryman
invests more than $500 million a year in
construction and is one of New Zealand’s largest
housebuilders. Anthony chairs our newly formed
Development and Construction Committee.
Reinvesting for the future
Twenty years ago when we listed on the NZX, we
had eight villages. At that time, our shareholders
invested $25 million in capital. Since then, we’ve
invested more than $3.7 billion in our new and
existing villages. We’ve opened 28 villages over
two decades and we have a significant future
development pipeline.
Through our rolling refurbishment programme,
we continually reinvest in the 36 villages currently
in operation.
Our shareholders benefit from the value created
by this reinvestment. Since listing, we’ve paid
out more than $800 million in dividends and
grown our shareholders’ capital by 21 percent
per annum.
We’ve been able to grow and invest while paying
a growing dividend stream, without the need for
any fresh capital.
Recognising the people who make
it happen
Ryman’s team of over 5,000 people does a
superb job. The board values the contribution
you make every day.
We’d like to say thank you to our residents, and
your families, for putting your trust in our team.
The board values the contribution that each one
of our team members makes each day, and we
are extremely grateful for what you do.
And to our shareholders, thank you for your
support. We’re glad you’ve shared in the success
of the past 20 years, and we’re looking forward to
sharing future successes with you.
It really is all about people.
Dr David Kerr
CHAIR, RYMAN HEALTHCARE
“When you treat every
day as audit day, excellent
outcomes follow.”
ANNUAL REPORT 2019
9
A care company
from the start
1984
Ryman Healthcare
was founded in 1984.
5,3 0 0
We employ over
5,300 staff.
36
villages
We own and operate
36 retirement villages in
New Zealand and Australia
and have a land bank of 16 more.
Our villages
are home to over
11,000 residents.
11,0 0 0
residents
RYMAN HEALTHCARE
10
20
It’s 20 years
since we listed
on the NZX.
35
We’ve been driven
by the same values
for 35 years.
8 41
We have 841 beds dedicated to
dementia care and plan to add
another 665 from our land bank.
$3.7 billion
We’ve invested $3.7 billion
in new and existing
villages since 1999.
7,000,000
We provided more than
7 million hours of care during the year.
20
ANNUAL REPORT 2019
11
CHIEF EXECUTIVE’S REPORT
We’re building
momentum for the
growth ahead
RYMAN HEALTHCARE
12
We’ve had a busy year ramping up investment in our people,
our residents, our systems, and making sure that everyone
gets home safe, every day.
We’ve built a lot of the momentum we need to tackle
the extraordinary years of growth we see ahead.
Our focus has been on improving the resident experience
and developing our people. If our residents and their families
love the experience of living in a Ryman village, and our people
love what they do and feel safe at work, our financial results
take care of themselves.
And that means our shareholders will continue
to share in our success as well.
RYMAN HEALTHCARE CHIEF EXECUTIVE
Gordon MacLeod
ANNUAL REPORT 2019
13
Lifting our build rate
During the year, we lifted our build rate by
42 percent to 757 units and beds.
All going well with consents and development
applications, we’re expecting to have work under
way on 12 sites in the coming year. This will take
us into our biggest-ever build programme.
Our land bank now totals more than 7,000 beds
and units, and 40 percent of these are consented.
We’ve got quality sites, and we’re turning them into
villages ready for sale to meet the demand ahead.
We encountered some headwinds during the year.
In Melbourne the housing market has come off
around 10 percent from its highs, and we’ve seen
a cooling-off in the wider Auckland market, with
volumes down 18 percent.
At a time when almost every newspaper
published in the past 365 days has had a negative
story about the property market on both sides
of the Tasman, our demand has held steady.
This is demonstrated by ending the year
with just 1 percent of our resale stock unsold,
and 97 percent occupancy in our established
care centres.
Making residents happy in Victoria
This year, we opened our second Melbourne
village, Nellie Melba. It’s now home to nearly
200 residents in independent living and care.
The village was opened by Lord Samuel Vestey,
an English peer and great grandson of
Dame Nellie. He told us he’d thought long
and hard before lending such a treasured
name to the village.
Lord Vestey told me on opening night that he’d
asked as many residents as he could about how
they were finding life in the village - because he’d
never seen anything like it in England. He couldn’t
believe how happy everyone was. To me that says
it all. Our success is defined by whether we make
people happy.
We’re conscious that it took longer than
anticipated to open our Nellie Melba village.
We’ve learned a lot. We’re our own worst critics,
and that’s how we keep improving.
“Our success is
defined by whether we
make people happy.”
RYMAN HEALTHCARE
14
The aged-care sector in Australia has
come under intense scrutiny from the Royal
Commission into Aged Care Quality and Safety.
We’ve made a submission to the Royal
Commission on how we believe the system
can be improved. We think that anything that
improves care for older people, and the way
it is delivered, is a good thing.
As a result of the Commission, and the bad press
about the retirement-village sector, residents
moving in with us have done their research.
They’re pleased with the experience of living at
a Ryman village, and they’re reassured to know
care options are available on the same site –
something that’s rare in Australia.
Growing in Victoria
We’ve added three sites in Victoria during the
year – taking us to a total of 10.
Our Aberfeldie site is not far from Melbourne’s
CBD, and in a good area with a shortage of
retirement-living options and care. Ocean Grove
is on the Bellarine Peninsula, just down the road
from Geelong, and is also an excellent prospect.
Our new site at Ringwood East is close to Eastland
Shopping Centre and is in Melbourne’s green belt,
bordered by Ringwood Lake Park. It has everything
we look for – a good-sized retired population
and a shortage of quality living options for them.
We think it’s a stunner.
Work has started at our Burwood East site,
our third village in Melbourne. We’ve also
recently received development approval for
our Highton site in Geelong and we plan to
start work there soon.
We’ve started early site works at Coburg and
we’ve applied for development approval for
Aberfeldie. At this stage, we’re likely to shuffle the
Aberfeldie site ahead of Coburg. Aberfeldie is a
shorter build and will allow us to get a beachhead
in that part of Melbourne faster, which will pave
the way for Coburg.
We’re well on the way to having five villages open
in Victoria by the end of 2020, and our Melbourne
development and construction team is fired up
about the future.
“Our Melbourne development
and construction team is
fired up about the future.”
ANNUAL REPORT 2019
15
Growing in New Zealand
We’ve made great progress at our Lynfield,
Hamilton, and Devonport villages in New Zealand,
where our first residents are settling in.
Our Auckland land bank has been boosted by
the acquisition of a premier site at Kohimarama.
We’ve also bought the medical centre next door
to our Grace Joel village in St Heliers. We have
no immediate plans to develop the site, but it’s
an important strategic deal for us.
We’ve bought two new sites in Christchurch,
subject to Overseas Investment Office approval.
The first is in Riccarton Park with views of the
racecourse, the Port Hills, and the Southern Alps.
It will provide us with a village near prime suburbs
with ageing populations, and it fits nicely within
our existing portfolio of Christchurch villages.
The second site we’ve bought is Bishopspark
village, from Anglican Care. Bishopspark is
near our existing Park Terrace site and looks
across Hagley Park in the heart of Christchurch.
Bishopspark suffered significant earthquake
damage and will be rebuilt.
We will take on the obligations to Bishopspark’s
existing residents and we are reviewing plans to
redevelop both sites as one village. The combination
of the sites right on Hagley Park, overlooking the
Avon, makes it an exciting prospect.
We have recently received resource consent for
our Havelock North village, so we’re gearing up
to start work there. Work has already started at
Lincoln Road in Auckland.
I want to acknowledge Andrew Mitchell, who
has led our development team for 12 years and
is moving into a consulting role, working on
special projects. Andrew has made a significant
contribution to Ryman and has built a strong
team that will continue to drive our expansion
in New Zealand and Victoria.
Jeremy Moore, who has been with us for 7 years
in the development team, has stepped up to lead
the team as acting chief development officer.
RYMAN HEALTHCARE
16
Standing with our Muslim community
On 15 March this year, we placed all of our
Christchurch villages and our Christchurch office
into lockdown after we learned that a gunman
was being pursued by police near Hagley Park.
Our Margaret Stoddart village is a short distance
from Al Noor Mosque and while none of our team
were caught up directly in the attacks, many of
our people were affected.
I’m proud of how our team responded. They
did everything possible to make sure our
residents were safe and comfortable as the
events unfolded.
Our Ryman family came together and raised
$100,000 for the victims and families of these
horrific terror attacks in New Zealand.
Giving back to our communities
During the year, we increased our engagement
with community organisations.
One example is our work with the
Stroke Foundation. We funded the purchase
and fit-out of a stroke van in New Zealand.
The van has travelled the length of the country
delivering around 10,000 free blood-pressure
checks. We’ve committed to funding the van
for another 3 years, and we’re putting an identical
van on the road in Melbourne.
“It is a privilege to
work alongside our team
of difference makers.”
All about people
As we celebrate 20 years on the NZX, I want
to acknowledge the support my team and I have
enjoyed from shareholders over the years. I look
forward to seeing you at our annual meeting.
Ryman is a success story thanks to the trust
that people have placed in us. We all look forward
to continuing to create value for our residents,
our people, and our shareholders for many years
to come.
Finally, I’d like to thank the team. In our
strongest-ever team survey results, our people
have told us they feel safe at work, and are
happier than ever. This is incredibly important
because our people make a massive difference
to the lives of our residents.
It is a privilege to work alongside our team
of difference makers. Our residents think the
world of you, and so do I.
Gordon MacLeod
CHIEF EXECUTIVE, RYMAN HEALTHCARE
ANNUAL REPORT 2019
17
George
Savvides
BE (HONS), MBA, FAICD
DIRECTOR
George lives in Melbourne
and has 20 years’
experience in Australia’s
healthcare industry.
After 14 years as managing
director of Medibank,
Australia’s largest health
insurer, he retired in 2016.
George joined Ryman’s
board in 2013 and is chair
of NextScience Limited
and deputy chair of Special
Broadcasting Service.
He is also a Fellow of
the Australian Institute
of Directors.
Claire
Higgins
BCOM, FCPA, FAICD
DIRECTOR
Based in Melbourne, Claire
is a director and consultant
with board experience in
Australia and New Zealand.
She joined Ryman’s board
in 2014 and is chair of REI
Superannuation Pty Ltd,
and holds director positions
in the property, health,
and philanthropic sectors.
Claire had a long executive
career at BHP and OneSteel
Limited before becoming a
professional director.
Anthony
Leighs
NZCB
DIRECTOR
Anthony is managing
director of Leighs
Construction, which he
founded in 1995 and built
into one of New Zealand’s
leading commercial
construction contractors.
He is a former chairman
of the New Zealand
Registered Master Builders’
Association. Anthony joined
the Ryman board in 2018.
Our
directors
RYMAN HEALTHCARE
18
Jo
Appleyard
LLB (HONS)
DIRECTOR
Jo is a partner at Chapman
Tripp. She is a skilled
advocate and litigator
specialising in commercial,
employment, and resource
management law. Jo has
been a member of the
NZ Markets Disciplinary
Tribunal since 2011.
Geoffrey
Cumming
BA (HONS), MSC (ECON), LLD
DIRECTOR
Geoff rejoined the board in
June 2018, having previously
served as a director from
1999 to 2000. He is a
Canada-based New Zealand
citizen who is an economist,
investor, and philanthropist.
He has more than 30 years’
experience as a chief executive
and as a company director,
having served on more than
25 corporate boards in
a wide range of countries
and industries.
Warren
Bell
MCOM, FCA
DIRECTOR
Warren joined the board
in 2011 and chairs the
Audit and Financial Risk
Committee. He is an
experienced public and
private company director,
and was previously an audit
partner. Warren is currently
chair of Hallenstein Glasson
and St George’s Hospital,
and is a director of several
private companies.
Dr David
Kerr
MB CHB, FRNZCGP
CHAIR
David joined Ryman’s board
in 1994 and has held the
role of chair since 1999.
A general practitioner,
David is a fellow and past
president of the New Zealand
Medical Association. He was
awarded a Fellowship with
Distinction by the Royal
New Zealand College of
General Practitioners.
He is chair of EcoCentral
and Centercare Limited and
a director of Forté Health,
Third Age Health Services,
and Ngāi Tahu Property.
ANNUAL REPORT 2019
19
Our senior
executives
Nicole
Forster
CHIEF PEOPLE AND
TECHNOLOGY OFFICER
Nicole joined Ryman in
2011 as a senior human
resources advisor. Before
joining Ryman, Nicole
worked in a variety of
human resource and
healthcare-related roles.
Nicole was promoted to
Group Shared Services
Manager before taking up
her current role in 2018.
Gordon
MacLeod
CHIEF
EXECUTIVE
Gordy joined Ryman in
2007. He had previously
been a corporate finance
partner with PwC and
finance director of a
London listed hi-tech
engineering company.
Gordy has a Bachelor of
Commerce degree and is
a chartered accountant.
He is a board member of
the New Zealand Aged
Care Association and
the Retirement Villages
Association.
Barbara
Reynen-Rose
CHIEF OPERATIONS
OFFICER
Barb joined Ryman in
1992 as a nurse manager
and is now our Chief
Operations Officer. Barb
has an Advanced Diploma
in Nursing, a Postgraduate
Diploma in Management,
and a Master of Health
Sciences (Gerontology).
RYMAN HEALTHCARE
20
To m
Brownrigg
CHIEF CONSTRUCTION
OFFICER
Tom joined Ryman in 2006
and has overseen the
construction of more than
20 Ryman villages. He has
over 30 years’ experience
in the construction industry
in New Zealand and the
United Kingdom, in roles
ranging from carpentry to
project management.
Debbie
McClure
CHIEF SALES AND
MARKETING OFFICER
Debbie joined Ryman
as an administrator in
1990 before moving into
sales. In 2013, she moved
to Melbourne to lead
Ryman’s sales expansion
in Victoria. Debbie is a
member of the Property
Council of Australia’s
Retirement Living
Committee in Victoria.
David
Bennett
CHIEF FINANCIAL
OFFICER
Dave joined Ryman in
2013 and was promoted to
Chief Financial Officer in
2017. Dave has a Bachelor
of Commerce degree and
is a chartered accountant.
Before joining Ryman,
he worked as an
accountant and auditor.
ANNUAL REPORT 2019
21
RYMAN HEALTHCARE
22
How we create
value over time
ANNUAL REPORT 2019
23
RYMAN HEALTHCARE
24
We put
care first
As a company, we don’t have a
complicated mission statement. We simply
put care at the heart of everything we do.
In 1984 when Ryman’s co-founder Kevin Hickman
was deciding how Ryman would do things, he thought about
how he’d like his Mum to be cared for. Kevin’s universal
benchmark became ‘It’s got to be good enough for Mum’.
Kevin set the bar high and, more than three decades later,
Ryman still works to maintain the same high standard
across the company.
Our residents, and their families, place their trust in us to
care for them. We see it as a privilege. We want our residents
to love the experience of living in a Ryman village.
ANNUAL REPORT 2019
25
1
Identify and
buy site
2
Design,
consult, and
consent village
3
Construction,
sales and
marketing begin
4
Recruit staff,
village opens
5
Village
complete and
fully operational
RYMAN HEALTHCARE
26
Our business
model revolves
around care
We design villages to meet the needs of
our residents. It starts with finding the right
site, developing a village and a community,
recycling cash, and reinvesting in the next village.
The development
team identifies
and buys a site
close to good
amenities in
an established
residential area
that needs quality
aged care and
independent living.
Our development and design teams design the
village and work through the consenting process.
Our construction team builds the village, our sales
team sells it down, and the operations team runs it.
The development
and community
relations teams
gather feedback
from the
community and
our internal teams
to form the plan
submitted for
resource consent.
The construction
team begins
work on the new
village and the
sales, marketing,
and community
relations teams
begin work to
attract residents.
The operations
team recruits
village staff and
begins day-to-day
operations at the
village. Independent
residents move in,
closely followed by
serviced-apartment
and care residents.
The village grows
until it is fully built
and occupied,
and becomes
fully operational.
The capital that
residents pay
when they move
in is recycled to
buy the next site,
and the cycle
begins again.
12 3 4 5
ANNUAL REPORT 2019
27
Highton
1
Mt Martha
1
Mt Eliza
1
Aberfeldie
1
Coburg
Weary Dunlop
1
Nellie Melba
1
Ringwood
East
•
Aberfeldie
•
Burwood East
•
Coburg
•
Highton
•
Mt Eliza
•
Mt Martha
•
Nellie Melba
•
Ocean Grove
•
Ringwood East
•
Weary Dunlop
Our villages in Victoria, Australia
Our villages in New Zealand
Whangarei
•
Jane Mander
Auckland
•
Bert Sutcliffe
•
Bruce McLaren
•
Edmund Hillary
•
Evelyn Page
•
Grace Joel
•
Hobsonville
•
Kohimarama
•
Lincoln Road
•
Logan Campbell
•
Murray Halberg
•
Possum Bourne
•
William Sanders
Hamilton
•
Hilda Ross
•
Linda Jones
Tauranga
•
Bob Owens
Gisborne
•
Kiri Te Kanawa
New Plymouth
•
Jean Sandel
Napier
•
Princess Alexandra
Havelock North
•
Te Aute Road
Whanganui
•
Jane Winstone
Palmerston North
•
Julia Wallace
Waikanae
•
Charles Fleming
Wellington
•
Bob Scott
•
Karori
•
Malvina Major
•
Newtown
•
Rita Angus
•
Shona McFarlane
Nelson
•
Ernest Rutherford
Rangiora
•
Charles Upham
Christchurch
•
Anthony Wilding
•
Diana Isaac
•
Essie Summers
•
Margaret Stoddart
•
Ngaio Marsh
•
Park Terrace*
•
Riccarton Park*
•
Woodcote
Dunedin
•
Frances Hodgkins
•
Yvette Williams
Invercargill
•
Rowena Jackson
Ocean Grove
Ryman village
Under construction
Council approval
Burwood East
1
1
1
1
Proposed village
*Subject to Overseas Investment Office approval
RYMAN HEALTHCARE
28
Our villages
Invercargill
1
Dunedin
Rangiora
1
Christchurch
62
Nelson
1
Wellington
42
Waikanae
1
Palmerston North
1
Whanganui
1
New Plymouth
1
Havelock
North
1
Napier
1
Gisborne
1
Tauranga
1
Hamilton
2
Whangarei
1
Auckland
9
2
2
1
ANNUAL REPORT 2019
29
“We create a village
environment that
people want to live in.”
Debbie McClure
CHIEF SALES AND
MARKETING OFFICER
RYMAN HEALTHCARE
30
Our pipeline
of villages
Brandon Park – Victoria
Lynfield – NZ
Devonport – NZ
River Road – NZ
Burwood East – Victoria
Lincoln Road – NZ
Highton– Victoria
Havelock North – NZ
Coburg – Victoria
Aberfeldie – Victoria
Hobsonville – NZ
Ocean Grove – Victoria
Riccarton Park – NZ
Mt Martha – Victoria
Kohimarama – NZ
Ringwood East – Victoria
Mt Eliza – Victoria
Park Terrace – NZ
Karori – NZ
Newtown – NZ
DesignVillagesConsentingConstructionVillage
open
Final
stages
Council
approval
The pipeline is subject to resource and building consent and various regulatory approvals.
ANNUAL REPORT 2019
31
We create value over
time through six capitals
Everything we do is the result of integrated thinking and planning.
Putting residents first benefits all our stakeholders
Ryman’s stakeholders include residents and their families, team members, neighbours
and local communities, investors, funders, suppliers, and our sponsorship partners.
Our first concern is the care,
companionship, quality of life, and
security of our residents. It is our
privilege to care for people at a
critical time of their life.
Our culture is to look after and
support each other. We value
kindness, health, and wellbeing.
Our people are our greatest
resource. We want them to get
home safe each day, and to go
home knowing they’ve made
a difference to the lives of our
residents.
We want our people to be well
trained and guided by strong
leadership. We want them to work
at Ryman for their entire career.
We develop our talent internally
and build our inhouse capability.
Constantly getting better at what
we do means we can be nimble as
we continue to grow.
Each time we build a Ryman
village, we establish a new
community dedicated to
meeting an important and
growing social need – the care
of older people.
We make it possible for older
people to move into a lifestyle
that directly benefits them. They
enjoy security, companionship,
and social connectedness.
In turn, the wider community
benefits from the long-term
sustainable jobs we create, and
the release of family homes for
new owners.
Our residents, and their families,
benefit from knowing their future
is assured with us.
LOOKING
AFTER
PEOPLE
CREATING AND
NURTURING
COMMUNITIES
Our business model creates a
high level of financial certainty
for residents and shareholders.
Our contracts are fair and easy
to understand. Residents, and
their families, have the certainty
of knowing that our management
fee is capped at one of the lowest
rates in the sector, and that their
weekly fee is fixed.
We create financial certainty
for our sub-contractors and
suppliers by building long-term
and sustainable partnerships
with them, and by paying on time.
For shareholders, we’ve provided
a steady pay-out and delivered
consistent growth for 20 years.
We distribute 50 percent of
our underlying profit to our
shareholders and invest the other
50 percent for future growth.
CREATING
FINANCIAL
CERTAINTY
213
CREATING AND
NURTURING
COMMUNITIES
2
RYMAN HEALTHCARE
32
Identifying material issues
We identify material issues through regular communications with our residents and their families,
our team members, and other stakeholders in New Zealand, Victoria, and around the world.
We collate the information and assess its effect on our ability to create value over time.
Our integrated thinking achieves
the best possible outcomes for
our residents. Everyone at Ryman
is encouraged to share their ideas
with others in different areas of
the business.
We value clear communication
and train our people to
communicate in plain language.
We invest heavily in innovative
technology that enables us to
improve the resident experience
and to share what we learn for the
good of all older people.
Our constant focus on learning
and improving raises our
expectations of what we can
achieve. Our achievements raise
the standard of what older
people should expect at a
retirement village.
SHARING
OUR
KNOWLEDGE
Retirement villages offer a low
impact and sustainable way to
house a community of people
with similar needs.
Building our villages using
energy-efficient designs and
reducing waste are the best
ways to ensure the sustainability
of our business over time.
As a Certified Emissions
Measurement And Reduction
Scheme (CEMARS®) company,
we’re measuring the impact we
make on the environment.
As well as reducing our energy
use and our waste streams, we
aim to work only with suppliers
and contractors who share our
sustainability values.
CONTINUING
TO BUILD
OUR ASSETS
When Ryman Healthcare listed
on the NZX 20 years ago in 1999,
$25 million in capital was raised
from its first investors. Since then,
the model has evolved to generate
more than $6.6 billion worth of
assets.
We have returned $800 million
worth of dividends to shareholders
and we’ve never had to raise
fresh capital.
We continue to recycle the cash
investment in each village and
establish recurring revenue streams
that will grow over time.
CARING
FOR THE
ENVIRONMENT
465
SHARING
OUR
KNOWLEDGE
CARING
FOR THE
ENVIRONMENT
46
ANNUAL REPORT 2019
33
RYMAN HEALTHCARE
34
Enhancing
the resident
experience
ANNUAL REPORT 2019
35
36
RYMAN HEALTHCARE
Our villages are people’s homes.
We provide our residents with the care,
companionship, quality of life,
and security they need.
We want our residents to be happy living in a Ryman village.
We constantly innovate and challenge everything we do so
that we can continue to enhance the resident experience.
We provide a range of retirement-living options to suit our
residents’ needs. We’ve cared for over 30,000 residents in
New Zealand and Victoria in villages that we’ve designed
and built, and operate ourselves.
ANNUAL REPORT 2019
37
RYMAN HEALTHCARE
38
We put our residents first
Our villages are affordable, our terms are fair,
and our contracts are easy to understand.
Residents, and their families, have the certainty
of knowing that our management fee is capped
at one of the lowest rates in the sector, and that
their weekly fee is fixed.
Our care options give independent residents
and their families the security of knowing that
we’re dedicated to caring for them now and into
the future.
Residents can choose from independent
apartments, townhouses, or serviced apartments.
And if their health needs change, they have
priority access to a range of care options, often
including secure dementia care.
We maintain an ongoing programme of
refurbishment, across all our villages, that enables
us to meet the changing needs of our residents.
Keeping the lines of
communication open
We regularly survey our residents, their families,
and our team members. They tell us what’s
working well and where we could improve.
We listen to what they say and we act on it.
When our independent residents asked us to
provide nutritious ready-to-eat meals for the days
when they didn’t feel like cooking, we acted on it.
This year, our ready-to-eat Delicious meals will
become a valuable service to our residents.
Village life meets older people’s
social needs
At Ryman, we create the kind of environment that
residents grew up in – a close community where
neighbours care about each other and have time
for a chat.
Feeling connected to a community can improve
physical health and wellbeing in older people.
It also helps to prevent loneliness and the risk
of depression and other mental health issues.
This year, we’ve started to roll out a new
programme of activities that take place in the
afternoons and evenings in our village centres.
Residents can come along to the village centre
for a drink and bar snacks. They can choose to
see a movie from the extra screenings at our
village cinemas.
We want the village centre to become even more
of a social destination where residents can meet
with their friends and families.
ANNUAL REPORT 2019
39
Sharing our buying power
Our team members enjoy using the Ryman
Benefits card to get discounts on purchases
from Ryman’s suppliers. During the year, we
extended the card to our residents, and they’re
now enjoying the same benefits.
Providing sustainable transport
for residents
At three of our villages, we’re trialling new Ryman
eCabs and a car-sharing scheme as a way to
help residents get to appointments. It’s also a
way to reduce our collective carbon footprint.
We provide a low-emissions eCab and a driver
to get them around safely. We also provide a
low-emissions car that residents can hire for a
minimal charge. The shared car is for residents
who no longer own a car, but still need one for
the occasional outing.
Achieving record results in our
clinical audits
Last year, 19 of our villages had achieved
4-year certification from the Ministry of Health.
We’ve now achieved the ‘gold standard’ in care
in six more villages, bringing the number to 25,
which is 81 percent of our New Zealand villages.
Our clinical audit results in Victoria have
also been excellent. We already exceed the
government standards in Australia and will
continue to improve.
Innovating to promote excellent
clinical care
Last year, we completed the roll-out of our
myRyman electronic care app, and more than
3,400 care residents are now benefitting from
the innovation.
This innovation promotes clinical excellence.
Clinical staff can identify and communicate any
changes in a resident’s health more quickly to
other team members, doctors, and family.
Using myRyman eliminates paperwork and
speeds up shift handovers. It creates links and
prompts, so our nursing and caregiving teams
know exactly what they need to do. Everything
is securely recorded.
Our teams can now spend more time with
residents and access and update their clinical
data more efficiently.
The app has proved its reliability, and the team
has embraced the change. Our most experienced
clinical team members describe myRyman as
‘magic’. It has made a once-in-a-generation
improvement to the way we deliver care.
“People aged 65 and
over are the most
under-researched
group in the
healthcare system.”
Dr Kathleen Potter
HEALTH RESEARCHER AND
MEMBER OF RYMAN’S MEDICATIONS
ADVISORY COMMITTEE
RYMAN HEALTHCARE
40
Working to improve the health
of all older people
The data we’re collecting can help improve
the wellbeing of all older people. By combining
myRyman with our standard medication system,
we can make connections between GPs, the
medications they prescribe, and the health
outcomes we observe and record.
We’ve engaged Dr Kathleen Potter, a health
researcher, to analyse the data. Dr Potter is
excited about the potential for learning from
this data. She says that people aged 65 and over
are the most under-researched group in the
healthcare system.
Ryman has set up a new Medications Advisory
Committee to better understand how
medications can affect the people they’re meant
to help. The committee meets quarterly, and
includes Dr Potter; Emeritus Professor Richard
Sainsbury from the University of Otago; clinicians
from different disciplines; and a representative
from the Health Quality & Safety Commission.
The Ryman Medications
Advisory Committee
Victoria Brevoort
Clinical Nurse Specialist, Ryman
Meegan Potts
Data Analyst, Ryman
Professor Richard Sainsbury
Consulting Geriatrician
Alex de Roo
Pharmacist
Dr Murray Robson
General Practitioner
Billy Allan
Health Quality & Safety Commission
Dr Kathleen Potter
Health Researcher
Jenny Thiele
Regional Operations Manager, Ryman
Melanie Asuncion
Clinical Manager, Ryman
Janine Snape
Operations Project Clinical Manager, Ryman
Karen Lake
Clinical and Quality Manager, Ryman
ANNUAL REPORT 2019
41
Revolutionising dementia care
Caring for residents with dementia has been a
core part of our clinical care for the past 20 years.
Today, we provide more than 840 dementia
care beds.
We are always looking to improve by learning from
the latest research. During the year, we reviewed
our dementia care. The review team had one
focus: for the person living with dementia to be
happy in the moment.
The team consulted with residents, their families,
our staff, and leading industry researchers.
They also organised a 2-day summit on designing
dementia-friendly environments for our residents.
The summit brought together 50 of our
architects, designers, clinicians, and contractors
with experts from the University of Stirling in
Scotland who specialise in designing for people
living with dementia.
The result is a new approach to dementia care
we’ve called myRyman Life. The approach
supports the person living with dementia
to be happy in the moment, in the best
environment possible.
We think myRyman Life will revolutionise the way
we deliver dementia care, adding value to our
clinical operations for many years to come.
The roll-out starts soon, and we will be closely
monitoring the benefits.
Taking innovation to new places
The potential for myRyman is growing as we gain
new insights from the data we’re collecting.
We can track which aspects of our care are going
exceptionally well and share that knowledge to
continuously improve what we do. We can also
quickly identify a spike in the number of falls,
infections, or other health issues we need to
know about.
The data in myRyman is secure and more
accurate than ever before. We can see that,
in the future, we’ll be able to use advanced
predictive tools to help us better assess the
clinical needs of our care residents.
RYMAN HEALTHCARE
42
Adopting telehealth technology to
improve care
We’ve adopted telehealth technology as another
way to improve our care for residents. Our clinical
teams across New Zealand and Victoria can use
this tool to connect and learn from each other.
One application of this technology is to help
treat people’s wounds – a core clinical skill.
Each of our village teams has a wound care
specialist. The specialists are all linked to a
telehealth clinic, led by a wound care clinician.
Bringing them together online makes efficient
use of time and resources to improve care
across all locations.
“We get excited about
innovation and the
future, and I’m very
excited about myRyman
Life, our new approach
to dementia care.”
Barbara Reynen-Rose
CHIEF OPERATIONS OFFICER
Understanding risk in care
Providing the range and level of care that Ryman
offers involves risk. Many of our residents are frail,
and their care is complex.
Putting care at the heart of everything we do
relies on team members who are passionate
about caring for people and understand the
risks involved.
All our team members are highly trained and
have the resources to provide our residents
with the best possible care. We make sure
everyone understands our universal standard
of care: ‘It’s got to be good enough for Mum’.
Ryman recognised for innovation
and trust
In May 2019, our myRyman care app was named
Innovation of the Year - Care Model at the Asia
Pacific Eldercare Innovation Awards in Singapore.
The award recognises the best care model that
improves the quality of life for older people.
Ryman also won the top award in the aged
care and retirement village category of the
New Zealand Reader’s Digest 2019 Most Trusted
Brands. These awards profile the brands Kiwis
trust the most. This is the fifth year we’ve won
the award.
The voters’ comments acknowledged our
kind staff, fair terms, and high standards of care.
ANNUAL REPORT 2019
43
For Julie Howell, visiting her husband Michael
in the special care unit at Ryman’s Bob Owens
village has been a surprisingly healing experience.
Michael, 79, was diagnosed with Alzheimer’s
8 years ago and now needs round-the-clock care.
The care Julie sees every day has changed her
view of the progressive illness.
“I wouldn’t be worried about having Alzheimer’s
now. It’s been such a loving, caring experience,”
says Julie. “There’s no pain, and Mike’s happy
and comfortable and safe.”
Moving into the village has given the couple
time to really appreciate life and their love,
which spans nearly 70 years. Julie is thankful
to have that time to share with their two children
and six grandchildren.
“I have a saying now, which is ‘I accept the gift
that life has given me, which is today’. I live by that.
As soon as I said that, I just relaxed about the past
and the future, and accepted that some things are
out of my control.”
RYMAN HEALTHCARE
44
RYMAN HEALTHCARE
A loving, caring
experience
Julie was nine when she set her sights on
Mike Howell.
“He got the dux at primary school and I thought,
‘Gosh, Mike Howell must be clever. I’m going to
marry him!’”
Indeed, Michael was an associate professor at
the Australian National University when he retired
at 53. He’d played for the university cricket team
against India at the age of 50.
“He did all the things you’re supposed to do –
he was very mentally active, and we had veggie
gardens and ate oily fish. We’d led a balanced sort
of a life, so this illness was quite a shock.”
After the diagnosis, Julie realised she’d need
support. In 2015 the couple moved into an
independent apartment at Bob Owens, knowing
that dementia care was on site for later.
That time came in March 2017. The move into
care lifted a huge weight off Julie’s shoulders.
“The 24-hour care is absolutely amazing.
It takes very special people to give care like that.
I feel it’s the jewel in the crown of the care centre.”
CONVERSATIONS
45
ANNUAL REPORT 2019
RYMAN HEALTHCARE
46
Our people are
our greatest
resource
ANNUAL REPORT 2019
47
RYMAN HEALTHCARE
48
Our culture is to look after
and support our people. They
make Ryman the company it is.
We will continue to do everything possible to make
sure health and safety is top of mind every day for all
our people, no matter where in the business they work.
Our commitment to safety starts with the board.
Ryman’s directors regularly visit our construction sites
and villages, and talk to people on the ground
to see for themselves what’s going on.
Health and safety is about more than what happens at work.
It’s about wellbeing in our broader lives. We’ve introduced
a wellness day for our operations staff, and we make sure
our leaders know how to best support their teams.
ANNUAL REPORT 2019
49
Speak up
Speak up on safety. Tell your manager or
supervisor if you’re not being supported in
working safely. Escalate it if nothing happens.
If you feel uncomfortable doing so, then call
the Confidential HR line.
3
1
Stop
If you don’t feel safe or comfortable doing
something, please stop. We will support you in
this decision even if it affects build timeframes
or any other project deadlines at our villages,
offices, or construction sites.
Intervene
If you see anyone doing something unsafe,
don’t sit back or walk by – please intervene.
2
We tell all our team members they are empowered
to keep everyone safe through three key actions.
RYMAN HEALTHCARE
50
A shared commitment to
health and safety
This year we launched our Stop. Think. Is it Safe?
campaign across the company. It’s a practical
campaign aimed at making sure the safety
message is part of our daily conversations.
In September 2018, we shut down all of
our construction sites for one day to hold
Safer Together, a safety expo attended by
350 people. Our construction team was joined
by village managers, gardeners, maintenance
people, directors, and external contractors to
take part in an interactive programme on safety.
Following the expo, we set up two safety forums
– one for construction and one for operations.
Members meet three times a year, providing
ongoing opportunities to discuss health and
safety. Their input helps us to continually
improve our safety performance at work.
“Safety is a 24/7
commitment for us.”
Claire Higgins
DIRECTOR
In honour of Graeme
In January 2018 Graeme Rabbits,
a contractor who worked on one
of our Auckland construction sites,
died in an accident on the site.
Graeme was a keen gardener and
loved the environment. To honour
him, we’ve set up an education
scholarship and a sustainability
award in his name. Graeme’s family,
who liked the idea of offering an
award as part of his legacy, is helping
to select the winners.
The first scholarship has been
awarded to George Hola, who works
on the construction team building our
Murray Halberg Retirement Village in
Auckland. George will benefit from a
3-year development programme that
will allow him to take on extra study
to pursue his dream career.
Key improvements in 2019
increase in safety observations
and near-miss reporting within
construction
27%
7%
decrease in frequency of
injury claims within operations
and offices
George Hola
Recipient of the Graeme Rabbits
Scholarship 2019
ANNUAL REPORT 2019
51
Ryman offers a lifetime career
We want our people to realise their full
potential with us.
Ryman has an important social purpose and
exceptional growth opportunities to build a
long-term career alongside like-minded people.
We believe in being kind, and we focus on
supporting and caring for each other.
We support our people to progress in their role
under the guidance of strong leadership.
During the year, Ryman senior leaders attended
tailored one-on-one coaching sessions as part
of a new individualised coaching programme.
We delivered our LEAP development programme
to 280 team members, and now we’re rolling out
the next stage.
We’ve provided extra leadership development
and coaching for Ryman’s construction project
managers. These managers work remotely with
the highest levels of responsibility on complicated
construction sites, and give very positive
feedback on the coaching.
The Ryman Academy will deliver
world-class education
This year, we will introduce the Ryman
Academy. The Academy will deliver a
portfolio of easily accessible learning
and development programmes.
We are partnering with leading education
providers, including polytechnics and
academies, to deliver the programmes.
One of our partners is Melbourne Business
School, and we’re excited about the world-class
programme of learning they will deliver for
our people.
The University of Auckland, another new
academic partner, will provide high-quality
courses for our property development team.
Finding the right people as we grow is a challenge.
It takes time to bring people up to speed.
By creating these career development
opportunities, we will attract and retain people
from Australasia and around the world to help
meet the demand ahead.
“The leadership
development and
coaching we’ve
delivered in construction
has given our team more
tools to do the job.’’
Tom Brownrigg
CHIEF CONSTRUCTION OFFICER
RYMAN HEALTHCARE
52
Providing more pathways for nurses
We’ve introduced an additional pay step for
our nurses that will further reward our more
experienced nurses for their advanced
knowledge and skills.
We’ve also developed our own Nursing Entry to
Practice programme so that graduate nurses with
a passion for aged care can start their careers in
a supportive and industry-leading environment.
We’re recruiting more apprentices
We continue to recruit apprentices to create
a pipeline of people to support the work
programme ahead.
We currently have 14 apprentices working in
construction while, in our inhouse kitchens,
four kitchen hands are training to become chefs.
“We want to be known
as the employer that’s
going to give you the
best development,
the best opportunities,
the place you can grow
and achieve the most.”
Nicole Forster
CHIEF PEOPLE AND TECHNOLOGY OFFICER
We increased wages again this year
Over the past 2 years, nursing and care staff have
received substantial wage increases; all village
staff received more sick-leave entitlements and
the option to take an annual wellness day.
The above-inflation increases we’ve introduced
mean that our adult minimum wage rate (in
New Zealand) will lift to $20 an hour by July 2019.
We’re pleased to break this barrier for our team.
We will continue to look for more ways to improve
the experience of working at Ryman, such as
extending the Ryman Benefits scheme we
introduced last year. All our staff receive a Ryman
Team Benefits card, which entitles them to a
range of discounts with leading retailers.
ANNUAL REPORT 2019
53
RYMAN HEALTHCARE
54
Serving our
communities
ANNUAL REPORT 2019
55
56
RYMAN HEALTHCARE
Ryman builds and operates
retirement villages that become part of the
communities we serve. Our villages enable
residents to stay in the areas they love.
Staying connected to their communities is important
for our residents. We recognise those connections by
supporting many of the groups they support.
We open our villages to community groups,
providing a venue for a range of organisations such
as Rotary, Lions, Probus, and SeniorNet.
The residents, themselves, give back to their local
communities through initiatives such as school reading
programmes. Helping children with their reading makes
great use of their skills, experience, and time.
Every Ryman village contributes to its local economy
by providing jobs that support thousands of families
across New Zealand and Victoria.
ANNUAL REPORT 2019
57
We value the support of our suppliers
Ryman has a network of more than 3,000
suppliers across diverse industries in New Zealand
and Australia.
Many of our suppliers have been with us for a long
time and have grown their businesses with us.
They understand our mission to look after older
people, and they’ve shared in our success.
We value the support our suppliers have given us,
and we look forward to working with them in the
years ahead.
Supporting people in times of need
The Christchurch mosque attacks had a profound
impact on our people and their families.
We gave assistance packages to our team
members who were directly affected, and
provided counselling services for residents
and our teams in Christchurch and around the
country. We held fundraisers for the victims
of the attacks, and donated $100,000 to the
Victim Support fund.
In August 2018, we gave assistance packages to
62 of our team members who had family directly
affected by the floods in Kerala in Southern India.
We donated $10,000 to Kerala’s flood relief fund.
In February this year, several team members
at our Ernest Rutherford village in Stoke were
caught up in the Wakefield fire evacuations.
We gave assistance packages to those
affected and donated $10,000 to the
Tasman Mayoral Fund.
We’re reducing our carbon footprint
Our communities tell us that caring for the
environment is important to them. They want
to know we’re doing our best to leave the
environment in good shape for future generations.
In 2018, Ryman signed up to the Certified
Emissions Measurement And Reduction Scheme
(CEMARS). We’ve measured our carbon footprint
and developed an emissions management and
reduction plan.
CEMARS certified companies are independently
audited each year on their carbon emissions
performance to ensure accurate measurement
and reporting.
Ryman has bought its first fleet of electric cars.
In Auckland, we’re building a network of electric
car-charging stations that our residents can
also use.
We also plan to trial the use of new-generation
solar technology in our townhouses.
We’re committed to improving our environmental
capital over time by:
• reducing travel, using renewable energy
wherever possible, and adopting
waste-reduction programmes to reduce
waste to landfill
• moving to village designs that exceed
existing building-code requirements and
include renewable energy sources, such
as solar power.
ISO 14064-1
certifi ed
organisation
RYMAN HEALTHCARE
58
Our communities benefit from
our support
Over the past 20 years, Ryman has contributed
more than $4 million to charity.
Since 1999 we’ve chosen one charity partner
each year as a focus for our fundraising efforts.
We now choose two charity partners each year -
one in New Zealand and one in Australia.
Ryman matches, dollar for dollar, the amount
our people and residents raise.
We’re making a difference to
people’s health
This year we partnered with the
Stroke Foundation in New Zealand and
the Stroke Foundation in Victoria.
We funded the purchase and fit-out of a stroke
van in New Zealand. During the year, the van
travelled the length of the country, delivering
more than 10,000 blood-pressure checks.
The van, which we’ve committed to supporting
for another 3 years, has made a tangible
difference to the health of thousands of people.
We’ve also funded a stroke van in Victoria,
which will be on the road later this year.
We build strong relationships with
many different groups
This year we supported 20 not-for-profit
partners, including Alzheimers New Zealand,
the New Zealand Dementia Co-operative,
Dementia Australia, Well Foundation,
New Zealand Red Cross, Christchurch City
Mission, and the Christ Church Cathedral
Restoration Fund.
We support large-scale arts organisations,
including the Melba Opera Trust, Royal
New Zealand Ballet, New Zealand Symphony
Orchestra, Melbourne Symphony Orchestra,
and the Dame Malvina Major Foundation.
“Climate action is a
critical issue for the
health sector, and I’m
delighted that Ryman
Healthcare has taken a
lead on tackling it.”
Dr Ann Smith
CHIEF EXECUTIVE,
ENVIRO-MARK SOLUTIONS
ANNUAL REPORT 2019
59
We support local sports clubs
We’ve been a major supporter of bowls in
New Zealand and have individual relationships
with more than 120 bowls clubs. We’re a key
sponsor of the Ultimate Bowls Competition
in Australia, and we’re proud to support
Ryman’s own bowls team, Southern Storm,
in the competition.
We continue to support sport in Victoria through
our partnerships with local bowls clubs and
Victorian football league club, the Coburg Lions.
“Ryman is investing in
and encouraging work
that’s so important
– particularly as our
age and demographic
profile in New Zealand
changes.’’
The Right Honourable
Jacinda Ardern
PRIME MINISTER OF NEW ZEALAND
The Ryman Prize recognises the world’s
most innovative thinkers
Every year, we award work anywhere in the
world that enhances the quality of life for older
people. The Ryman Prize is a $250,000 award
that encourages the world’s most innovative
thinkers to help solve the problems that older
people experience.
The Right Honourable Jacinda Ardern presented
the 2018 prize to Professor Takanori Shibata,
a Japanese inventor and robotics pioneer.
Previous winners include founding director
of the Fred Hollows Foundation Gabi Hollows,
who has helped to restore sight for millions of
people in developing countries. World-renowned
researchers into Alzheimer’s disease
Professor Henry Brodaty and Professor
Peter St George-Hyslop won the prize in 2016
and 2017, respectively.
RYMAN HEALTHCARE
60
ANNUAL REPORT 2019
61
Apprentices at Ryman’s William Sanders village
in Devonport mastered some new skills and
made some local schoolchildren very happy.
Regional Construction Manager Matt Hutchinson
needed a project to allow his apprentices to
work on their weatherboarding skills. Matt’s
apprentices needed to master the material to
complete their qualifications. The problem was,
the village didn’t need any weatherboard work.
“We’ve built a strong relationship with the
Devonport community, so we put the word
out that we were looking for a special project.”
Matt received dozens of suggestions, including
one from Stanley Bay School who said they’d
love a playhouse for their playground.
“We thought that idea would work perfectly.”
Apprentice Rory Tai was involved in the project.
“It’s awesome that local kids get to enjoy a
playhouse. I’m really happy about that.
And I’m really happy that I’ve now got that
knowledge of weatherboard, which gets
me closer to completing my apprenticeship.”
62
RYMAN HEALTHCARE
Building community
connections
CONVERSATIONS
Lucy Naylor, principal at Stanley Bay School,
was thrilled when she saw their new playhouse
being lifted into place.
“The Ryman team did a fabulous job, and the
playhouse has been a hit with the children.”
Lucy says the timing was perfect after their
swing, which had reached the end of its life,
had to be removed.
“We were facing years of fundraising to replace it,
so we were really pleased when this opportunity
came up.”
“Thank you very much, Ryman Healthcare.”
“We’ve built a strong
relationship with the
Devonport community.”
Matt Hutchinson
REGIONAL CONSTRUCTION MANAGER
ANNUAL REPORT 2019
63
RYMAN HEALTHCARE
64
The long-term
opportunities
are significant
ANNUAL REPORT 2019
65
RYMAN HEALTHCARE
66
As the proportion of older people
in the population increases, so will
the demand for quality aged care.
Ryman will continue to create value for shareholders by
building Ryman communities wherever there’s a need.
The number of people aged 80 and over in New Zealand
and Victoria is forecast to nearly quadruple over the
next 40 years. In New Zealand, the population in this age
group is forecast to rise from around 175,000 today to
over 620,000 by 2058. In Victoria, it will rise from around
255,000 today to around 1.1 million by 2058.
We have a significant ongoing development programme
stretching out ahead in New Zealand and Victoria.
ANNUAL REPORT 2019
67
We’re planning ahead to meet
the demand
Our land bank is the strongest it’s ever been.
By the end of 2020, we plan to have five villages
open in Victoria. Our goal is to keep the land banks
in both countries at a supply of not less than 4 years.
From that point, we want to open four villages
a year: two in Victoria, one in Auckland, and one
somewhere else in New Zealand.
Our future growth depends on maintaining a solid
land bank at different stages of development –
planning, design, consenting, and construction.
We will develop more villages in Victoria. In 7 years,
Victoria alone will have a population of seven
million people. That in itself creates enormous
potential for Ryman.
Happiness creates long-term value
We put our residents’ interests first, and that’s
what drives all our decisions.
We create value for stakeholders by making sure
that our residents are happy. To do this, we have
to make sure our people are happy and that they
share our values.
We constantly look to improve the experience
of working at Ryman. This year, we increased
pay rates and invested heavily in learning and
development.
FORECAST TOTAL POPULATION AGED 80+ OVER THE NEXT 40 YEARS
0
0.4M
NEW ZEALANDVICTORIA
0.8M
1.2M
20082013201820232028203320382043204820532058
RYMAN HEALTHCARE
68
Careful decision-making
minimises the risks
We are in a strong financial position. This allows
us to constantly innovate and improve, and to fulfil
our promises to our residents and their families.
While there is extraordinary demand ahead,
continued success is never guaranteed. Our
reputation is one of our greatest assets. We need
to deliver excellent care and a great experience
for our residents and families every day.
Our 35 years of experience assessing and
responding to market cycles helps us to make
sound decisions. We know what drives people
to choose Ryman. Affordability is key, as is a
location that’s connected to the local community
and facilities. We tailor our offering to meet local
demand and demographics.
We manage our occupancy rates closely.
We know that our good reputation results in
high occupancy and that, in turn, high occupancy
enhances our reputation as we impact the lives
of more people.
We’ve strengthened our
governance capacity
A fundamental part of what we do involves
buying land, consulting, designing and consenting
villages, and then building them safely. As the
scale and number of projects we’re working on
grows, so too does the complexity.
This year, the board responded by establishing
the Development and Construction Committee,
chaired by Anthony Leighs. As founder and
managing director of one of New Zealand’s
leading construction companies, Leighs
Construction, Anthony brings invaluable insights
and expertise.
Our development and construction executive
team has direct contact with the committee.
The committee, which reports to the main board,
is a valuable resource for the executive team as
they work through complex projects.
Good governance challenges and
supports our decision-makers
The board and the senior executive team work
collaboratively. The board’s role is to challenge
and support the team, making sure they have the
tools and resources to do their job.
If the board supports the views the executive
team puts forward, they let them know. If they
don’t support the views, they ask questions and
challenge them to reach the best decision.
ANNUAL REPORT 2019
69
We invest in our people and
our processes
To meet the demand ahead, we need to be
constantly evolving the way we do things.
We’ve made substantial progress on building
capacity in our inhouse development,
consultation, design, and construction teams.
In Melbourne, Auckland, and Christchurch,
we’ve added to all our teams so that we can
identify sites more quickly, create concept
designs, consult with the community, and get the
designs through the consenting process faster.
We’re always thinking ahead. As soon as one
team starts doing something differently, other
teams start to think about how they can continue
to evolve and develop their processes.
We’ve expanded our construction apprentice
scheme and we’re adding resources to our
quantity surveying and in-house design teams.
We’ve refined the way our design teams work
and we’ve added a new interior design team.
By using better technology and systems,
we continue to streamline our design processes.
The work we’ve done to recruit and train people
means we can have more projects on the go,
at one time.
We continue to build depth. If a team member
steps up to a new role, our goal is that the next
person is ready to take their place.
We are extending our use of building information-
management systems, and starting to use virtual
reality to bring our designs to life.
These system enhancements will help our
builders interpret information on site, and allow
our operations team to give better feedback
on concepts.
“We’ve now got more depth,
more muscle, more people
to do the work. We don’t
rely on any one person.”
Gordon MacLeod
CHIEF EXECUTIVE
RYMAN HEALTHCARE
70
ANNUAL REPORT 2019
71
Turning an investment
into a lifestyle
CONVERSATIONS
RYMAN HEALTHCARE
72
What started out as a small speculative
investment 20 years ago, has turned into
a way of life for investor-turned-resident,
John Harwood.
“I guess you could say I’ve been completely
Rymanised,’’ laughs John as he reflects on
his association with Ryman Healthcare over
two decades.
John invested when Ryman listed in 1999, and
sold a few shares along the way to pay back that
original investment. Thanks to steady growth over
the years, he now has a substantial investment.
His faith in Ryman has paid dividends – literally.
Around 5 years ago, John and his wife Marlene
were looking for a place to live with security
for the years ahead. They needed to know that
care would be available in the future, in case
something happened. The couple lived in
Orewa for 15 years after they’d retired, so knew
Evelyn Page Retirement Village well.
“I think the challenge
for Ryman is to keep
on growing and to
keep the same culture
and philosophy.”
John Harwood
INVESTOR-TURNED-RESIDENT
“The relief on our children’s faces when we said
we were moving in here was immense. Two of our
daughters work in health, so they know just how
good it is to be in a place where there’s care if you
need it. One of our daughters works in America
and says there’s nothing over there like Ryman.’’
John and Marlene love their life at Evelyn Page.
“There’s no doubt it’s a different life from normal
retirement. There’s so much here – there’s not
much else we need.’’
As a shareholder, John takes a keen interest
in Ryman. He’s attended annual meetings and
likes to have a chat with Chief Executive
Gordon MacLeod when he visits the village.
As a former business owner himself, he knows
there is always plenty to worry about. He’s
observed over the years, through his visits
to friends in other retirement villages, that
the competition has to work hard to catch
up to Ryman.
“I think the challenge for Ryman is to keep
on growing and to keep the same culture and
philosophy. The best thing you can do is to
keep on doing what you do – providing homes
and care that’s good enough for Mum – or Dad.’’
ANNUAL REPORT 2019
73
RYMAN HEALTHCARE
74
We are in a
strong financial
position
ANNUAL REPORT 2019
75
FINANCIAL RESULTS
Happy residents,
happy staff,
happy shareholders
We have a strong balance sheet. For the first
time, our net assets exceeded $2 billion.
We received $1 billion in cash receipts from
residents and we built 757 units and beds.
RYMAN HEALTHCARE
76
6-year summary
FOR THE YEAR ENDED 31 MARCH 2019
201920182017201620152014
Financial
Underlying profit (non-GAAP)$m2 27.0203.5 178.3 1 57.7 136.3
118.2
Reported net profit after tax$m326.0388.2 356.7 305.4 241.9
194.8
Net operating cash flows$m401.4349.3 322.8 315.5 234.0
238.4
Net assets$m2 ,170.11,940.5 1,652 .1 1 ,3 27.5 1,101.3 926.7
Interest-bearing debt to interest-
bearing debt plus equity ratio %38%35% 34% 29% 27% 23%
Dividend per sharecents22 .720.4 1 7. 8 15.8 13.6 11.8
Villages
New sales of occupation rightsno.414458600518545
436
Resales of occupation rightsno.
824825718690630541
Total sales of occupation rightsno.1,2381,2831,3181,2081,175
977
Land bank (to be developed)
1, 2, 3, 4
no.6,5935,9525,5544,2114,228
4,208
Portfolio:
Aged-care bedsno.3,6603,3673,2813,12 12,807
2,517
Retirement-village unitsno.6,8786,4145,9685,3474,7924,207
Total units and bedsno.10,5389,7819,2498,4687,5996,724
1 Includes retirement-village units and aged-care beds.
2 Included in the 6,593 beds and units are site acquisitions at Bishopspark (Christchurch) and Riccarton Racecourse (Christchurch) which are
subject to Overseas Investment Office approval.
3 In May 2019, Ryman entered into an unconditional sale and purchase agreement for the acquisition of land at Ringwood East (Melbourne). This
site adds an additional 299 retirement-village units and 120 residential-care beds to the land bank at 31 March 2019.
4 Of the 6,593 units and beds in the land bank, 3,681 are subject to resource and building consent.
201920182017201620152014
Underlying profit (non-GAAP)$m 2 27.0 203.5 178.3 1 57.7 136.3 118.2
Plus unrealised gains on
retirement-village units$m 102.4 185.3 184.7 151.6 105.7
85.1
Less deferred tax movement$m
(3.4) (0.6) (6.3) (3.9) (0.1) (8.5)
Reported net profit after tax$m
326.0 388.2 356.7 305.4 241.9 194.8
Underlying profit is a non-GAAP* measure and differs from NZ IFRS profit for the period. Underlying profit does not have a standardised meaning
prescribed by GAAP and so may not be comparable to similar financial information presented by other entities.
The Group uses underlying profit, with other measures, to measure performance. Underlying profit is a measure that the Group uses consistently
across reporting periods.
Underlying profit excludes deferred taxation, taxation expense, and unrealised gains on investment properties because these items do not reflect the
trading performance of the Company. Underlying profit determines the dividend payout to shareholders.
*Generally Accepted Accounting Principles
ANNUAL REPORT 2019
77
RYMAN HEALTHCARE
78
Financial
statements
80Primary statements
80Consolidated income statement
80Consolidated statement of comprehensive income
81Consolidated statement of changes in equity
82Consolidated balance sheet
83Consolidated statement of cash flows
85
Notes to the consolidated financial statements
85Statement of compliance
85Basis of preparation
85Measurement base
85Critical judgements in applying accounting policies
86Summary of significant accounting policies
94Other notes
94Operating expenses
94Depreciation and amortisation expense
95Finance costs
95Income tax
97Trade and other receivables
98Property, plant and equipment
100Investment properties
101Bank overdraft
101Trade and other payables
101Employee entitlements
102Borrowings
102Occupancy advances
103Share capital
103Reserves
104Dividends
104Related-party transactions
105Key management personnel compensation
106Financial instruments
111Commitments
111Contingent liabilities
112Reconciliation of net profit after tax with net cash flow from operating activities
113Subsidiary companies
113Segment information
115Employee share schemes
116Subsequent events
116Authorisation
118Independent auditor’s report
ANNUAL REPORT 2019
79
Consolidated income statement
FOR THE YEAR ENDED 31 MARCH 2019
Notes20192018
$000$000
Care fees302,003270,483
Management fees78,94470,087
Interest received532441
Other income8551,528
Total revenue382,334342,539
Fair-value movement of investment properties7292,910351,514
Total income675,244694,053
Operating expenses1(303,745)(268,040)
Depreciation and amortisation expense2(23,125)(20,580)
Finance costs3(18,959)(16,577)
Total expenses(345,829)(305,197)
Profit before income tax329,415388,856
Income-tax expense4(3,429)(640)
Profit for the year325,986388,216
Earnings per share
Basic and diluted (cents per share) 1365.27 7.6
Consolidated statement of comprehensive income
FOR THE YEAR ENDED 31 MARCH 2019
Notes20192018
$000$000
Profit for the year325,986388,216
Items that may be later reclassified to profit or loss
Fair-value movement and reclassification of interest-rate swaps14(5,181)(725)
Deferred tax movement on interest-rate swap reserve141,451203
Gain on hedge of foreign-owned subsidiary net assets141,3332,193
Loss on translation of foreign operations14(4,966)(5,502)
(7,363)(3,831)
Items that may be later reclassified to profit or loss
Revaluation of property, plant and equipment (unrealised)6, 1424,456–
24,456–
Other comprehensive income17,093(3,831)
Total comprehensive income343,079384,385
All profit and total comprehensive income is attributable to parent company shareholders and is derived from continuing operations.
The accompanying notes form part of these financial statements.
RYMAN HEALTHCARE
80
Consolidated statement of changes in equity
FOR THE YEAR ENDED 31 MARCH 2019
Notes
Issued
capital
Asset
revaluation
reserve
Interest-
rate swap
reserve
Foreign-
currency
translation
reserve
Treasury
stock
Retained
earnings
Total
equity
$000$000$000$000$000$000$000
Balance at 1 April 201733,290233,319(5,391)1,066(20,540)1,410,3471,652,091
Profit and total
comprehensive income
for the year14––(522)(3,309)–388,216384,385
Treasury stock
movement14––––(1,957)–(1,957)
Dividends paid to
shareholders15–– – – – (94,000) (94,000)
Closing balance at
31 March 201833,290233,319 (5,913) (2,243) (22,497) 1,704,563 1,940,519
Balance at 1 April 201833,290233,319(5,913)(2,243)(22,497)1,704,5631,940,519
Profit and total
comprehensive income
for the year14–24,456(3,730)(3,633)–325,986343,079
Treasury stock
movement14––––(4,968)–(4,968)
Dividends paid to
shareholders15–––––(108,500)(108,500)
Closing balance at
31 March 201933,2902 5 7,7 7 5(9,643)(5,876)( 2 7, 4 6 5 )1,922,0492 ,1 7 0,1 3 0
The accompanying notes form part of these financial statements.
ANNUAL REPORT 2019
81
Consolidated balance sheet
AT 31 MARCH 2019
Notes20192018
$000$000
Assets
Trade and other receivables5344,8143 57,4 8 3
Advances to employees248,1525,836
Property, plant and equipment61,188,9401,014,514
Investment properties75,081,6074,398,304
Intangible assets27,96820,713
Total assets6,651,4815,796,850
Equity
Issued capital1333,29033,290
Asset revaluation reserve142 57,7 75233,319
Interest-rate swap reserve14(9,643)(5,913)
Foreign-currency translation reserve14(5,876)(2,243)
Treasury stock14, 24(27,4 6 5 )(22,497)
Retained earnings141,922,0491,704,563
Total equity2 ,1 7 0,1 3 01,940,519
Liabilities
Trade and other payables9126,90998,308
Employee entitlements1023,83420,237
Revenue in advance57,84551,955
Interest-rate swaps1813,3938,212
Refundable accommodation deposits34,01330,757
Bank loans (secured)111,324,0031,060,493
Occupancy advances (non-interest bearing) 122,827,6902 ,514,683
Deferred tax liability (net)473,66471,686
Total liabilities 4,481,3513,856,331
Total equity and liabilities6,651,4815,796,850
Net tangible assets
Basic and diluted (cents per share)13 428.4384.0
The accompanying notes form part of these financial statements.
RYMAN HEALTHCARE
82
Consolidated statement of cash flows
FOR THE YEAR ENDED 31 MARCH 2019
Notes20192018
$000$000
Operating activities
Receipts from residents 211,009,496875,140
Interest received588515
Payments to suppliers and employees(306,234)(270,231)
Payments to residents(283,736)(241,676)
Interest paid(18,689)(14,491)
Net operating cash flows21401,425349,257
Investing activities
Purchase of property, plant and equipment(150,252)(178,897)
Purchase of intangible assets(6,918)(6,407)
Purchase of investment properties(364,186)(269,936)
Capitalised interest paid(31,003)(22 ,701)
Advances to employees(2,316)(952)
Net investing cash flows(554,675)(478,893)
Financing activities
Drawdown of bank loans (net)266,718225,592
Dividends paid(108,500)(94,000)
Purchase of treasury stock (net)(4,968)(1,956)
Net financing cash flows153,250129,636
Net increase in cash and cash equivalents––
Cash and cash equivalents at the beginning of the year––
Cash and cash equivalents at the end of the year––
The accompanying notes form part of these financial statements.
ANNUAL REPORT 2019
83
RYMAN HEALTHCARE
84
Notes to the consolidated financial statements
FOR THE YEAR ENDED 31 MARCH 2019
STATEMENT OF COMPLIANCE
The financial statements presented are those of
Ryman Healthcare Limited (the Company), and
its subsidiaries (the Group). Ryman Healthcare
Limited is a profit-oriented entity incorporated in
New Zealand that develops, owns, and operates
integrated retirement villages, resthomes, and
hospitals for the elderly within New Zealand
and Australia.
Ryman Healthcare Limited is a Financial Markets
Conduct reporting entity under the Financial
Reporting Act 2013 and the Financial Markets
Conduct Act 2013. Its financial statements comply
with these Acts.
The consolidated financial statements have been
prepared in line with Generally Accepted Accounting
Principles in New Zealand (NZ GAAP). The statements
comply with New Zealand equivalents to International
Financial Reporting Standards (NZ IFRS) and other
applicable financial-reporting standards.
The consolidated financial statements also
comply with International Financial Reporting
Standards (IFRS).
BASIS OF PREPARATION
Accounting policies are selected and applied in a
way that ensures the resulting financial information
satisfies the concepts of relevance and reliability,
and the substance of the underlying transactions
or other events is reported.
Apart from the new standards adopted in the current
period (see (t) below), the accounting policies
set out below have been consistently applied in
preparing the financial statements for the year ended
31 March 2019. These policies have also been applied
to the comparative information presented for the
year ended 31 March 2018.
The information is presented in thousands of
New Zealand dollars.
All reference to AUD refers to Australian dollars.
MEASUREMENT BASE
The Group follows the accounting principles
recognised as appropriate for measuring and
reporting financial performance and financial
position on a historical-cost basis, except when:
• certain property, plant and equipment is subject
to revaluation (note 6)
• investment property is measured at fair value
(note 7)
• certain financial assets and liabilities are
measured at fair value (note 18).
CRITICAL JUDGEMENTS IN APPLYING
ACCOUNTING POLICIES
In applying the Group’s accounting policies,
management must make judgements, estimates,
and assumptions about the carrying value of assets
and liabilities that are not readily apparent from
direct sources.
The estimates and associated assumptions are
based on historical experience and various other
factors that are reasonable under the circumstances.
The results form the basis of making the judgements.
Actual results may differ from these estimates.
The estimates and underlying assumptions
are reviewed on an ongoing basis. Revisions to
accounting estimates are recognised in the period
in which the estimate is revised, if the revision affects
only that period. Revisions to accounting estimates
are recognised in the period of the revision and
future periods, if the revision affects both current
and future periods.
The following accounting policies and notes
contain information about significant areas of
estimation uncertainty and critical judgements
in applying accounting policies that have the
most significant effect on the amounts recognised
in the financial statements.
• Valuation of property, plant and equipment –
policy (d) and note 6
• Valuation of investment property – policy (e)
and note 7
ANNUAL REPORT 2019
85
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES
The following significant accounting policies have
been adopted to prepare and present the financial
statements of the Group.
a. Basis of consolidation – purchase method
The consolidated financial statements are
prepared by combining the financial statements
of all the entities that comprise the Group,
being the Company (the parent entity) and
its subsidiaries as defined in NZ IFRS 10
Consolidated Financial Statements. A list
of subsidiaries appears in note 22 to the
financial statements.
Consistent accounting policies are used to
prepare and present the consolidated financial
statements. All significant inter-company
transactions and balances are eliminated in
full on consolidation.
The financial statements of subsidiaries
are prepared for the same reporting period
as the parent company, using consistent
accounting policies.
Income and expenses for each subsidiary whose
functional currency is not New Zealand dollars are
translated at exchange rates that approximate
the rates at the actual dates of the transactions.
Assets and liabilities of such subsidiaries are
translated at exchange rates at balance date.
All resulting exchange differences are recognised
in the foreign-currency translation reserve, which
is a separate component of equity.
b. Revenue recognition
The Group recognises revenue and income from
the following major sources.
• Care fees
• Management fees
• Interest received
Revenue is recognised as follows.
Care fees
Care facility and retirement-village service
fees are linked to providing service on a specific
day (service date). Revenue from care and
retirement-village service fees are recognised
on completion of the service date.
Management fees
Residents of the Group’s independent-living units
and serviced apartments pay a management fee
for the right to share in the use of the village centre
and other common facilities. The management
fee is calculated as a percentage of the
occupation-right agreement amount. The fee
accrues monthly, for a set period, based on the
terms of individual contracts.
Management fees are recognised on a
straight-line basis over the period of service.
The period is determined as being the greater
of the expected period of tenure, or the
contractual right to management fees.
The expected periods of tenure, based on
historical experience across our villages, are
estimated to be 7 years for independent units
and 3 to 4 years for serviced units. The estimated
expected periods of tenure are unchanged from
last year.
The timing of when management fees are
recognised is an accounting estimate.
Historical experience across all villages is
used in determining periods of tenure.
Interest received
Interest income is recognised in the income
statement as it accrues, using the effective
interest method.
RYMAN HEALTHCARE
86
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
c. Borrowing costs
Borrowing costs directly attributable to acquiring,
constructing, or producing qualifying assets
(assets that take a substantial period of time
to get ready for their intended use) are added
to the cost of those assets until the assets are
substantially ready for use.
All other borrowing costs are recognised in profit
and loss in the period in which they are incurred.
d. Property, plant and equipment
Property, plant and equipment comprises
completed care facilities, corporate assets and
land, and care facilities under development.
All property, plant and equipment is initially
recorded at cost. Typically, these costs include
the cost of land, materials, wages, and interest
incurred during the period required to complete
and prepare the asset for its intended use.
Following initial recognition at cost, completed
care-facility land and buildings are carried at a
revalued amount, which is the fair value at the
date of the revaluation, less any subsequent
accumulated depreciation on buildings and
accumulated impairment losses.
Independent valuations are performed with
sufficient regularity to ensure that the carrying
amount does not differ materially from the asset’s
fair value at the balance-sheet date.
Any revaluation surplus is recorded in other
comprehensive income and credited to the
asset-revaluation reserve included in the equity
section of the balance sheet, unless it reverses a
revaluation decrease of the same asset previously
recognised in the income statement. In this case,
the increase is credited to the income statement
to the extent of the decrease previously charged.
Any revaluation deficit is recognised in the income
statement unless it directly offsets a previous
surplus of the same asset in the asset revaluation
reserve, in which case the revaluation deficit is
recorded in other comprehensive income.
In addition, any accumulated depreciation at the
revaluation date is eliminated against the gross
carrying amount of the asset, and the net amount
is restated to the revalued amount of the asset.
On disposal, any revaluation reserve relating to
the particular asset being sold is transferred to
retained earnings.
An item of property, plant and equipment is
derecognised on disposal or when no future
economic benefits are expected to arise from
the continued use of the asset.
Any gain or loss arising on disposal of the asset
(calculated as the difference between the net
disposal proceeds and the carrying amount of
the item) is included in the income statement in
the period the item is derecognised.
e. Investment properties
Investment properties include land and
buildings, equipment, and furnishings relating to
retirement-village units and community facilities,
including units and facilities under development.
They are intended to be held for the long term to
earn rental income and for capital appreciation.
Retirement-village units and community
facilities are revalued on a semi-annual basis
and restated to fair value as determined by an
independent registered valuer. Any change in
fair value is taken to the income statement.
The fair value is determined using discounted
cash-flow methodology.
Rental income from investment properties, being
the management fee and retirement-village
service fees, is accounted for in line with
accounting policy (b).
ANNUAL REPORT 2019
87
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
f. Depreciation
Depreciation is provided on all property, plant
and equipment, other than freehold land, at
straight-line (SL) rates calculated to allocate
the asset’s cost or valuation, less estimated
residual value, over their estimated useful lives,
starting from the time the assets are ready for
use, as follows.
• Buildings 2% SL
• Plant and equipment 10–20% SL
• Furniture and fittings 20% SL
• Motor vehicles 20% SL
The estimated useful lives, residual value,
and depreciation method are reviewed at the
end of each reporting period, with the effect
of any changes in estimate accounted for
on a prospective basis.
No depreciation is provided for investment
properties.
g. Impairment of assets
At each interim and annual balance-sheet
date, the Group reviews the carrying amounts
of its assets to determine whether there is any
indication that those assets have suffered an
impairment loss. If such an indication exists, the
recoverable amount of the asset is estimated to
determine the extent of any impairment loss.
Where the asset does not generate cash flows
that are independent from other assets, the
Group estimates the recoverable amount of the
cash-generating unit to which the asset belongs.
Recoverable amount is the higher of fair value
less costs to sell and value in use. In assessing
value in use, the estimated future cash flows are
discounted to their present value. The Group
uses a discount rate that reflects current market
assessments of the time value of money and the
risks specific to the asset, for which the estimates
of future cash flows have not been adjusted.
If the recoverable amount of an asset
(cash-generating unit) is estimated to be less
than its carrying amount, the carrying amount
of the asset (cash-generating unit) is reduced
to its recoverable amount.
An impairment loss is immediately recognised
as an expense, unless the asset is carried at fair
value. In this case, the impairment loss is treated
as a revaluation decrease.
Where an impairment loss subsequently reverses,
the carrying amount of the asset (cash-generating
unit) is increased to the revised estimate of its
recoverable amount. However, this is only to the
extent that the increased carrying amount does
not exceed the carrying amount that would have
been determined had no impairment loss been
recognised for the asset (cash-generating unit)
in prior years.
A reversal of an impairment loss is immediately
recognised as income, unless the asset is carried at
fair value. In this case, the reversal of the impairment
loss is treated as a revaluation increase.
h. Operating leases
Leases under which all the risks and benefits of
ownership are effectively retained by the lessor
are classified as operating leases. Operating lease
payments are charged to the income statement
on a straight-line basis over the periods of
expected benefit.
i. Revenue in advance
Revenue in advance represents those amounts by
which the management fees over the contractual
period exceed recognition of the management
fee based on expected tenure.
j. Financial instruments
Financial assets and financial liabilities are
recognised on the Group’s balance sheet when
the Group becomes party to the contractual
provisions of the instrument.
RYMAN HEALTHCARE
88
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
Cash and cash equivalents
Cash and cash equivalents comprise cash on
hand, cash in banks and on-demand deposits,
and other short-term, highly liquid investments
readily convertible to a known amount of cash
and subject to an insignificant risk of changes
in value. This includes all call borrowing, such
as bank overdrafts, used by the Group as part
of its day-to-day cash management.
Financial assets at amortised costs
Trade receivables are held to collect contractual
cash flows. The cash flows are the payment of
principal and interest.
Trade receivables are measured at amortised
cost, less any impairment. This is equivalent to
fair value, being the receivable face (or nominal)
value, less appropriate allowances for estimated
irrecoverable amounts.
The allowance recognised is the lifetime expected
credit losses based on an assessment of each
individual debtor. It is estimated based on the
Group’s historical credit loss experience and
general economic conditions. Expected credit
loss represents the expected credit losses that
will result from all possible default events over the
expected life of the debtor.
Trade receivables are written off when there is no
realistic chance of recovery.
Occupancy advances
Occupation agreements confer to residents
the right of occupancy of the retirement-village
unit for life, or until the resident terminates
the agreement.
Amounts payable under occupation agreements
(occupancy advances) are non-interest
bearing and recorded as a liability in the balance
sheet, net of management fees receivable.
The resident-occupancy advance is initially
recognised at fair value and later at amortised cost.
As the resident may terminate their occupancy
with limited notice, and the occupancy advance
is non-interest bearing, the occupancy advance
has demand features and so is carried at face
value, which is the original advance received.
The advance, net of management fee, is
repayable following both the termination of
the occupation agreement and the settlement
of a new occupancy advance for the same
retirement-village unit.
Refundable accommodation deposits
Refundable accommodation deposits relate to
deposits held on behalf of residents who reside in
rooms in the care centres in Australia. Refundable
accommodation deposits confer to residents the
right of occupancy of the room for life, or until the
resident terminates the agreement.
Amounts payable under refundable accommodation
deposits are non-interest bearing and recorded
as a liability in the balance sheet.
As the resident may terminate their occupancy
with limited notice, and the refundable
accommodation deposit is non-interest bearing,
the refundable accommodation deposit has
demand features and so is carried at face value,
which is the original deposit received.
Trade and other payables
Trade and other payables are measured
at amortised cost. This is equivalent to the face
(or nominal) value of payables, which
is assumed to approximate their fair value.
Interest-bearing loans and borrowings
Loans and borrowings are initially recorded at fair
value, less directly attributable transaction costs.
After initial recognition, loans and borrowings
are measured at amortised cost. Any differences
between the initial amount recognised and the
redemption value is recognised in profit and loss
using the effective interest-rate method.
ANNUAL REPORT 2019
89
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
In practice, this means that Group interest-bearing
borrowings are recognised at face (or nominal)
value due to the repayment and cost of borrowing
terms associated with them.
Fair-value estimation
The fair value of financial assets and financial
liabilities must be estimated for recognition and
measurement, or for disclosure purposes.
The face (or nominal) value less estimated credit
adjustments of trade receivables and payables
are assumed to approximate their fair values.
Hedge accounting
The Group designates certain derivatives
as hedging instruments. At the start of the
hedge relationship, the Group documents the
relationship between the hedging instrument and
the hedged item. Risk-management objectives
and strategies for undertaking hedge transactions
are documented. The Group also documents at
the start and on an ongoing basis whether the
hedging instrument is effective.
Interest-rate swaps
The Group enters into interest-rate swaps to
manage cash-flow interest-rate risk.
Interest-rate swaps are initially recognised
at fair value on the date a contract is entered
into and remeasured to their fair value at each
reporting date.
When Group swap arrangements meet the
requirements of cash-flow hedge accounting,
changes in the fair value of interest-rate swaps
are recognised in other comprehensive income,
and accumulated as a separate component
of equity.
Amounts deferred in equity are recycled in profit
or loss in the periods when the hedged item is
recognised in profit.
Hedges of a net investment
Hedges of a net investment in a foreign operation,
including a hedge of a monetary item that is
accounted for as part of the net investment,
are accounted for in two ways. Gains or losses
relating to the effective portion of the hedge are
recognised in other comprehensive income. Any
gains or losses relating to the ineffective portion
of the hedge are recognised in profit or loss.
k. Employee entitlements
A liability for benefits accruing to employees for
wages and salaries, annual leave, long-service
leave, and sick leave is accrued and recognised
in the balance sheet when it is probable that
settlement will be required, and the liabilities are
capable of being measured reliably. The liability is
equal to the present value of the estimated future
cash outflows as a result of employee services
provided at balance date.
l. Taxation
Income tax on the profit or loss for the year
comprises current and deferred tax. Income tax
is recognised in the income statement except
when it relates to items recognised in other
comprehensive income or directly in equity. In this
case, it is recognised in other comprehensive
income or in equity.
Current tax
Current tax is the expected tax payable on
the taxable income for the year, using tax
rates enacted or substantively enacted at the
balance-sheet date, and any adjustment to
tax payable for previous years. Current tax for
current and prior periods is recognised as a
liability (or asset) if it is unpaid (or refundable).
RYMAN HEALTHCARE
90
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
Deferred tax
Deferred tax is provided using the comprehensive
balance-sheet liability method. This method
provides for temporary differences between
the carrying amount of assets and liabilities for
financial reporting purposes and the amounts
used for taxation. Deferred tax is not provided
for on non-depreciating assets included
within property, plant and equipment, and
investment properties.
The amount of deferred tax provided is based
on the way the carrying amount of assets and
liabilities are expected to be realised and settled.
The tax rates used are those expected to apply
in the period of settlement, based on tax rates
enacted or substantively enacted.
A deferred tax asset is recognised only when it is
probable that future taxable profits will be available,
and against which the asset can be used. Deferred
tax assets are reduced if it is no longer probable
that the related tax benefit will be realised.
Deferred tax assets and liabilities are offset when
they relate to income taxes levied by the same
taxation authority and the Group intends to settle
current tax assets and liabilities on a net basis.
m. Treasury stock
Shares purchased on market under the leadership
share scheme are treated as treasury stock on
acquisition at cost. On vesting to the employee,
treasury stock shares are credited to equity and
an employee advance is recorded initially at fair
value and later at amortised cost.
Any loss on disposal by the Company (for
example, when the employee elects not to take
full responsibility for the loan or leaves before the
end of the 3-year restrictive period) accrues to
the Company and is taken directly against equity.
n. Consumables
Purchases of supplies by the villages are
expensed in the period they are incurred.
o. Maintenance costs
Maintenance costs are accounted for
in the period they are incurred.
p. GST
Revenues, expenses, assets, and liabilities are
recognised net of the amount of Goods and
Services Tax (GST) except when:
• the GST incurred on a purchase of goods
and services is not recoverable from the
taxation authority
• receivables and payables are stated with
the amount of GST included.
The net amount of GST recoverable from,
or payable to, the taxation authority is included
as part of the receivables or payables in the
balance sheet.
Commitments and contingencies are disclosed
net of the amount of GST recoverable from,
or payable to, the taxation authority.
q. Statement of cash flows
The statement of cash flows is prepared
exclusive of GST. This is consistent with the
method used in the income statement.
Cash and cash equivalents comprise:
• cash on hand and demand deposits
• other short-term, highly liquid investments.
Short-term, highly liquid investments are
investments that are readily convertible to a
known amount of cash and are subject to an
insignificant risk of changes in value. These
investments include all call borrowing such as
bank overdrafts used by the Group as part of
their day-to-day cash management.
ANNUAL REPORT 2019
91
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
Operating activities represent all transactions and
other events that are not investing or financing
activities and include receipts and repayments of
occupancy advances.
Investing activities are those activities relating
to the acquisition and disposal of investments
and any other property, plant and equipment,
or investment properties.
Financing activities are those activities relating to
changes in the equity and debt capital structure
of the Group and those activities relating to the
cost of servicing the Company’s equity capital.
All cash funds at balance date are applied against
term loans as per the bank facility.
r. Foreign currency translation
Functional and presentation currency
Both the functional and presentation currency of
Ryman Healthcare Limited and its New Zealand
subsidiaries is New Zealand dollars ($). The
functional currency for its Australian subsidiaries
is Australian dollars (AUD).
Transactions and balances
Transactions in foreign currencies are initially
recorded in the functional currency by applying
the exchange-rates ruling at the date of the
transaction. Monetary assets and liabilities
denominated in foreign currencies are
retranslated at the rate of exchange ruling at the
balance-sheet date.
All exchange differences relating to the following
two items are recognised in other comprehensive
income and accumulated in reserves.
• The effective portion of a hedge of a net
investment in foreign operations
• Differences arising on translation of a
foreign operation
• Non-monetary items that are measured
at historical cost in a foreign currency are
translated using the exchange rate at the date
of the initial transaction. Non-monetary items
carried at fair value that are denominated in
foreign currencies are retranslated at the rates
at the date when the fair value was determined.
s. Intangible assets
Expenditure on research activities is recognised
as an expense in the period in which it is incurred.
An internally generated intangible asset arising
from development (or from the development
phase of an internal project) is only recognised
if all of the following criteria have been
demonstrated.
• It is technically feasible to complete the
intangible asset so that it is available for use
or sale.
• The Group intends to complete the intangible
asset and use or sell it.
• The intangible asset can be used or sold.
• Probable future economic benefits of the
intangible asset can be generated.
• Adequate technical, financial, and other
resources are available to complete the
development and use or sell the intangible asset.
• The expenditure attributable to the intangible
asset can be measured during its development.
The amount initially recognised for internally
generated intangible assets is the sum of the
expenditure incurred from the date when the
intangible asset first meets the recognition criteria
listed above. Where no internally generated
intangible asset can be recognised, development
expenditure is recognised in profit or loss in the
period in which it is incurred.
RYMAN HEALTHCARE
92
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
After initial recognition, internally generated
intangible assets are reported at cost less
accumulated amortisation and accumulated
impairment losses, on the same basis as
intangible assets that are acquired separately.
t. Adopting new and amended standards
and interpretations
In the current year, the Group adopted all
mandatory new and amended standards and
interpretations. During the period, NZ IFRS 15
Revenue from Contracts with Customers and
NZ IFRS 9 Financial Instruments have been
adopted with no material impact on the
accounting policies or disclosures of the Group.
NZ IFRS 15 Revenue from Contracts with
Customers was effective for the Group from
1 April 2018. NZ IFRS 15 requires identification
of discrete performance obligations within a
transaction. An associated transaction price is
then allocated to these obligations. Revenue is
recognised on satisfaction of these performance
obligations. These occur when control of the
goods or services are transferred to the customer
and can be at a point in time or over time.
The application of NZ IFRS 15 has not resulted
in changes in revenue recognition.
NZ IFRS 9 Financial Instruments was effective
for the Group from 1 April 2018. There was no
material impact of the adoption and therefore
no prior period restatements were required as
a result of the adoption. No financial assets or
financial liabilities were reclassified because of
the application of NZ IFRS 9. However, there have
been some updates to the note disclosures in
the financial statements.
Outlined below are NZ IFRS Standards and
Interpretations that have recently been issued or
amended, but are not yet effective and have not
been adopted by the Group for the annual report
period ending 31 March 2019.
NZ IFRS 16 Leases – effective for the Group
for the period beginning 1 April 2019
The new standard introduces a single lessee
accounting model that brings all leases on balance
sheet except low-value or short-term leases.
The Group has assessed the impact of NZ IFRS 16.
Based on this assessment, the Group does not
expect any material impact on the financial
statements from adopting this standard.
The assessment has identified operating leases
that are currently off balance sheet that will
be brought on balance sheet under NZ IFRS 16
through the recognition of right-of-use assets and
associated liabilities. This recognition will result
in lease expenses being classified as finance
costs and amortisation, as opposed to only
operating costs.
The amount recognised on the balance sheet will
be based on the discounted value of the operating
lease commitments of approximately $8.9 million
at 31 March 2019 (see note 19).
The recognition exemptions allowed in NZ IFRS 16
for short-term leases or leases of low-value assets
will be applied. The expenses incurred for these
leases will continue to be recognised on a
straight-line basis in the income statement.
Rental and operating lease expenses previously
recognised within other operating expenses will
be recognised as amortisation for right-of-use
assets and finance costs for lease liabilities in the
income statement.
Operating lease payments previously classified
as cash flows from operating activities will be
reclassified as cash flows from financing activities
for principal repayments of the lease liability.
There will be no impact on actual cash payments.
For leases where the Group is the lessor there will
be no change to the recognition or measurement
on adoption of NZ IFRS 16.
ANNUAL REPORT 2019
93
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
1. OPERATING EXPENSES
20192018
$000$000
Employee costs (see below)212,514179,555
Property-related expenses38,91932,251
Other operating costs (see below)52,31256,234
Total operating expenses303,745268,040
Employee costs and other operating costs include:
Post-employment benefits (KiwiSaver/Superannuation) 5,4524,521
Auditor’s remuneration to Deloitte Limited comprises:
• Audit of financial statements
• Australia aged-care reporting
• IT and cyber-security assurance.
197
6
–
186
6
10
Directors’ fees (note 17)893828
Donations^386315
Lease and rental payments2,1981,577
^ No donations have been made to any political party (2018: $Nil).
2. DEPRECIATION AND AMORTISATION EXPENSE
20192018
$000$000
Depreciation
• Buildings6,9396,597
• Plant and equipment6,9895,7 76
• Furniture and fittings5,5105, 874
• Motor vehicles1,0861,020
20,52419,267
Amortisation
• Software2,6011,313
2,6011,313
Total2 3 ,1 2 520,580
RYMAN HEALTHCARE
94
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
3. FINANCE COSTS
20192018
$000$000
Total interest paid on bank loans47,4 2 236,427
Release of interest-rate swap reserve2,5402,851
Amount of interest capitalised (note 6)(31,003)(22 ,701)
Net interest expense on bank loans18,95916,577
4. INCOME TAX
20192018
$000$000
a. Income tax recognised in income statement
Tax expense comprises:
Current tax expense ––
Deferred tax expense 3,429640
Total income-tax expense3,429640
The income-tax expense on pre-tax accounting profit from operations
reconciles to the income-tax expense in the financial statements as follows.
Profit before income-tax expense329,415388,856
Income-tax expense calculated at 28%92,236108,880
Tax effect of:
Non-taxable income(82,015)(98,423)
Other(6,792)(9,817)
Total tax expense3,429640
Non-taxable income arises principally from the fair-value movement of investment property.
The tax rate used in the above reconciliation is the corporate tax rate of 28 percent (2018: 28 percent)
payable by New Zealand corporate entities on taxable profits under New Zealand tax law.
Total Group tax losses available in New Zealand amounted to $193.4 million (2018: $114.9 million).
Recognition of the deferred tax asset is based on expected taxable earnings in future periods.
There are no unrecognised tax losses in New Zealand (2018: $Nil).
Australian tax losses have not been recognised in the current year. Total tax losses available in
Australia amounted to $49.4 million (2018: $35.2 million).
ANNUAL REPORT 2019
95
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
4. INCOME TAX (CONTINUED)
20192018
%$000%$000
Reconciliation of effective tax rate
Profit before tax 329,415388,856
Income tax using the corporate tax rate 28.0%92,236 28.0%108,880
Non-taxable income (24.9)%(82,015) (25.3)%(98,423)
Other (2 .1)%(6,792) (2.5)%(9,817)
Total income-tax expense 1.0%3,429 0.2%640
b. Taxable and deductible temporary differences arise from the following items.
Opening
balance
Recognised
in income
Recognised
in equity
Closing
balance
$000$000$000$000
2019
Property, plant and equipment(52,465)(6,109)–(58,574)
Investment properties(4 4,670)(5,707)–(50,377)
Deferred management-fee revenue in advance(12,744)(14,155)–(26,899)
Interest-rate swap2,300–1,4513,751
Other3,710565–4,275
Tax value of loss carry-forwards recognised32,18321,977–54,160
Total deferred taxation(71,686)(3,429)1,451(73,664)
Opening
balance
Recognised
in income
Recognised
in equity
Closing
balance
$000$000$000$000
2018
Property, plant and equipment(46,958)(5,507)–(52,465)
Investment properties(40,740)(3,930)–(4 4,670)
Deferred management-fee revenue in advance(1,833)(10,911)–(12,744)
Interest-rate swap2,097–2032,300
Other3,083627–3,710
Tax value of loss carry-forwards recognised13,10219,081–32,183
Total deferred taxation(71,249)(640)203(71,686)
RYMAN HEALTHCARE
96
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
4. INCOME TAX (CONTINUED)
20192018
$000$000
c. Imputation credit memorandum account
Closing balance88108
Imputation credits available directly and indirectly to shareholders
of the parent company, through:
• parent company––
• subsidiaries.88108
Closing balance88108
5. TRADE AND OTHER RECEIVABLES
20192018
$000$000
Trade debtors 331,677 349,694
Other receivables13,1377,78 9
Total trade and other receivables344,8143 5 7, 4 8 3
Debtors are non-interest bearing, although the Group has the right to charge interest on overdue settlements
of occupancy advances or overdue care fees. Debtors principally comprise amounts due for occupancy
advances and care fees.
Occupancy advances are payable by residents on occupation of a retirement-village unit. Care fees are
received from residents (payable 4-weekly in advance) and various government agencies. Government-agency
payment terms vary, but are typically paid fortnightly in arrears for care services provided to residents.
There is no significant concentration of credit risk as trade debtors are either individual residents or
government agencies. Apart from the adoption of NZ IFRS 9, no changes have been made to the techniques
or significant assumptions used in determining expected credit losses during the reporting period.
ANNUAL REPORT 2019
97
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
6. PROPERTY, PLANT AND EQUIPMENT
Freehold
land at
valuation
Buildings at
valuation
Property
under
development
at cost
Plant and
equipment
at cost
Furniture
and fittings
at cost
Motor
vehicles
at costTotal
$000$000$000$000$000$000$000
2019
Gross carrying amount
Balance at 1 April 2018291,660335,144336,15166,7 7843,27410,0651,083,072
Additions–10,247174,18612,9631,7081,439200,543
Net foreign-currency exchange
difference(508)(199)(2,560)(18)(3)(1)(3,289)
Transfer from property under
development6,19025,790(36,733)2 ,4272,326––
Transfer from property under
development to investment property––(26,760)–––(26,760)
Revaluation24,456(11,500)––––12,956
Balance at 31 March 2019321,798359,482444,28482,15047,30511,5031,266,522
Accumulated depreciation
Balance at 1 April 2018–(6,662)–(23,771)(32,248)(5,877)(68,558)
Current-year depreciation–(6,939)–(6,989)(5,510)(1,086)(20,524)
Revaluation–11,500––––11,500
Balance at 31 March 2019–(2,101)–(30,760)(37,758)(6,963)(77,582)
Total book value321,798357,381444,28451,3909,5474,5401,188,940
2018
Gross carrying amount
Balance at 1 April 2017268,837251,776447,68950,28135,1319,2141,062,928
Additions1,21512,498130,2177,4 8 82,085854154,357
Net foreign-currency exchange
difference(837)(324)(4,7 75)(26)(15)(3)(5,980)
Transfer from property under
development22 ,44574,393(111,946)9,0356,073––
Transfer from property under
development to investment property––(125,034)–––(125,034)
Disposals–(3,199)––––(3,199)
Balance at 31 March 2018291,660335,144336,1516 6,7 7 843,27410,0651,083,072
Accumulated depreciation
Balance at 1 April 2017–(155)–(17,995)( 2 6 , 3 74 )(4,857)(49,381)
Current-year depreciation–(6,597)–(5,7 76)(5,874)(1,020)(19,267)
Disposals–90––––90
Balance at 31 March 2018–(6,662)–(23,771)(32,248)(5,877)(68,558)
Total book value291,660328,482336,15143,00711,0264,1881,014,514
RYMAN HEALTHCARE
98
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
6. PROPERTY, PLANT AND EQUIPMENT (CONTINUED)
All completed resthomes and hospitals included within the definition of freehold land and buildings were
revalued to fair value based on an independent valuation report prepared by registered valuers, CBRE Limited,
at 31 March 2019, in line with NZ IFRS 13. These revaluations are undertaken every 2 years, unless there is
sustained market evidence of a significant change in fair value.
To estimate and determine fair value, the valuer made key assumptions that include capitalisation of earnings
(using capitalisation rates ranging from 11 percent to 15 percent), together with observed transactional
evidence of the market value per care bed (ranging from $60,000 to $150,000 per care bed).
As the fair value of land and buildings is determined using inputs that are unobservable, the Group has
categorised property, plant and equipment as level 3 under the fair-value hierarchy in line with NZ IFRS 13
Fair Value Measurements.
The significant unobservable inputs used in the fair-value measurement of the Group’s freehold land and
buildings are the capitalisation rate and the market value per care bed.
A significant decrease in the capitalisation rate would result in a significantly higher fair-value
measurement. Conversely, a significant increase in the capitalisation rate would result in a significantly
lower fair-value measurement.
A significant increase in the market value per care bed would result in a significantly higher fair-value
measurement. Conversely, a significant decrease in the market value per care bed would result in a
significantly lower fair-value measurement.
Property under development includes land held pending the development of a retirement village amounting
to $327.2 million (2018: $258.7 million) and is valued at cost.
Interest for the Group of $31.0 million (2018: $22.7 million) has been capitalised during the period of
construction in the current year. The weighted-average capitalisation rate on funds borrowed is 3.89 percent
per annum (2018: 3.64 percent per annum).
The assets shown at cost are care-facility assets under development, plant and equipment, furniture and
fittings, and motor vehicles, plus additions since the last valuation.
The carrying amount at which each revalued class of property, plant and equipment would have been
carried had the assets been measured under historical cost is shown below.
Freehold land BuildingsTotal
$000$000$000
Carrying amount (at cost)
Carrying amount at 31 March 201981,062341,1154 2 2 ,1 7 7
Carrying amount (at cost)
Carrying amount at 31 March 201875,380312,216387,596
ANNUAL REPORT 2019
99
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
7. INVESTMENT PROPERTIES
20192018
$000$000
At fair value
Balance at beginning of financial year4,398,3043,661,445
Additions395,931391,221
Fair-value movement:
Realised fair-value movement:
• new retirement-village units87,86658,955
• existing retirement-village units.102,600107,233
190,466166,188
Unrealised fair-value movement102,444185,326
292,910351,514
Net foreign-currency exchange differences(5,538)(5,876)
Net movement for the year683,303736,859
Balance at end of financial year5,081,6074,398,304
The realised fair-value movement arises from the sale and resale of occupancy advances to residents.
Investment properties are not depreciated and are fair valued. As the fair value of investment property
is determined using inputs that are unobservable, the Group has categorised investment property as
level 3 under the fair-value hierarchy in line with NZ IFRS 13 Fair Value Measurements.
The carrying value of completed investment property is the fair value as determined by an independent
valuation report prepared by registered valuers CBRE Limited, at 31 March 2019. This report combines
discounted future cash flows and occupancy advances received from residents for retirement-village
units that are complete or nearing completion, for which there is an unconditional agreement to occupy.
The valuer used significant assumptions that include long-term house-price inflation (ranging from
0.5 percent to 3.5 percent nominal) (2018: 0.5 percent to 3.5 percent) and discount rate (ranging from
12 percent to 16 percent) (2018: 12 percent to 16 percent).
A 0.5 percent decrease in the discount rate would result in a $72.0 million higher fair-value measurement.
Conversely, a 0.5 percent increase in the discount rate would result in a $67.1 million lower fair-value
measurement.
A 0.5 percent decrease in the 5-year plus growth rate would result in a $114.1 million lower fair-value measurement.
Conversely, a 0.5 percent increase in the 5-year plus growth rate would result in a $121.2 million higher
fair-value measurement.
Other inputs used in the fair-value measurement of the Group’s investment property portfolio include the
average age of residents and the occupancy period.
A significant increase in the average age of entry of residents or the long-term nominal house-price inflation
rate would result in a significantly higher fair-value measurement. Conversely, a significant decrease in
the average age of entry of residents or the long-term nominal house-price inflation rate would result in a
significantly lower fair-value measurement.
RYMAN HEALTHCARE
100
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
7. INVESTMENT PROPERTIES (CONTINUED)
Investment property includes investment property work in progress of $325.1 million (2018: $252.9 million),
which has been valued at cost. For work in progress, cost represents fair value.
The CBRE valuation also includes within its forecast cash flows the Group’s expected costs relating to rebuild
works at Malvina Major. The estimate of the gross cash outflows included for remediation works is $6 million
over a remaining 6-month period (31 March 2018: $17.5 million over an 18-month period). The estimates are
based on currently available information.
Operating expenses
Direct operating expenses arising from investment property that generated income from management fees
during the period amounted to $5.1 million (2018: $4.8 million). All investment property generated income
from management fees during the period for the Group, except for investment property work in progress.
Security
Residents make interest-free advances (occupancy advances) to the retirement villages in exchange
for the right to occupy retirement-village units. Under the terms of the occupancy agreement, the resident
receives a unit title for life and a first mortgage over the residual interest for security purposes, or a first
mortgage is held over the individual title by the statutory supervisor.
8. BANK OVERDRAFT
The bank overdraft facilities are secured by a general security agreement and mortgages over the freehold
land and buildings of the Group in the same manner as the bank loans (note 11). The interest rate on all
overdraft facilities at 31 March 2019 was 10.05 percent (2018: 10.05 percent).
9. TRADE AND OTHER PAYABLES
20192018
$000$000
Trade payables55,28348,663
Other payables71,62649,645
Total trade and other payables126,90998,308
Trade payables are typically paid within 30 days of the invoice date or on the 20th of the month following the
invoice date. Other payables at 31 March 2019 includes $68.1 million (2018: $45.5 million) for the purchase of land.
10. EMPLOYEE ENTITLEMENTS
20192018
$000$000
Holiday-pay accrual and other benefits23,83420,237
ANNUAL REPORT 2019
101
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
11. BORROWINGS
20192018
$000$000
Bank loans (secured) – NZD1,063,342880,007
Bank loans (secured) – AUD in NZD260,661180,486
Total bank loans (secured) 1,324,0031,060,493
Less than 1 year4,34214,007
Within 1–5 years1,319,6611,046,486
Average interest rates – NZD 3.95% 3.72%
Average interest rates – AUD 3.69% 3.80%
The bank loans are secured by a general security agreement over the parent and subsidiary companies
and supported by first mortgages over the freehold land and buildings. Retirement-village unit titles provided
as security to residents are excluded (see note 7).
The subsidiary companies listed at note 22 have all provided guarantees for the Group’s secured loans
as parties to the general security agreement.
The average interest rates disclosed above exclude the impact of interest-rate swap agreements described
in note 18.
Full repayment terms are disclosed in note 18.
12. OCCUPANCY ADVANCES (NON-INTEREST BEARING)
20192018
$000$000
Gross occupancy advances (see below)3,203,8512,836,314
Less management fees and resident loans(376,161)(321,631)
Closing balance2,827,6902,514,683
Movement in gross occupancy advances
Opening balance2,836,3142,407,644
Plus net increases in occupancy advances:
• new retirement-village units290,701307,282
• existing retirement-village units.102,600107,233
Net foreign-currency exchange differences(3,408)(4,457)
(Decrease)/increase in occupancy advance receivables(22,356)18,612
Closing balance3,203,8512,836,314
Gross occupancy advances are non-interest bearing.
RYMAN HEALTHCARE
102
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
13. SHARE CAPITAL
Issued and paid-up capital consists of 500,000,000 fully paid ordinary shares (2018: 500,000,000) less
treasury stock of 2,577,272 shares (2018: 2,477,076 shares) (note 24). All shares rank equally in all respects.
Basic and diluted earnings and net tangible assets per share have been calculated on the basis of
500,000,000 ordinary shares (2018: 500,000,000 shares).
Shares purchased on market under the leadership share scheme (note 24) are treated as treasury stock
(note 14) until vesting to the employee.
14. RESERVES
20192018
$000$000
Asset revaluation reserve
Opening balance233,319233,319
Revaluation24,456–
Closing balance2 5 7,7 7 5233,319
Interest-rate swap reserve
Opening balance(5,913)(5,391)
Valuation of interest-rate swap(7,721)(3,576)
Released to income statement2,5402,851
Deferred tax movement on interest-rate swap reserve1,451203
Closing balance(9,643)(5,913)
Treasury stock
Opening balance(22,497)(20,540)
Acquisitions(11,990)(9,420)
Vesting /forfeiture of shares7,0 2 27,463
Closing balance( 2 7, 4 6 5 )(22,497)
Foreign currency translation reserve
Opening balance(2,243)1,066
Gain on hedge of foreign-owned subsidiary net assets1,3332,193
Loss on translation of foreign operations(4,966)(5,502)
Closing balance(5,876)(2,243)
Retained earnings
Opening balance1,704,5631,410,347
Net profit attributable to shareholders325,986388,216
Dividends paid(108,500)(94,000)
Closing balance1,922,0491,704,563
ANNUAL REPORT 2019
103
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
15. DIVIDENDS
2019201920182018
Cents
per share
Total
$000
Cents
per share
Total
$000
Recognised amounts
Final dividend paid – prior year10.9054,5009.3046,500
Interim dividend paid – current year10.8054,0009.5047,500
108,50094,000
Unrecognised amounts
Final dividend – current year11.9059,50010.9054,500
Full-year dividend – current year22 .70113,50020.40102,000
16. RELATED-PARTY TRANSACTIONS
Parent company
The parent entity in the Group is Ryman Healthcare Limited.
Equity interests in related parties
Details of the percentage of ordinary shares held in subsidiaries are disclosed in note 22.
Salaries and consulting fees paid to directors
Payments to directors are disclosed in note 17.
Transactions with companies associated to directors
20192018
$000$000
Rental expense 1791,089
In August 2012, Ryman Healthcare Limited entered into an office lease agreement with Airport Business Park
Christchurch Limited (the Airport Business Park).
Kevin Hickman has a significant financial interest in this agreement through a trust that is a shareholder
of the Airport Business Park. Mr Hickman is also a director of the Airport Business Park.
Kevin Hickman resigned as a director of Ryman Healthcare Limited on 1 June 2018. The rental expense
for the period to the date Kevin Hickman resigned was $178,879.
Warren Bell is a trustee of certain Airport Business Park shareholders, but has no personal financial interest.
RYMAN HEALTHCARE
104
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
17. KEY MANAGEMENT PERSONNEL COMPENSATION
20192018
$000$000
Compensation
Short-term employee benefits (senior executive team)4,4884,495
Salary to managing director (resigned June 2017)–844
Directors’ fees893828
Total key management personnel and directors’ compensation5,3816 ,1 6 7
Key management personnel are the senior executive team of the Group and include the chief executive
and six senior executive team members at 31 March 2019 (2018: chief executive and nine members
of the senior management team). The short-term employee benefits detailed above are those of the
seven members of the senior executive team in place at 31 March 2019 (2018: chief executive and
nine members of the senior management team).
In addition, NZ IAS 24 Related Party Disclosures requires directors’ fees to be included within key
management personnel compensation. All directors are non-executive and are not involved in the
day-to-day operations of the Group (2018: all directors). Directors’ fees above exclude remuneration
paid to the managing director in 2018.
Post-employment benefits (KiwiSaver/Superannuation) employer contributions included in short-term
employee benefits (senior executive team) above is $112,455 (2018: $110,881 senior management team
and included in salary to managing director in 2018: $62,909).
In addition, the Company provides certain senior employees with limited recourse loans on an interest-free
basis to support employees’ participation in the leadership share scheme (note 24).
Simon Challies, the managing director, resigned with effect from 30 June 2017. The salary and bonuses
paid to the outgoing managing director during the period to 30 June 2017 totalled $0.84 million.
This was made up of salary $0.19 million, annual leave $0.26 million, short-term incentives $0.33 million,
and KiwiSaver $0.06 million. During the year to 31 March 2018, in addition to the compensation detailed
above, Simon Challies received additional payments totalling $1.32 million following his resignation,
including in his role as an advisor to the board.
ANNUAL REPORT 2019
105
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
18. FINANCIAL INSTRUMENTS
The financial instruments consist of cash and cash equivalents, trade and other receivables, trade and other
payables, occupancy advances, refundable accommodation deposits, employee advances, loans, overdrafts,
and interest-rate swaps.
Categories of financial instruments
20192018
$000$000
Financial assets
Financial assets at amortised cost (loans and receivables)352,966363,319
352,966363,319
Financial liabilities
Amortised cost4,312,6153,704,241
Derivative instruments in designated hedge accounting relationships
(interest-rate swaps)13,3938,212
4,326,0083,712,453
a. Credit risk management
Credit risk is the risk of the failure of a debtor or counterparty to honour its contractual obligation resulting
in financial loss to the Group.
Financial assets, which potentially subject the Group to credit risk, consist principally of cash and
cash equivalents, trade and other receivables, and advances to employees. The maximum credit risk
at 31 March 2019 is the fair value of these assets. The Group’s cash equivalents are placed with high-credit,
quality financial institutions. The Group does not require collateral from its debtors.
The directors consider the Group’s exposure to any concentration of credit risk to be minimal,
given that (typically):
• the occupation of a retirement-village unit does not take place until an occupation advance has
been received
• care fees are payable 4-weekly in advance when due from residents
• care fees not due from residents are paid by government agencies.
The total credit risk to the Group at 31 March 2019 was $353.0 million (2018: $363.3 million) and there
were no material overdue debtors at 31 March 2019 (2018: $Nil). The composition of financial assets
is shown in the table below.
20192018
$000$000
Trade and other receivables (note 5)344,8143 57,4 8 3
Advances to employees (note 24)8,1525,836
352,966363,319
RYMAN HEALTHCARE
106
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
18. FINANCIAL INSTRUMENTS (CONTINUED)
b. Interest-rate risk
The interest rate applicable to the bank overdraft is variable. The interest rates applicable to the bank
loans are reviewed at each 3-monthly rollover. The Group seeks to obtain the most competitive interest
rate at all times.
The Group has entered into an interest-rate swap agreement to provide an effective cash-flow hedge
against floating interest-rate variability on a defined portion of core Group debt.
These interest-rate swaps qualify for cash-flow hedge accounting. Interest-rate swaps are initially
recognised at fair value on the date a contract is entered into and remeasured to their fair value at each
reporting date. The effective portion of the change in the fair value of the swaps is recognised in other
comprehensive income and accumulated as a separate component of equity. The ineffective portion is
recognised in the income statement.
The hedge ratio is 1:1. The face value of the interest-rate swaps is the same value as the face value of the
bank loans. As the critical terms of the interest-rate swap contracts and the hedged item are the same,
significant hedge ineffectiveness is not expected.
At 31 March 2019, the Group had several interest-rate swaps in place, which are set out in the table below.
The agreement effectively changes the Group’s interest-rate exposure on the principal of $250 million
(2018: $120 million) from a floating rate to a fixed rate of 3.145 percent (2018: 4.260 percent).
The fair value of the swaps at 31 March 2019 was a liability of $13.4 million (2018: liability of $8.2 million).
The interest-rate swaps cover notional debt amounts for a term of 5 years at a composite interest rate
of 3.145 percent (2018: 4.260 percent).
No interest-rate swaps have been taken out for the Australian dollar borrowings.
The balance of the interest-rate swap reserve is expected to be released to the income statement over
the maturity profile of the underlying debt as detailed in the table below. At the end of the reporting period,
the fair value of interest-rate swaps is determined by discounting the future cash flows using the yield
curves at the end of the reporting period and the credit risk inherent in the contract.
The notional amortising principal amounts and remaining terms of interest-rate swap contracts
outstanding at 31 March are shown below.
Cash-flow hedges
Average contracted fixed-interest rateNotional principal amount
2019201820192018
%%$000$000
Outstanding
Less than 1 year3.145%4.260%180,000120,000
1–2 years3.145%4.260%180,000110,000
2–3 years3.145%4.260%250,000110,000
3–4 years3.145%4.260%200,00090,000
4–5 years3.145%4.260%150,00090,000
ANNUAL REPORT 2019
107
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
18. FINANCIAL INSTRUMENTS (CONTINUED)
c. Liquidity risk
Liquidity risk is the risk that the Group will not be able to meet its financial obligations as they fall due
without incurring unacceptable losses or risking reputational damage. The Group manages liquidity to
ensure that it has sufficient liquidity to meet its liabilities when due. This includes under both normal
and stressed conditions.
The Group manages the liquidity risk on occupancy advances through the contractual requirements
in the occupation agreement.
Following termination of the agreement, in New Zealand the occupancy advance is repaid at the earlier of:
• receipt of the new occupancy advance from the incoming resident
• at the end of 3 years.
Following termination of the agreement, in Australia the occupancy advance is repaid at the earlier of:
• 14 days after a new resident takes up residence
• receipt of the new occupancy advance from the incoming resident
• at the end of 6 months.
Ultimate responsibility for liquidity risk management rests with the directors, who have built an appropriate
liquidity risk management framework for the management of the Group’s short, medium, and long-term
funding and liquidity management requirements.
The Group manages liquidity risk by maintaining adequate reserves, banking facilities, and reserve
borrowing facilities, and by regularly monitoring forecast and actual cash flows and the maturity profiles
of financial assets and liabilities.
At balance date, the Group had NZD $314.1 million (2018: NZD $239.5 million) and AUD $30.5 million
(2018: AUD $Nil) of undrawn facilities at its disposal to further reduce liquidity risk.
RYMAN HEALTHCARE
108
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
18. FINANCIAL INSTRUMENTS (CONTINUED)
Maturity profile
The following table details the Group’s exposure to liquidity risk (including contractual interest obligations
for bank loans).
Contractual maturity dates
20192018
On
demand
Less
than
1 year
Greater
than
1 yearTotal
On
demand
Less
than
1 year
Greater
than
1 yearTotal
$000$000$000$000$000$000$000$000
Financial liabilities:
Trade and other payables–126,909–126,909–98,308–98,308
Interest-rate swaps–13,393–13,393–8,212–8,212
Refundable
accommodation deposits34,013––34,01330,757––30,757
Bank loans (secured)–9,4501,319,6611,329,111–23,3581,046,4871,069,845
Occupancy advances
(non-interest bearing)–348,0862,479,6042,827,690–315,4602,199,2232 ,514,683
34,013497,8383,799,2654,331,1163 0,757445,3383 , 24 5,7 1 03,721,805
Gross occupancy advances and refundable accommodation deposits are non-interest bearing.
The above figures have been calculated on the anticipated level of occupancy advance repayments based on
historical experience. To date, new occupancy advances received have always exceeded repaid occupancy
advances (net of management fees), and represent a positive net operating cash flow to the Group.
The Group maintains the following lines of credit.
• $2.8 million (2018: $2.8 million) overdraft facility that is secured. Interest would be payable at the
3-month BKBM rate, plus a specified margin (note 8).
• Bank debt facilities of the Group total approximately $1.7 billion (2018: $1.3 billion) made up as follows.
–An NZD loan facility of $1.46 billion (2018: $1.3 billion), of which 35.0 million (2018: $35.0 million) is for
1 year, $521.25 million (2018: $316.25 million) is for 3 years, $485.3 million (2018: $632.5 million) is for
4 years, and $416.25 million (2018: $316.25 million) is for 5 years.
–An AUD loan facility of AUD$220 million (2018: AUD$Nil), of which AUD$220.0 million (2018: AUD$Nil)
is for 4 years.
–In 2019, the NZD loan facility of $1.46 billion is provided by ANZ Bank New Zealand Ltd ($350.0 million),
Commonwealth Bank of Australia ($274.9 million), Bank of New Zealand / National Australia Bank
($320.5 million), Westpac ($237.4 million), MUFG ($175.0 million), and Bank of China ($100.0 million)
under the terms of a syndicated loan agreement. The facility allows for the funds to be drawn down in
NZD up to the $1.46 billion NZD limit.
ANNUAL REPORT 2019
109
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
18. FINANCIAL INSTRUMENTS (CONTINUED)
–In 2019, the AUD loan facility of AUD$220 million is provided by ANZ Bank New Zealand Ltd
(AUD$100.0 million), Commonwealth Bank of Australia (AUD$42.5 million), Bank of New Zealand/
National Australia Bank (AUD$42.0 million), and Westpac (AUD$35.5 million) under the terms of a
syndicated loan agreement.
–In 2018, the NZD loan facility of $1.3 billion was provided by ANZ Bank New Zealand Ltd ($315.0 million),
Commonwealth Bank of Australia ($305.0 million), Bank of New Zealand / National Australia Bank
($300.0 million), Westpac ($255.0 million), and MUFG ($125.0 million) under the terms of a
syndicated loan agreement.
–In 2018, our AUD borrowing was part of a facility which allowed us to draw down in either AUD or NZD,
up to the $1.3 billion NZD limit.
The Group renews its facilities annually to ensure an appropriate portion matures on a rolling 1, 3, 4, and
5-year basis.
d. Fair values
The carrying amounts of financial instruments in the Group’s balance sheet are the same as their fair value
in all material aspects, due to the demand features of these instruments and/or their interest-rate profiles.
The fair value of interest-rate swaps is derived using inputs supplied by third parties that are observable,
either directly (prices) or indirectly (derived from prices). The Group has therefore categorised these
liabilities as level 2 under the fair-value hierarchy contained within NZ IFRS 13.
e. Market risk
The Group is primarily exposed to interest-rate risk (note 18 (b)) and foreign-currency risk (note 18 (f)).
Based on the Group’s average net level of interest-bearing debt, the Group’s profit and total
comprehensive income for the year ended 31 March 2019 would not change materially if there
was a movement of plus/(minus) 50 basis points.
f. Foreign-currency risk
Foreign-currency risk is the risk that the value of the Group’s assets, liabilities, and financial performance
will fluctuate due to changes in foreign-currency rates.
The Group is primarily exposed to currency risk as a result of its subsidiaries in Australia.
The risk to the Group is that the value of the overseas subsidiaries’ financial position and financial
performance will fluctuate in economic terms and, as recorded in the consolidated accounts,
due to changes in the overseas exchange rates.
The Group’s profit and total comprehensive income for the year ended 31 March 2019 would not
change materially by a movement of plus/(minus) 1 cent in AUD/NZD.
The Group hedges the currency risk relating to its Australian subsidiaries by holding a portion of
its bank borrowings in Australian dollars. Any foreign-currency movement in the net assets of the
Australian subsidiary is partially offset by an opposite movement in the Australian dollar debt.
RYMAN HEALTHCARE
110
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
18. FINANCIAL INSTRUMENTS (CONTINUED)
g. Capital management
The Group’s capital includes share capital, reserves, and retained earnings. The objective of the Group’s
capital management is to ensure a strong credit rating to support business growth and maximise
shareholder value.
The Group’s capital is managed at parent-company level. The Group is subject to capital requirements
imposed by its bank through covenants agreed as part of the lending facility arrangements. The Group has
met all externally imposed capital requirements for the 12 months ended 31 March 2019 and 31 March 2018.
The Group’s capital structure is managed, and adjustments are made with board approval to the structure,
in light of economic conditions at the time. There were no changes to objectives, policies, or processes
during the year.
19. COMMITMENTS
Capital expenditure commitments
The Group had commitments relating to construction contracts amounting to $127.3 million at 31 March 2019
(2018: $101.2 million).
Operating lease and other commitments
Operating lease expenditure committed to, but not recognised, in the financial statements relating to
property rental.
20192018
$000$000
Commitments:
less than 1 year1,8581,445
between 1 and 5 years6,7282,271
more than 5 years315187
8,9013,903
The Group has an ongoing commitment for maintaining the land and buildings of the integrated retirement
villages, resthomes, and hospitals.
20. CONTINGENT LIABILITIES
The Group had no contingent liabilities at 31 March 2019 (2018: $Nil).
ANNUAL REPORT 2019
111
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
21. RECONCILIATION OF NET PROFIT AFTER TAX WITH NET CASH FLOW
FROM OPERATING ACTIVITIES
20192018
$000$000
Net profit after tax325,986388,216
Adjusted for:
Movements in balance-sheet items
Occupancy advances367,538428,670
Accrued management fees(54,652)(51,571)
Refundable accommodation deposits3,2562,284
Revenue in advance5,8907, 2 5 3
Trade and other payables2,165(2,402)
Trade and other receivables12,669(100,869)
Employee entitlements3,5974,070
Non-cash items:
Depreciation and amortisation23,12520,580
Deferred tax3,429640
Unrealised foreign-exchange loss1,3323,900
Adjusted for:
Fair-value movement of investment properties(292,910)(351,514)
Net operating cash flows401,425349,257
Net operating cash flows includes occupancy advance receipts from retirement-village residents
of $703.6 million (2018: $603.7 million).
Also included in operating cash flows are net receipts from refundable accommodation deposits
of $3.8 million (2018: $3.1 million).
Net operating cash flows also includes management fees collected of $39.0 million (2018: $34.7 million).
RYMAN HEALTHCARE
112
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
22. SUBSIDIARY COMPANIES
All trading subsidiaries operate in the aged-care sector in New Zealand and Australia, are 100 percent owned,
and have a balance date of 31 March. The operating subsidiaries are listed below.
• Anthony Wilding Retirement Village Limited
• Bert Sutcliffe Retirement Village Limited
• Bob Owens Retirement Village Limited
• Bob Scott Retirement Village Limited
• Bruce McLaren Retirement Village Limited
• Charles Fleming Retirement Village Limited
• Charles Upham Retirement Village Limited
• Diana Isaac Retirement Village Limited
• Edmund Hillary Retirement Village Limited
• Ernest Rutherford Retirement Village Limited
• Essie Summers Retirement Village Limited
• Evelyn Page Retirement Village Limited
• Frances Hodgkins Retirement Village Limited
• Grace Joel Retirement Village Limited
• Hilda Ross Retirement Village Limited
• Jane Mander Retirement Village Limited
• Jane Winstone Retirement Village Limited
• Jean Sandel Retirement Village Limited
• Julia Wallace Retirement Village Limited
• Kiri Te Kanawa Retirement Village Limited
• Linda Jones Retirement Village Limited
• Logan Campbell Retirement Village Limited
• Malvina Major Retirement Village Limited
• Margaret Stoddart Retirement Village Limited
• Murray Halberg Retirement Village Limited
• Nellie Melba Retirement Village Pty Limited
• Ngaio Marsh Retirement Village Limited
• Possum Bourne Retirement Village Limited
• Rita Angus Retirement Village Limited
• Rowena Jackson Retirement Village Limited
• Ryman Aged Care (Australia) Pty Limited
• Ryman Healthcare (Australia) Pty Limited
• Ryman Napier Limited
• Shona McFarlane Retirement Village Limited
• Weary Dunlop Retirement Village Pty Limited
• William Sanders Retirement Village Limited
• Yvette Williams Retirement Village Limited
23. SEGMENT INFORMATION
Products and services from which reportable segments derive their revenue
The Ryman Group operates in one industry, being the provision of integrated retirement villages for
older people in New Zealand and Australia. The service provision process for each of the villages is similar,
and the class of customer and methods of distribution and regulatory environment is consistent across
all of the villages.
Segment revenues and results
The accounting policies of the reportable segment are the same as the Group’s accounting policies.
The segment profit represents profit earned for the segment after all costs, including all administration costs,
directors’ fees, interest revenue, finance costs, and income-tax expense.
The board makes resource allocation decisions to the segment, based on the expected cash flows and
results of Group operations as a whole. No operations were discontinued during the year. To monitor segment
performance and allocate resources to the segment, the board monitors assets attributable to the segment.
All assets are allocated to the reportable segment.
ANNUAL REPORT 2019
113
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
23. SEGMENT INFORMATION (CONTINUED)
Information about major customers
Included in total revenue are revenues that arose from sales to the Group’s largest customers.
The Group derives care-fee revenue for eligible government-subsidised, aged-care residents who
receive resthome, hospital, or dementia-level care. The government aged-care subsidies received from
the Ministry of Health included in group care fees amounted to $109.3 million (2018: $96.7 million).
There are no other significant customers.
Geographical information
The Group operates in New Zealand and Australia.
In presenting information on the basis of geographical areas, net profit, underlying profit, and revenue are
based on the geographical location of operations. Assets are based on the geographical location of the assets.
New ZealandAustraliaGroup
$000$000$000
Year ended 31 March 2019
Revenue358,52422,970381,494
Underlying profit (non-GAAP)189,90337,068226,971
less deferred tax expense (note 4)(3,429)–(3,429)
plus unrealised fair-value movement (note 7)90,16712,277102,444
Profit for the year276,64149,345325,986
Non-current assets5,598,182700,3336,298,515
Year ended 31 March 2018
Revenue324,67217,867342,539
Underlying profit (non-GAAP)184,81318,717203,530
less deferred tax expense (note 4)(640)–(640)
plus unrealised fair-value movement (note 7)179,1646,162185,326
Profit for the year363,33724,879388,216
Non-current assets4,939,996493,5355,433,531
Underlying profit is a non-GAAP (Generally Accepted Accounting Principles) measure and differs from
NZ IFRS profit for the period. Underlying profit does not have a standardised meaning prescribed by GAAP
and so may not be comparable to similar financial information presented by other entities. The group uses
underlying profit, with other measures, to measure performance. Underlying profit is a measure that the Group
uses consistently across reporting periods.
Underlying profit excludes deferred taxation, taxation expense, and unrealised gains on investment properties
because these items do not reflect the trading performance of the Company. Underlying profit determines the
dividend payout to shareholders.
RYMAN HEALTHCARE
114
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
24. EMPLOYEE SHARE SCHEMES
Leadership share scheme
The Group operates an employee share scheme for certain senior employees, other than non-executive
directors, to purchase ordinary shares in the Company.
The Group provides the employees with limited recourse loans on an interest-free basis to support
employees’ participation in the scheme. These shares are treated as treasury stock when purchased
on market, due to the features of the scheme.
The loans are applied to the purchase of shares on market, so the number of shares and the consideration
for each share is determined by the market price at that time. The scheme holds 2,577,272 fully allocated
shares, which represents 0.52 percent of the total shares on issue (2018: 2,477,076 fully allocated shares,
which represented 0.50 percent of the total shares on issue).
Shares purchased under the scheme are held by two directors as custodians, and the shares carry the same
rights as all other ordinary shares. The loan is repayable if the employee is no longer employed by the Group.
The following table reconciles the shares purchased on market under the scheme at the beginning and end
of the financial year.
20192018
Number
of shares
Number
of shares
Balance at beginning of the financial year2 ,47 7,0762,320,851
Purchased on market during the year922,1271,008,945
Forfeited during the financial year(112,977)(334,773)
Vested during the financial year(708,954)(517,947)
Balance at end of the financial year2 , 5 7 7, 2 7 22 , 47 7,0 7 6
Shares were purchased under the scheme in August 2018 at a price of $12.98 per share. Remaining shares
held by the scheme were purchased in August 2017 ($9.32) and July 2016 ($9.55).
Shares vested in August 2018 were originally purchased at $8.29 per share in 2015 and are now held directly by
employees. The amounts owed by employees in these vested shares are included within advances to employees.
This balance includes $4,390,591 owing by management personnel in the share scheme (2018: $4,176,836).
The directors estimate the fair value of each employee advance granted at the time of the purchase of shares
on market, on behalf of the selected employee. Due to the on-market purchase and sale features of the
scheme, and the scheme agreement arrangements, the directors consider any such value to be immaterial.
Shares subject to this scheme vest 3 years from the date of purchase.
ANNUAL REPORT 2019
115
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2019
24. EMPLOYEE SHARE SCHEMES (CONTINUED)
All staff employee share scheme
In addition, the Group operates a share scheme that is available to all staff.
Participants in this scheme contribute a minimum of $500 (and up to a maximum amount of $10,000)
towards the on-market purchase of Ryman Healthcare Limited shares. To help the staff member purchase
more shares, the Group advanced an interest-free loan equal to the employee’s contribution towards the
share purchase (financial assistance).
The loan is repayable when the staff member leaves the Group. Shares purchased under the scheme
are held in the employee’s name. The financial assistance provided by the Group is recorded in advances
to employees.
25. SUBSEQUENT EVENTS
The directors resolved to pay a final dividend of 11.90 cents per share or $59.5 million, with no imputation
credits attached, to be paid on 21 June 2019.
26. AUTHORISATION
The directors authorised the issue of these financial statements on 23 May 2019.
Warren Bell Dr David Kerr
Non-Executive Director Chair
and Chair of Audit and
Financial Risk Committee
RYMAN HEALTHCARE
116
ANNUAL REPORT 2019
117
118
Independent Auditor’s Report
To the shareholders of Ryman Healthcare Limited
Opinion We have audited the consolidated financial statements of Ryman Healthcare Limited and its
subsidiaries (the Group). The statements comprise the consolidated balance sheet at
31 March 2019, and the consolidated income statement, statement of comprehensive
income, statement of changes in equity and statement of cash flows for the year then ended,
and notes to the consolidated financial statements, including a summary of significant
accounting policies.
In our opinion, the accompanying consolidated financial statements, on pages 80 to 116,
present fairly, in all material respects, the consolidated financial position of the Group at 31
March 2019, and its consolidated financial performance and cash flows for the year then
ended, in accordance with New Zealand Equivalents to International Financial Reporting
Standards (NZ IFRS) and International Financial Reporting Standards (IFRS).
Basis for opinion We conducted our audit in accordance with the International Standards on Auditing (ISAs)
and International Standards on Auditing (New Zealand) (ISAs (NZ)). Our responsibilities
under those standards are further described in the Auditor’s Responsibilities for the Audit of
the Consolidated Financial Statements section of our report.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide
a basis for our opinion.
We are independent of the Group as required by Professional and Ethical Standard 1
(Revised) Code of Ethics for Assurance Practitioners issued by the New Zealand Auditing and
Assurance Standards Board and the International Ethics Standards Board for Accountants’
Code of Ethics for Professional Accountants, and we have fulfilled our other ethical
responsibilities under these requirements.
Our firm carries out other assignments for the Group relating to Australian aged care. These
services have not impaired our independence as auditor of the Company and Group.
In addition to this, partners and employees of our firm deal with the Company and its
subsidiaries on normal terms within the ordinary course of trading activities of the business
of the Company and its subsidiaries. The firm has no other relationship with, or interest in,
the Company or any of its subsidiaries.
Audit materiality
We consider materiality primarily in terms of the magnitude of misstatement in the financial
statements of the Group that in our judgement would make it probable that the economic
decisions of a reasonably knowledgeable person would be changed or influenced (the
quantitative materiality).
We also assess whether other matters that come to our attention during the audit would in
our judgement change or influence the decisions of such a person (the qualitative
materiality). We use materiality both in planning the scope of our audit work and in
evaluating the results of our work.
We determined materiality for the consolidated financial statements to be $16.4m.
Key audit matters Key audit matters are those matters that, in our professional judgement, were of most
significance in our audit of the consolidated financial statements of the current period. These
matters were addressed in the context of our audit of the consolidated financial statements
as a whole, and in forming our opinion. We do not provide a separate opinion on these
matters.
118
Independent Auditor’s Report
To the shareholders of Ryman Healthcare Limited
Opinion We have audited the consolidated financial statements of Ryman Healthcare Limited and its
subsidiaries (the Group). The statements comprise the consolidated balance sheet at
31 March 2019, and the consolidated income statement, statement of comprehensive
income, statement of changes in equity and statement of cash flows for the year then ended,
and notes to the consolidated financial statements, including a summary of significant
accounting policies.
In our opinion, the accompanying consolidated financial statements, on pages 80 to 116,
present fairly, in all material respects, the consolidated fi nancial position of the Group at 31
March 2019, and its consolidated financial performance and cash flows for the year then
ended, in accordance with New Zealand Equivalents to International Financial Reporting
Standards (NZ IFRS) and International Financial Reporting Standards (IFRS).
Basis for opinion We conducted our audit in accordance with the International Standards on Auditing (ISAs)
and International Standards on Auditing (New Zealand) (ISAs (NZ)). Our responsibilities
under those standards are further described in the Auditor’s Responsibilities for the Audit of
the Consolidated Financial Statements section of our report.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide
a basis for our opinion.
We are independent of the Group as required by Professional and Ethical Standard 1
(Revised) Code of Ethics for Assurance Practitioners issued by the New Zealand Auditing and
Assurance Standards Board and the International Ethics Standards Board for Accountants’
Code of Ethics for Professional Accountants, and we have fulfilled our other ethical
responsibilities under these requirements.
Our firm carries out other assignments for the Group relating to Australian aged care. These
services have not impaired our independence as auditor of the Company and Group.
In addition to this, partners and employees of our firm deal with the Company and its
subsidiaries on normal terms within the ordinary course of trading activities of the business
of the Company and its subsidiaries. The firm has no other relationship with, or interest in,
the Company or any of its subsidiaries.
Audit materiality
We consider materiality primarily in terms of the magnitude of misstatement in the financial
statements of the Group that in our judgement would make it probable that the economic
decisions of a reasonably knowledgeable person would be changed or influenced (the
quantitative materiality).
We also assess whether other matters that come to our attention during the audit would in
our judgement change or influence the decisions of such a person (the qualitative
materiality). We use materiality both in planning the scope of our audit work and in
evaluating the results of our work.
We determined materiality for the consolidated financial statements to be $16.4m.
Key audit matters Key audit matters are those matters that, in our professional judgement, were of most
significance in our audit of the consolidated financial statements of the current period. These
matters were addressed in the context of our audit of the consolidated financial statements
as a whole, and in forming our opinion. We do not provide a separate opinion on these
matters.
RYMAN HEALTHCARE
118
119
Valuation of investment properties How our audit addressed the key audit matter
As explained in policy (e) and note 7 in the consolidated
financial statements, investment properties are carried at
fair value on the balance sheet.
The fair value was
determined by independent registered valuers appointed
by the Group.
These properties were valued at $5,081m (2018:
$4,398m). The revaluation gain recognised in the income
statement was $293m (2018: $352m).
We included the valuation of investment properties as a key
audit matter for two reasons.
1. The significance to the financial statements:
the investment properties account for 76% of the total
assets (2018: 76%), mak
ing it the most significant
balance on the balance sheet.
2. The complexity of the valuation model:
t
he valuation model relies on various estimates and
underlying assumptions. It combines discounted future
cash flows and occupancy advances received from
residents. It uses significant assumptions, including
long-term house-price inflation and discount rates. The
valuation model also uses inputs for the average age
of residents.
Our procedures focused on:
the appropriateness of the valuation methodology
the accuracy of the underlying data used for the
valuation
the reasonableness of underlying assumptions in the
valuation model.
Our procedures included, amongst others:
evaluating the Group’s processes for the independent
valuation of the investment properties
reviewing the valuation methodology and the
reasonableness of the significant underlying
assumptions
assessing the competence, objectivity, and integrity
of the independent registered valuers. We assessed
their professional qualifications and experience. We
also obtained representation from them about their
independence and the scope of their work
meeting with the valuer to understand the valuation
process adopted. The purpose of the meeting was to
identify and challenge the critical judgement areas in
the valuation model and to confirm the valuation
approach was in accordance with NZ IFRS 13 Fair
Value Measurement
using our in-house valuation specialists to assess the
appropriateness of the valuation methodology and
challenge the reasonableness of the underlying
assumptions. Our specialists focused on the
assumptions for long-term house-price inflation and
discount rates applied
agreeing a sample of sales and resales to contracts,
recalculating actual growth rates on resales, and
recalculating the average age of residents based on a
sample of contracts
assessing the discount rates for reasonableness by
comparing the rates to those adopted in the previous
year and adjusting it for expected changes and the
rates adopted by comparable entities.
ANNUAL REPORT 2019
119
120
Valuation of care-facility land and buildings How our audit addressed the key audit matter
As explained in policy (d) and note 6 in the consolidated
financial statements, care-facility land and buildings are
carried at their fair value at the date of revaluation less any
subsequent accumulated depreciation and impairment
losses.
The fair value was determined by independent registered
valuers appointed by the Group.
The net book value of care-facility land and buildings was
$679m (2018: $620m). The revaluation gain recognised in
other comprehensive income was $24m (2018: $nil).
We included the valuation of care-facility land and buildings
as a key audit matter for two reasons.
1. The materiality of the revaluation gains.
2. The complexity of the valuation model:
the valuation model includes both observable and non-
observable inputs. It uses significant assumptions,
including the determination of the earnings that were
capitalised, the capitalisation rates adopted, and the
assessment of the market value per care bed. These
inputs require significant judgement.
Our procedures focused on:
• the appropriateness of the valuation methodology
• the accuracy of the underlying data used for the
valuation
• the reasonableness of underlying assumptions in
the valuation model.
Our procedures included, amongst others:
• evaluating the Group’s processes regarding the
independent valuation
• reviewing the valuation methodology and the
reasonableness of the significant valuation
assumptions
• assessing the competence, objectivity, and
integrity of the independent registered valuers.
We assessed their professional qualifications and
experience. We also obtained representation from
them about their independence and the scope of
their work
• meeting with the valuer to understand the
valuation process adopted. The purpose of the
meeting was to identify and challenge the critical
judgement areas in the valuation model and to
confirm the valuation approach was in accordance
with NZ IFRS 13 Fair Value Measurement
• using our in-house valuation specialists to assess
the appropriateness of the valuation methodology
and challenge the reasonableness of the underlying
assumptions. Our specialists focused on the
assumptions for earnings capitalisation rates and
the market value per care bed
• agreeing, on a sample basis, the earnings
capitalised to the underlying accounting records and
challenging the valuers on the adjustments made to
actual earnings in deriving at the earnings used in
the valuation
• assessing the reasonableness of the capitalisation
rates and market value per care bed adopted in the
valuation.
120
Valuation of care-facility land and buildings How our audit addressed the key audit matter
As explained in policy (d) and note 6 in the consolidated
financial statements, care-facility land and buildings are
carried at their fair value at the date of revaluation less any
subsequent accumulated depreciation and impairment
losses.
The fair value was determined by independent registered
valuers appointed by the Group.
The net book value of care-facility land and buildings was
$679m (2018: $620m). The revaluation gain recognised in
other comprehensive income was $24m (2018: $nil).
We included the valuation of care-facility land and buildings
as a key audit matter for two reasons.
1. The materiality of the revaluation gains.
2. The complexity of the valuation model:
the valuation model includes both observable and non-
observable inputs. It uses significant assumptions,
including the determination of the earnings that were
capitalised, the capitalisation rates adopted, and the
assessment of the market value per care bed. These
inputs require significant judgement.
Our procedures focused on:
• the appropriateness of the valuation methodology
• the accuracy of the underlying data used for the
valuation
• the reasonableness
of underlying assumptions in
the valuation model.
Our procedures included, amongst others:
• evaluating the Group’s processes regarding the
independent valuation
• reviewing the valuation methodology and the
reasonableness of the significant valuation
assumptions
• assessing the competence, objectivity, and
integrity of the independent registered valuers.
We assessed their professional qualifications and
experience. We also obtained representation from
them about their independence and the scope of
their work
• meeting with the valuer to understand the
valuation process adopted. The purpose of the
meeting was to identify and challenge the critical
judgement areas in the valuation model and to
confirm the valuation approach was in accordance
with NZ IFRS 13 Fair Value Measurement
• using our in-house valuation specialists to assess
the appropriateness of the valuation methodology
and challenge the reasonableness of the underlying
assumptions. Our specialists focused on the
assumptions for earnings capitalisation rates and
the market value per care bed
• agreeing, on a sample basis,
the earnings
capitalised to the underlying accounting records and
challenging the valuers on the adjustments made to
actual earnings in deriving at the earnings used in
the valuation
• assessing the reasonableness of the capitalisation
rates and market value per care bed adopted in the
valuation.
RYMAN HEALTHCARE
120
121
Other information
The directors are responsible on behalf of the Group for the other information. The other
information comprises the information in the Annual Report that accompanies the
consolidated financial statements and the audit report. The Annual Report will be made
available to us after the date of this report.
Our opinion on the consolidated financial statements does not cover the other information
and we do not express any form of assurance conclusion on it.
Our responsibility is to read the other information and consider whether it is materially
inconsistent with the consolidated financial statements or our knowledge obtained in the
audit, or otherwise appears to be materially misstated.
If, when we read the Annual Report, we conclude that there is a material misstatement, we
are required to communicate this to the directors and consider further appropriate actions.
Directors’ responsibilities for
the consolidated financial
statements
The directors are responsible on behalf of the Group for preparing and fairly presenting the
consolidated financial statements in accordance with NZ IFRS and IFRS. They are also
responsible for whatever internal control they determine as necessary to ensure the
consolidated financial statements are prepared free from material misstatement, whether
due to fraud or error.
In preparing the consolidated financial statements, the directors are responsible on behalf
of the Group for assessing the Group’s ability to continue as a going concern and disclosing,
as applicable, matters related to going concern and using the going-concern basis of
accounting unless the directors either intend to liquidate the Group or to stop operations, or
have no realistic alternative but to do so.
Auditor’s responsibilities for
the audit of the consolidated
financial statements
Our objectives are to obtain reasonable assurance about whether the consolidated financial
statements as a whole are free from material misstatement, whether due to fraud or error, and
to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of
assurance, but is not a guarantee that an audit conducted in accordance with ISAs and ISAs
(NZ) will always detect a material misstatement when it exists. Misstatements can arise from
fraud or error and are considered material if, individually or in aggregate, they could reasonably
be expected to influence the economic decisions of users taken on the basis of these
consolidated financial statements.
A further description of our responsibilities for the audit of the consolidated financial statements
is located on the External Reporting Board’s website at:
https://www.xrb.govt.nz/standards-for-assurance-practitioners/auditors-responsibilities/audit-
report-1
This description forms part of our auditor’s report.
Restriction on use
This report is made solely to the Company’s shareholders, as a body. Our audit was performed
so that we might state to the Company’s shareholders those matters we are required to state
to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law,
we do not accept or assume responsibility to anyone other than the Company’s shareholders as
a body, for our audit work, for this report, or for the opinions we have formed.
Paul Bryden, Partner
for Deloitte Limited
Christchurch, New Zealand
23 May 2019
121
Other information
The directors are responsible on behalf of the Group for the other information. The other
information comprises the information in the Annual Report that accompanies the
consolidated financial statements and the audit report. The Annual Report will be made
available to us after the date of this report.
Our opinion on the consolidated financial statements does not cover the other information
and we do not express any form of assurance conclusion on it.
Our responsibility is to read the other information and consider whether it is materially
inconsistent with the consolidated financial statements or our knowledge obtained in the
audit, or otherwise appears to be materially misstated.
If, when we read the Annual Report, we conclude that there is a material misstatement, we
are required to communicate this to the directors and consider further appropriate actions.
Directors’ responsibilities for
the consolidated financial
statements
The directors are responsible on behalf of the Group for preparing and fairly presenting the
consolidated financial statements in accordance with NZ IFRS and IFRS. They are also
responsible for whatever internal control they determine as necessary to ensure the
consolidated financial statements are prepared free from material misstatement, whether
due to fraud or error.
In preparing the consolidated financial statements, the directors are responsible on behalf
of the Group for assessing the Group’s ability to continue as a going concern and disclosing,
as applicable, matters related to going concern and using the going-concern basis of
accounting unless the directors either intend to liquidate the Group or to stop operations, or
have no realistic alternative but to do so.
Auditor’s responsibilities for
the audit of the consolidated
financial statements
Our objectives are to obtain reasonable assurance about whether the consolidated financial
statements as a whole are free from material misstatement, whether due to fraud or error, and
to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of
assurance, but is not a guarantee that an audit conducted in accordance with ISAs and ISAs
(NZ) will always detect a material misstatement when it exists. Misstatements can arise from
fraud or error and are considered material if, individually or in aggregate, they could reasonably
be expected to influence the economic decisions of users taken on the basis of these
consolidated financial statements.
A further description of our responsibilities for the audit of the consolidated financial statements
is located on the External Reporting Board’s website at:
https://www.xrb.govt.nz/standards-for -assurance-practitioners/auditors-responsibilities/audit-
report-1
This description forms part of our auditor’s report.
Restriction on use
This report is made solely to the Company’s shareholders, as a body. Our audit was performed
so that we might state to the Company’s shareholders those matters we are required to state
to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law,
we do not accept or assume responsibility to anyone other than the Company’s shareholders as
a body, for our audit work, for this report, or for the opinions we have formed.
Paul Bryden, Partner
for Deloitte Limited
Christchurch, New Zealand
23 May 2019
ANNUAL REPORT 2019
121
RYMAN HEALTHCARE
122
We value
strong
corporate
governance
ANNUAL REPORT 2019
123
Statement of corporate governance
Ryman believes in the benefit of good
corporate governance and the value
it provides for our shareholders,
residents, staff, and other stakeholders.
The company’s approach to applying
the recommendations outlined in the
NZX Corporate Governance Code (the
Code) are set out below in the order of
the principles detailed in the Code.
Ryman’s policy documents referred
to in this section are available at
www.rymanhealthcare.co.nz/about-us/
investors/governance.
NZX Listing Rules
The NZX Main Board Listing Rules have been
amended by NZX following their review in 2018.
The new NZX Main Board Listing Rules (new listing
rules) came into effect on 1 January 2019, subject
to a 6-month transitional period. The company
will apply the new listing rules from 1 July 2019.
As this annual report has been prepared in the
transition period and before the company has started
to apply the new listing rules, it has been prepared
using the NZX Main Board Listing Rules dated
1 October 2017 (existing listing rules) and the
Code applying under the existing listing rules.
References to the new listing rules are included
where the company considers it useful to
shareholders to understand the position that
will apply under the new listing rules (and updated
Code) from 1 July 2019.
PRINCIPLE 1 – CODE OF ETHICAL
BEHAVIOUR
“Directors should set high standards of ethical
behaviour, model this behaviour and hold
management accountable for these standards
being followed throughout the organisation.”
Code of ethics
As part of the board’s commitment to the highest
standards of behaviour and accountability, the
company has adopted a code of ethics to guide
directors, senior management, and employees in
carrying out their duties and responsibilities.
Ryman’s code of ethics is the framework of standards
by which the directors, senior management,
and employees are expected to conduct their
professional lives. It is intended to support decision-
making that is consistent with Ryman’s values,
business goals, and legal and policy obligations,
rather than to prescribe an exhaustive list of
acceptable and non-acceptable behaviour.
The board approved the code of ethics, which
covers matters such as:
• interacting with residents and their families,
employees, and suppliers
• accepting gifts or other benefits
• dealing with conflicts of interest
• protecting company assets
• complying with laws and policies
• maintaining confidentiality
• reporting breaches.
New employees receive a copy of the code of ethics,
which is accessible to all staff on the Ryman intranet
and the company website.
The company has a whistleblower and protected
disclosure policy. The purpose of the policy is to
protect an employee who wishes to raise concerns
of serious wrongdoing from reprisals or victimisation
for reporting their concerns.
RYMAN HEALTHCARE
124
Statement of corporate governance (continued)
Financial product trading policy
Ryman supports the integrity of New Zealand’s
financial markets. This integrity is maintained,
in part, through the insider trading laws that apply
in New Zealand. Ryman’s financial product trading
policy outlines how those laws apply, as well as
the rules that Ryman has put in place so that those
laws are followed.
Directors, certain employees, and their related parties
must seek approval from the company to trade in the
company’s shares. Trading is limited to two ‘trading
windows’: between the full-year announcement date
and 31 August, and between the half-year
announcement date and 31 January each year.
The directors’ shareholdings and all trading of shares
during the year by the directors is disclosed in the
section headed Directors’ disclosures. A director
or senior manager is obliged to advise the NZX
promptly if they trade in the company’s shares.
PRINCIPLE 2 – BOARD COMPOSITION
AND PERFORMANCE
“To ensure an effective board, there should be
a balance of independence, skills, knowledge,
experience and perspectives.”
The board of directors
The directors are responsible for the corporate
governance practices of the company. The practices
adopted by the board are prescribed in a charter that
sets out the protocols for how the board operates.
The charter complies with the relevant
recommendations in the Code and is reviewed annually.
The board’s primary role is to effectively represent
and promote the interests of shareholders with a view
to adding long-term value to the company’s shares.
The board carries out its responsibilities according
to the following mandate.
• The board should consist of a majority of
non-executive directors.
• At least a third of the directors should be
independent of management and free from any
business or other relationship or circumstance
that could materially interfere with the exercise
of a director’s independent judgement.
• The board’s chair should be a non-executive
director (and not the chief executive).
• Directors should possess a broad range of skills,
qualifications, and experience and remain up to date
on how best to perform their duties as directors.
• Management must provide information of
sufficient content, quality, and timeliness as the
board considers necessary to allow the board
to effectively discharge its duties.
• The effectiveness and performance of the
board and its individual members should be
re-evaluated annually.
The board consists entirely of non-executive directors.
The directors of the company at 31 March 2019
are Dr David Kerr, Jo Appleyard, Warren Bell,
Claire Higgins, George Savvides, Geoffrey Cumming,
and Anthony Leighs.
The board determines that Dr David Kerr,
Jo Appleyard, Warren Bell, Claire Higgins,
George Savvides, and Anthony Leighs are
independent directors under both the existing
and the new NZX Listing Rules.
The board determines that Geoffrey Cumming is
not independent due to his shareholding in Ryman.
Dr David Kerr has been a director since 1995
and the chair since 1999. The board considered
David’s tenure as a director when determining his
independence under the NZX Listing Rules.
The board is satisfied that David’s length of service
as a director does not compromise his independence.
The board believes David continues to bring
independent judgement to the role and to act in
Ryman’s best interests in a manner that is unaffected
by his tenure.
ANNUAL REPORT 2019
125
Statement of corporate governance (continued)
Jo Appleyard is a partner at Chapman Tripp,
which provides legal services to Ryman. The board
considered Jo’s position at Chapman Tripp when
determining her independence under the NZX
Listing Rules. In reaching its view, the board took
into account both:
• the safeguards implemented by Ryman and
Chapman Tripp to prevent this factor impeding
Jo’s independence
• Ryman’s ability to seek legal advice from any legal
firm at its discretion and without impediment.
The median tenure of the board of directors
is 6 years.
More information on the directors, including their
experience, interests, qualifications, length of service,
and shareholdings, is provided in the Directors’
disclosures section of this report and is on the
company’s website.
Day-to-day management of Ryman is delegated to
the chief executive and the senior executive team.
The board’s responsibilities
The primary responsibilities of the board are to:
• ensure the company’s goals are clearly established
and that strategies are in place for achieving them
• establish policies for strengthening the performance
of the company and ensure that management is
proactively seeking to build the business
• monitor the performance of management
• appoint the chief executive and set the terms
of the chief executive’s employment agreement
• decide on what steps are needed to protect the
company’s financial position and its ability to
meet its debts and other obligations when they
fall due, and ensure that such steps are taken
• ensure the company’s financial statements are
true and fair and conform with the law
• ensure the company adheres to high standards
of ethics and corporate behaviour
• ensure the company has appropriate risk
management/regulatory compliance policies
in place.
On appointment to the board by the shareholders,
new directors sign a written agreement that covers
the terms of their appointment.
Every year, the board and committees critically
evaluate their own performance, and their own
processes and procedures. Through this process,
the board identifies any training opportunities for
individual directors to ensure they have relevant
and up-to-date skills for performing their role.
Under the existing listing rules, one third of the
directors must retire by rotation each year. This
requirement has changed under the new listing
rules. The new listing rules require every director to
stand for re-election on the later of 3 years and the
third annual meeting after their appointment. These
directors may offer themselves for re-election. The
new listing rules will apply to Ryman’s 2019 annual
shareholder meeting.
The Governance, Remuneration, and Nominations
Committee undertakes the process for nominating
and appointing directors on behalf of the board, and
makes appropriate recommendations to the board.
The committee’s terms of reference include the
process for nominating and appointing directors.
Independent professional advice
With the prior approval of the chair, each director
has the right to seek independent legal and other
professional advice at the company’s expense
about any aspect of the company’s operations or
undertakings to assist in fulfilling their duties and
responsibilities as directors.
Diversity
The board and management ensure that all eligible
people get an equal opportunity to demonstrate
that they have the right skills and experience for
a particular role, which forms the basis of our
diversity policy.
Ryman embraces the uniqueness in all of our
people and welcomes diversity. We encourage
all of our employees to listen to each other and
RYMAN HEALTHCARE
126
Statement of corporate governance (continued)
to our residents and their families, and to work
to meet the needs of individual people.
Our approach to diversity is to continually develop
a work environment that supports equality and
inclusion, regardless of difference.
The board sets measurable objectives for assessing
performance against Ryman’s diversity policy
(including achieving gender diversity) and assesses
progress annually. The board ensures Ryman’s
objectives are appropriate for promoting diversity
and inclusion.
Through this policy, we have achieved the following
gender diversity.
• Of the seven directors, two are women and five
are men (2018: two women and four men).
• Of the seven members of the senior executive
team, three are women and four are men (2018:
three women and four men). The senior executive
team includes the chief executive and his
direct reports.*
• Of the 423 Ryman leaders, 286 are women and
137 are men (2018: 362 Ryman leaders, 257 women
and 105 men).
* In April 2018, the senior management team was restructured, resulting
in the creation of the senior executive team. At 31 March 2018, the senior
management team consisted of 10 members: four women and six men.
PRINCIPLE 3 – BOARD COMMITTEES
“The board should use committees where this
will enhance its effectiveness in key areas,
while still retaining board responsibility.”
Board committees
The board has five standing committees: Audit
and Financial Risk; Health and Safety; Clinical
Governance; Development and Construction;
and Governance, Remuneration, and Nominations.
A separate Independent Directors’ Committee
meets as needed.
Each committee operates under specific
terms of reference approved by the board.
Any recommendations they make are
recommendations to the board.
The terms of reference for each committee
are reviewed annually.
Audit and Financial Risk Committee
The objective of the Audit and Financial Risk
Committee (AFRC) is to assist the board in discharging
its responsibilities for financial reporting, and risk
and financial/secretarial compliance.
The committee makes recommendations to the
board on appointing external auditors to ensure
that they are independent and to ensure that the
company provides for 5-yearly rotation of the lead
audit partner.
The committee provides a forum for the effective
communication between the board and external
auditors. The committee’s responsibilities include:
• reviewing the appointment of the external
auditor, the annual audit plan, and addressing
any recommendations from the audit
• reviewing any dividend proposals and financial
information to be issued to the public
• ensuring that appropriate financial systems
and internal controls are in place.
The AFRC must consist of at least three directors,
who must wherever possible be independent non-
executive directors. The board chair must also not
be the chair of the AFRC. The current members are
Warren Bell (chair), Geoff Cumming, Dr David Kerr,
Claire Higgins, and George Savvides. Warren Bell,
Dr David Kerr, Claire Higgins, and George Savvides
are all independent non-executive directors.
Warren Bell is a member of Chartered Accountants
Australia New Zealand and Claire Higgins is a
Fellow of CPA Australia.
The committee generally invites the chief executive,
chief financial officer, and the external auditor to
attend AFRC meetings as appropriate. The committee
also meets and receives regular reports from the
external auditor without management present,
concerning any matters that arise in connection
with the performance of the auditor’s role.
ANNUAL REPORT 2019
127
Statement of corporate governance (continued)
Health and Safety Committee
The Health and Safety Committee assists the board
in discharging its responsibilities in overseeing and
reviewing health and safety matters arising out of
Ryman’s activities and the impact of these activities
on staff, contractors, residents, and visitors to Ryman.
The committee recognises the critical role health
and safety forms as part of its day-to-day operations
and wants to ensure a safety-first culture across all
business operations.
The members of the committee are Claire Higgins
(chair), Dr David Kerr, and Jo Appleyard.
The committee’s responsibilities include:
• considering and approving health and safety
strategies, policies, and procedures
• setting health and safety indicators in consultation
with management
• ensuring the board and directors are properly
and regularly informed on matters relating to
health and safety governance, performance,
and compliance
• conducting regular assessments and audits
of the risk profile and control processes.
Clinical Governance Committee
The Clinical Governance Committee supports,
and enhances the quality of, the company’s clinical
performance and care and service provision.
The committee assists the board in discharging its
oversight of clinical reporting and clinical compliance
and is focused on innovation in healthcare and ensuring
alignment with emerging best clinical practice.
The committee consists of three non-executive
directors: George Savvides (chair), Dr David Kerr,
and Jo Appleyard. Tim Wilkinson, a professor at
Otago Medical School and a consulting geriatrician,
and Dr Doug Wilson, an author and biotechnologist,
are also members of the committee.
The committee’s responsibilities are to:
• liaise with internal and external clinical auditors
• review internal and external clinical audit findings
• review significant changes to clinical policies
• review significant complaints and investigations
relating to care of residents
• ensure appropriate clinical information systems
and external controls are in place
• review changes in clinical practice in aged care.
The committee maintains direct lines of
communication with the external clinical auditors,
the chief executive, the chief operations officer,
and the internal clinical auditor.
External clinical auditors are invited to attend a
meeting each year and report to the committee,
including presenting a review of the internal clinical
audit function.
Development and Construction Committee
The Development and Construction Committee
reviews and enhances the quality of the company’s
development and construction performance.
The committee assists the board in discharging
its oversight of the company’s development and
construction activities and practices.
The committee consists of four non-executive
directors: Anthony Leighs (chair), Jo Appleyard,
Warren Bell, and Claire Higgins.
The committee’s responsibilities include:
• ensuring the consent and construction programme
assists in delivering the company’s long-term plan
• investigating new innovative construction
and design methods to improve resident and
staff experiences
• reviewing New Zealand and Victoria cost
trends, buildability, availability of resources, and
compliance with regulatory and quality protocols
• reviewing site feasibilities and due diligence
outcomes to provide confirmation of review
to the board
• reviewing systems and procedures supporting
the design, consent, and building process
• The committee maintains direct lines of
communication with the chief executive, the chief
development officer, and the chief construction officer.
RYMAN HEALTHCARE
128
Statement of corporate governance (continued)
Governance, Remuneration, and
Nominations Committee
The Governance, Remuneration, and Nominations
Committee assists the board in establishing
remuneration policies and practices for the company
in discharging the board’s responsibilities for
remuneration. The committee also undertakes the
process for nominating and appointing directors
on behalf of the board, and makes appropriate
recommendations to the board.
The committee’s terms of reference include the
process for nominating and appointing directors.
Membership of the committee must comprise
non-executive directors, a majority of whom must
be independent. At 31 March 2019 the committee
consists of Geoff Cumming (chair), Dr David Kerr,
and George Savvides.
Management attends committee meetings only
at the invitation of the committee.
The committee’s objectives are to:
• assist the board in establishing remuneration
policies and practices for the company
• assist in discharging the board’s responsibilities
for reviewing the chief executive’s and the
directors’ remuneration
• advise and assist the chief executive in setting
remuneration for the senior executive team
• regularly review and recommend changes
to the composition of the board and identify
and recommend individuals for nomination
as members of the board and its committees.
The directors’ remuneration is set out in the
Directors’ disclosures section of this report.
Detail of the chief executive’s remuneration
is set out under Principle 5.
Independent Directors’ Committee
The Independent Directors’ Committee is convened
as needed and consists of independent non-executive
directors who address significant conflicts of interest
and any other matters referred by the board.
Ryman has protocols that set out the procedures
to be followed if there is a takeover offer. These
procedures are set out in the Takeover Response
Protocols that have been adopted by the board.
Reviewing the membership of the committees
After establishing the Development and Construction
Committee, the board reviewed the membership
of the committees. The changes from this review
are set out in the table on the following page.
Attendance at board and committee meetings
Director attendance at board and committee meetings is shown in the table below.
Board
Audit
and
Financial Risk
Health
and
Safety
Clinical
Governance
Development
and
Construction
1
Governance,
Renumeration,
and Nominations
Number of
meetings held
633331
Dr David Kerr6/6 (chair)3/33/33/31/1
Jo Appleyard6/62/23/33/3
2/3
Warren Bell6/63/3 (chair)3/3
Claire Higgins6/63/33/3 (chair)2/3
George Savvides6/6
1/13/3 (chair)1/1
Geoff Cumming5/5
1/11/1 (chair)
Anthony Leighs3/33/3 (chair)
The Independent Directors’ Committee did not meet during the year.
1 The Development and Construction Committee was established during the year. The establishment of this committee resulted in the
memberships of the committees being reviewed.
ANNUAL REPORT 2019
129
Statement of corporate governance (continued)
CommitteeMembers before reviewMembers after review
Audit and Financial RiskWarren Bell (chair), Dr David Kerr,
Claire Higgins, Jo Appleyard
Warren Bell (chair), Dr David Kerr,
Claire Higgins, George Savvides,
Geoff Cumming
Health and SafetyClaire Higgins (chair), Dr David Kerr,
Jo Appleyard
Claire Higgins (chair), Dr David Kerr,
Jo Appleyard
Clinical GovernanceGeorge Savvides (chair), Dr David Kerr,
Jo Appleyard
George Savvides (chair), Dr David Kerr,
Jo Appleyard
Development and Constructionn /aAnthony Leighs (chair), Jo Appleyard,
Warren Bell, Claire Higgins
Governance, Remuneration,
and Nominations
Dr David Kerr (chair), George Savvides,
Geoff Cumming
Geoff Cumming (chair), Dr David Kerr,
George Savvides
PRINCIPLE 4 – REPORTING
AND DISCLOSURE
“The board should demand integrity
in financial and non-financial reporting,
and in the timeliness and balance of
corporate disclosures.”
Reporting and disclosure
The board focuses on providing accurate, adequate,
and timely information both to existing shareholders
and to the market generally. This enables all investors
to make informed decisions about the company.
Ryman, as a company listed on the NZX Main Board,
has an obligation to comply with the disclosure
requirements under the NZX Main Board Listing Rules.
Ryman recognises that these requirements aim to
provide equal access for all investors or potential
investors to material price-sensitive information
concerning issuers or their financial products.
This in turn promotes confidence in the market.
Ryman’s market disclosure policy outlines the
obligations of Ryman and relevant Ryman personnel
in satisfying the disclosure requirements. It also
covers other related matters including external
communications by Ryman.
This annual report is produced using the principles
of Integrated Reporting <IR>. An integrated report
provides more information on the company’s
business model and how we create value over time.
As a result, an annual report produced under the
<IR> framework will have a broader narrative than
an annual report that does not use the framework.
Ryman publishes its key governance and other
relevant documents in the investor centre of the
company’s website at www.rymanhealthcare.co.nz/
about-us/investors/governance.
All significant announcements made to the NZX
and reports issued are also posted on the
company’s website.
PRINCIPLE 5 – REMUNERATION
“The remuneration of directors and executives
should be transparent, fair and reasonable.”
The Governance, Remuneration, and Nominations
Committee makes recommendations to the board
on remuneration matters in keeping with the
committee’s terms of reference. The committee does
not have the authority to make decisions on behalf
of the board.
The committee is also responsible for making
recommendations to the board on the remuneration
of the chief executive.
The total director remuneration pool is approved
by shareholders at the annual general meeting (AGM)
as required under both the existing listing rules and
the new listing rules.
RYMAN HEALTHCARE
130
Statement of corporate governance (continued)
The board is responsible for the setting of individual
directors’ fees in line with the approved pool and the
listing rules.
Details of the directors’ remuneration for the year
are in the Directors’ disclosures section of this report.
Ryman has in place a remuneration policy that
outlines the key principles that influence Ryman’s
remuneration practices.
The remuneration of the chief executive and
the senior executive team is determined by the
significance of their role and the industry. The total
remuneration is made up of fixed remuneration
and short-term cash-based incentives. The chief
executive and senior executive team are also
members of the senior leadership share scheme
(see note 24 of the financial statements).
The short-term incentives are at-risk payments
that reward performance. They are designed to
motivate and incentivise senior staff in the delivery
of performance over a 1-year operating cycle. The
amount payable is set annually. The payment of the
short-term incentive depends on achieving certain
results and outcomes. Performance over the financial
year is measured against ‘stretch’ performance
targets. The performance metrics differ with each role.
Every year, the committee reviews the levels and
appropriateness of these incentives and weighting.
There are no long-term incentives for the senior
executive team that are subject to performance risk.
The senior leadership share scheme provides
the employees with limited recourse loans on
an interest-free basis to support employees’
participation in the scheme.
For accounting purposes, these shares are treated
as treasury stock when purchased on market, due
to the features of the scheme.
Shares subject to this scheme have a restricted
period of 3 years from the date of purchase, to
appropriately incentivise participants over a longer
period. The loan is repayable if the employee is no
longer employed by Ryman.
Employees’ remuneration
The table below details the number of Ryman group
employees who have earned over $100,000 during
the year ended 31 March 2019. The remuneration
includes salary, short-term incentives, and employer’s
contribution to KiwiSaver and Superannuation.
RemunerationNumber of employees
1,220,000–1,230,0001
730,000–740,0001
660,000–670,0001
580,000–590,0001
560,000–570,0001
390,000–400,0001
320,000–330,0001
310,000–320,0003
300,000–310,0001
280,000–290,0002
270,000–280,0001
260,000–270,0003
240,000–250,0001
230,000–240,0001
220,000–230,0002
210,000–220,0004
200,000–210,0006
190,000–200,0004
180,000–190,0003
170,000–180,0005
160,000–170,00010
150,000–160,00012
140,000–150,00022
130,000–140,00019
120,000–130,00035
110,000–120,00034
100,000–110,00051
ANNUAL REPORT 2019
131
Chief executive remuneration
Gordon MacLeod was appointed chief executive on 1 July 2017. Before this time, he was deputy
chief executive. His remuneration for the year is as follows:
SalaryKiwiSaverSubtotal
Short-term
incentive
Total
remuneration*
Loan provided under the
leadership share scheme
FY19992,964 35,789 1,028,753 200,000 1,228,7531,000,000
FY18762,978 28,889 791,867 200,000 991,867 1,000,000
* There were no other benefits (including long-term incentives) received in the financial year.
The at-risk short-term incentive is payable on the achievement of certain key performance indicators (KPIs).
These KPIs are focused on the financial performance of Ryman, specific operational targets, and
people-related expectations.
At 31 March 2019, the total number of shares owned by and/or held for the benefit of the chief executive
totalled 621,555 (2018: 610,059). For these shares, loans totalling $2,648,036 (2018: $2,533,974)
are outstanding.
Statement of corporate governance (continued)
PRINCIPLE 6 – RISK MANAGEMENT
“Directors should have a sound understanding
of the material risks faced by the issuer and
how to manage them. The board should
regularly verify that the issuer has appropriate
processes that identify and manage potential
and material risks.”
The board is responsible for overseeing the company’s
system of internal controls to manage key risks and
have overall responsibility for managing risk.
The company maintains a group risk register to
identify and manage risk. Specific health and safety,
and clinical risk registers are separately maintained
given the significance of these areas to the business.
The senior executive team is responsible for
maintaining the risk registers.
Ryman operates an extensive internal accreditation
programme that addresses issues such as service
delivery, health and safety, and administration.
Internal audits are undertaken regularly. The results
of these audits and critical indicators are regularly
reported to the board.
Through the AFRC, the board considers the
recommendations and advice of external auditors,
and ensures that those recommendations are
investigated and, where considered necessary,
appropriate action is taken.
Health and safety is discussed regularly at board,
senior executive team, construction team, and
operational team meetings. Regular reporting of
key metrics is prepared to assist these teams in
managing health and safety risks. Further information
is in the health and safety section of this report.
PRINCIPLE 7 – AUDITORS
“The board should ensure the quality and
independence of the external audit process.”
The AFRC makes recommendations to the board on
the appointment of the external auditor as set out in
the terms of reference. The committee also monitors
the independence and effectiveness of the external
auditor and reviews and approves any non-audit
services performed by the external auditor.
RYMAN HEALTHCARE
132
Statement of corporate governance (continued)
The committee regularly meets with the external
auditor to approve the terms of engagement, audit
partner rotation (at least every 5 years) and audit fee,
and to review and provide feedback on the annual
audit plan. Every year, a comprehensive review
and formal assessment of the independence and
effectiveness of the external auditor is undertaken.
The assessment uses an external auditors’
assessment tool, which is internationally recognised
and endorsed by the Independent Directors Council.
The committee routinely has time with Ryman’s
external auditor, Deloitte, without management
present. Deloitte attends the company’s AGM.
The company continually monitors its internal control
environment. Clinical auditors and health and safety
officers regularly test and assess controls and report
their findings to the Clinical Governance Committee
and the Health and Safety Committee.
PRINCIPLE 8 – SHAREHOLDER RIGHTS
AND RELATIONS
“The board should respect the rights of
shareholders and foster constructive
relationships with shareholders that
encourage them to engage with the issuer.”
Information for shareholders
The company seeks to ensure that investors
understand its activities by communicating
effectively with them and providing access to clear
and balanced information.
The company website rymanhealthcare.co.nz
provides an overview of the business and information
about Ryman. This information includes details of
operational sites, latest news, investor information,
key corporate governance information, and copies
of significant NZX announcements. The website
also provides profiles of the directors and the senior
executive team.
Copies of previous annual reports, financial
statements, and results presentations are available
on the website.
Shareholders have the right to vote on major
decisions of the company in line with the
requirements set out in the Companies Act 1993 and
both the existing listing rules and new listing rules.
Communicating with shareholders
Ryman has a dedicated investor relations manager
and corporate affairs manager. These two roles allow
us to develop strong relationships and ensure our
shareholders are kept informed.
Ryman’s investor centre sets out the investor
relations manager’s and corporate affairs manager’s
contact details for communications from shareholders.
We send the notice of the AGM to shareholders and
publish it on the company website at least 28 days
before the meeting each year.
Voting by shareholders
Voting on all resolutions at Ryman’s shareholder
meetings is conducted by poll. This means that
Ryman shareholders enjoy one share, one vote
(subject to any voting restrictions applying under
the listing rules).
ANNUAL REPORT 2019
133
General disclosures of interest
FOR THE YEAR ENDED 31 MARCH 2019
JO APPLEYARD
PartnerChapman Tripp^
MemberNZX Disciplinary Committee
MemberUniversity of Canterbury Vice Chancellor’s
Employment Committee
TrusteeThe Cathedral Grammar School Foundation*
WARREN BELL
ChairHallenstein Glasson Holdings Ltd Group
ChairSt George’s Hospital Inc
DirectorMeadow Mushrooms Group of Companies
DirectorCyprus Enterprises Limited
DirectorSabina Limited
DirectorBildeford Holdings Ltd
DirectorWarren Bell Ltd
DirectorCHC Properties Limited
DirectorGlasson Trustee Limited
Director152 Hereford Limited
DirectorCraigPine Timber Limited
DirectorAmalgamated Holdings Limited
TrusteeEmerald Trust (part shareholder of
Airport Business Park)
TrusteeWaiwetu Trust (part shareholder of
Airport Business Park)
Bare trusteeRyman Healthcare Share Scheme
( jointly with Dr David Kerr)
Director/
Shareholder
Poraka Limited
GEOFFREY CUMMING
Chair, CEO, and
sole shareholder
Karori Capital Limited
Shareholder,
lender, and joint
manager
Various commercial property
investment companies in the Caniwi
Capital Partners group of entities
Advisory board
member and
unit holder
Viewpoint Global Fund Trust
Advisory board
member and
sponsor
Cumming Medical Research
Fund, University of Calgary
Director/
Shareholder
Amira Medical Technologies Inc
* Resigned during the year
^ Jo has been a director since 2009 and since that time has
performed no professional services for the company in her
capacity as a partner at Chapman Tripp.
CLAIRE HIGGINS
ChairREI Superannuation Fund Pty Ltd
Acting chairPancare Foundation Inc
DirectorRailway and Transport Health Fund Ltd
DirectorTransport Health Pty Ltd
TrusteeHelen Macpherson Smith Trust
ChairNorthWest Healthcare Properties
Management Limited*
DR DAVID KERR
ChairEcoCentral Limited
ChairCentercare Limited
AdvisorCanterbury District Health Board
Bare trusteeRyman Healthcare Share Scheme
( jointly with Warren Bell)
DirectorForté Health Limited
DirectorNgāi Tahu Property
DirectorHealth Workforce New Zealand*
ANTHONY LEIGHS
Managing
Director
Leighs Construction Holdings Limited
and associated entities
DirectorPortus Property Limited and
associated entities
DirectorStar Scaffolding Limited
DirectorChrist Church Cathedral
Reinstatement Limited
DirectorLabour Logistics Auckland Limited
Director/
Shareholder
ALISANCA Holdings and
associated entities
GEORGE SAVVIDES
ChairNextScience Limited
Deputy chairSpecial Broadcasting Service (SBS)
Director/
Shareholder
Teamflow Asset Management Pty Ltd
Partner CFMC Consulting Pty Ltd (Sodia)
ChairKings Group Pty Ltd*
ChairMacquarie University Hospital*
KEVIN HICKMAN (resigned June 2018)
TrusteeThe Hickman Family Trust
DirectorJames Lloyd Developments Limited
DirectorValachi Downs Limited
Director/
Shareholder
Rita May Limited
DirectorAirport Business Park Christchurch Limited
Director Russley Estates No.1 Limited
Director Russley Estates No. 2 Limited
TrusteeThe Waiwetu Trust (part shareholder
of Airport Business Park)
DirectorFab Consortium Limited
RYMAN HEALTHCARE
134
SHAREHOLDINGS AT 31 MARCH 2019
DirectorRelevant interest
Jo Appleyard 78,700(1)
Warren Bell 5,000
Geoffrey Cumming50,949,900(2)
Claire Higgins 12,650(3)
Dr David Kerr 343,000(4)
Anthony Leighs –
George Savvides 54,030(5)
(1) Held as trustees of The Appleyard and Larkin Family Trust
(2) An initial disclosure notice was made on 1 June 2018 showing
25,425,000 shares held by Geoffrey A Cumming, 24,900,000
shares held by New Zealand Central Securities Depository Limited
and 624,900 shares held by Emerald Capital Limited
(3) Held as trustees of Adam Higgins Superannuation Fund Pty Ltd
(4) Shares held by DW & DJ Kerr and The DW Kerr Family Trust
(5) Shares held by Teamflow Asset Management Pty Ltd
(6) Geoffrey Cummings joined the board in June 2018
(7) Anthony Leighs joined the board in October 2018 and was chair of
the Development and Construction Committee from November 2018
(8) Kevin Hickman resigned with effect from 1 June 2018
Directors’ disclosures
FOR THE YEAR ENDED 31 MARCH 2019
DIRECTORS’ REMUNERATION FOR THE YEAR
Director
Board
fees
Audit and
Financial
Risk chair
Health
and Safety
chair
Clinical
Governance
chair
Development
and
Construction
chair
Governance,
Remuneration,
and
Nominations
chair
Foreign
exchange
Total
directors’
fees
Jo Appleyard108,000 – – – – – – 108,000
Warren Bell108,000 17,500 – – – – – 125,500
Geoffrey Cumming (6)90,833 – – – – – – 90,833
Claire Higgins108,000 – 17,500– – – 10,510 136,010
Dr David Kerr217,000 – – – – –– 217,000
Anthony Leighs (7)55,250 – – – 7,500 – – 62,750
George Savvides108,000 – – 17,500 – – 10,510 136,010
Kevin Hickman (8)17,167 – – – – – – 17,167
812,250 17,500 17,50017,500 7,500 – 21,020 893,270
DIRECTORS’ REMUNERATION POOL
Director’s fees are reviewed every 2 years. From 1 August 2018, the maximum aggregate amount of
directors’ remuneration was increased from $910,000 to $985,000 (based on a board of 7 directors).
Australian director fees are paid in Australian dollars (AUD).
MEMBERSHIP OF COMMITTEES
Directors do not receive additional fees for membership of committees. Additional fees are paid
to
directors who act as the chair of a committee. During the year Warren Bell, George Savvides,
Claire Higgins, Anthony Leighs, and Geoffrey Cumming held committee chair positions. The chair
of the Governance, Remuneration, and Nominations Committee does not receive any additional fees.
DIRECTORS OF SUBSIDIARY COMPANIES
Dr David Kerr, Warren Bell, Gordon MacLeod, and David Bennett are directors of all the Company’s
New Zealand subsidiaries. Claire Higgins, George Savvides, Gordon MacLeod, and David Bennett
are directors of Ryman Healthcare (Australia) Pty Ltd and its subsidiaries. No fees are paid to
individuals in their capacity as directors of the subsidiaries.
ANNUAL REPORT 2019
135
SPECIFIC DISCLOSURES
In line with the company’s constitution and the Companies Act 1993, the company has provided
insurance for, and indemnities to, directors of the company and its subsidiaries.
SHARE TRANSACTIONS DURING THE YEAR
DirectorNature of interest
Number of shares
acquired/(disposed)Consideration ($)Date
Kevin HickmanBeneficial(834,955)(9,521,455)25 May 2018
George SavvidesBeneficial19,000 218,988 30 May 2018
Warren BellBeneficial(10,000)(133,000)21 August 2018
Geoffrey Cumming*Beneficial250,000 3,389,250 23 August 2018
Geoffrey Cumming*Beneficial(250,000)(3,389,250)23 August 2018
Dr David KerrBeneficial10,000 111,857 29 November 2018
Geoffrey CummingBeneficial624,900 7,011,378 13 December 2018
Geoffrey Cumming –
Emerald Capital LimitedBeneficial(624,900)(7,011,378)13 December 2018
Geoffrey Cumming*Beneficial260,000 2,945,800 14 December 2018
Geoffrey Cumming*Beneficial(260,000)(2,945,800)14 December 2018
Warren BellBeneficial(7,000)(77,564)21 December 2018
* Geoffrey Cumming made an off-market charitable donation of shares to the University of Calgary. He then made an off-market purchase of shares
for the same value.
Dr David Kerr and Warren Bell, as joint custodians of the Ryman Healthcare Leadership Share Purchase
Scheme, acquired 922,127 shares during the year, disposed of 821,931 shares during the year, and held
2,577,272 shares in total at 31 March 2019 (see note 24 of the financial statements).
Directors’ disclosures (continued)
FOR THE YEAR ENDED 31 MARCH 2019
RYMAN HEALTHCARE
136
SUBSTANTIAL PRODUCT HOLDERS AT 31 MARCH 2019
ShareholderRelevant interest%
Geoffrey Cumming50,949,900 10.19%
KJ Hickman, J Hickman & J A Callaghan
1
35,000,000 7.00%
1 Held as trustees of the Hickman Family Trust
Substantial product holder notices were received from FMR LLC and a number of other entities on 11 May 2018 and 14 May 2018. These other entities
comprise FMR Investment Management (UK) Limited, Fidelity Institutional Asset Management Trust Company, FMR Co., Inc, FIAM LLC, Fidelity
Management and Research (Hong Kong) Limited, and Fidelity Capital Markets. A further substantial holder notice was received from FMR LLC and
a number of other entities on 18 October 2018, disclosing that they had ceased being a substantial product holder at this date due to holding less
than 5 percent. These other entities comprise FMR Investment Management (UK) Limited, Fidelity Institutional Asset Management Trust Company,
FMR Co., Inc, FIAM LLC, Fidelity Management and Research (Hong Kong) Limited, and Fidelity Capital Markets.
Shareholder information
DISTRIBUTION OF SHAREHOLDERS AT 16 MAY 2019
Size of shareholding Number of shareholders Shares held
1–1,000 4,970 34.15% 2,688,984 0.54%
1,001–5,000 6,286 43.19% 16,438,039 3.29%
5,001–10,000 1,724 11.84% 13,191,865 2 .64%
10,001–50,000 1,318 9.06% 27,225,306 5.45%
50,001–100,000 136 0.93% 9,560,904 1.91%
Greater than 100,000 121 0.83% 430,894,902 86.18%
Total 14,555 100.00% 500,000,000 100.00%
TOP 20 SHAREHOLDERS AT 16 MAY 2019
Rank Investor NameNumber of shares% Issued capital
1HSBC Nominees (New Zealand) Limited
1
86,672,789 17.33
2JPMORGAN Chase Bank
1
77,263,034 15.45
3HSBC Nominees (New Zealand) Limited
1
38,390,803 7.68
4Joanna Hickman & John Anthony Callaghan & Kevin James Hickman
2
35,000,000 7.00
5Geoffrey A Cumming 26,049,900 5.21
6Citibank Nominees (NZ) Ltd
1
21,952,679 4.39
7Forsyth Barr Custodians Ltd 10,700,603 2 .14
8Ngāi Tahu Capital Limited 9,005,669 1.80
9Tea Custodians Limited
1
8,844,378 1.7 7
10Custodial Services Limited 8,561,849 1.71
11Accident Compensation Corporation
1
8,246,471 1.65
12Custodial Services Limited 5,534,133 1.11
13New Zealand Superannuation Fund Nominees Limited
1
5,525,361 1.11
14Premier Nominees Limited
1
5,448,971 1.09
15BNP Paribas Nominees NZ Limited
1
5,101,479 1.02
16National Nominees New Zealand Limited
1
4,591,046 0.92
17FNZ Custodians Limited 4,103,057 0.82
18Private Nominees Limited
1
3,578,828 0.72
19Custodial Services Limited 3,450,258 0.69
20Cogent Nominees Limited
1
3,140,537 0.63
1 Held by New Zealand Central Securities Depository Ltd as custodian
2 Held as trustees of the Hickman Family Trust
ANNUAL REPORT 2019
137
We value our people
Aarju Karki · Aaron Brown · Aaron Edwards · Aaron Enriquez · Aaron Essenberg · Aaron Eyles · Aaron Van Biene · Aashu Baskota · Abbe King · Abbey Santos · Abbey Turner · Abbey Winskill · Abby Birkett · Abby Carballo
· Abby Fernandez · Abby Thornton · Abhina Poonjen · Abhishek Kochar · Abigail Webb · Abin Augustine · Abitha Thomas · Able Mathew · Abraham Nolasco · Acacia Tucker · Ace Catajoy · Ace Somosot · Achala WB
Palihanaralalage · Adalia Campbell · Adam Allan · Adam Birss · Adam Young · Adele Jacobs · Adele Sowden · Adele Thorpe · Adeline Plamenco · Adi Cuizon · Adi Tupou · Adjie Vargas · Adnan Mahamud · Adore Davis ·
Adrian Wiggill · Adriana Aarminiei · Adriana Abreu · Adriana Draganidis · Adrianna Pavlekovic · Adrienne Marsh · Adrienne Sincock · Adrienne Todd · Aez Pega · Afroz Arif · Aga Gonzales · Agnes Wallace · Agnes Cuanan
· Agnieske Keenan · Agnus Shaju · Agustine Affandi · Aida Cachuela · Aik Eng · Ailean Cook · Aileen Bagtang · Aileen Wild · Ailen Gaw · Aima Polestico · Aimee McKendry · Aimee Ryberg · Aimee Trotter · Aimee Verran ·
Ainslee Buchanan · Ainslie Baxter · Aiselyn Tabuzo · AJ Lasaca · Ajay Philip · Ajo Jose · Aka Raveti · Akko Ibe · Aklima Akter · Al Fleming · Al Lim · Alan Trusler · Alan Wood · Alana Bagley · Alana Reeves · Alana Watson ·
Alanah French · Alannah Smith · Alastair Hibbard · Alastair Joyce · Alba Antony · Albie Calope · Aldrin George · Aleesha Ratcliffe · Alefina Baleisuva · Aleisha Ferris-Duggan · Alena McCulloch · Aletta Beneke · Alex
Bouron · Alex Cagalitan · Alex Carter · Alex McNeillie · Alex Rauber · Alex Thurlow · Alex Pope · Alex Taylor · Alexandra Rougas · Alfana Shazmeem · Alfy Varghese · Algine Ingking · Ali Amin · Ali Ealam · Alica Abrams ·
Alice Blair · Alice Greatrix · Alice Kim · Alice McDuff · Alice Trubshaw · Alice Twigley · Alice Vargas · Alice Stevens · Alicia Angell · Alicia Prima · Alicia Stephenson · Alina George · Alisha Thakur · Alisi Vuluma · Alison Martin
· Alison Westoby · Alison Naylor · Alister Safaei · Aljieboy Famulagan · Alka Sebastian · Alke Stubbe · Allan Brown · Allan Dempsey · Allan Macala · Allan Taylor · Alli Beattie · Allison Murphy · Alma Azarcon · Alma
Cagalitan · Alma Eparaima · Alma Ramirez · Almond Morente · Alofa Fanueli · Aloha Starr · Alpha Gordon · Alphonsa George · Alphy Thomas · Alun Dodd · Aly McLean · Aly Procter · Alyse Hurley · Alysha Russell · Alyssa
Jerusalem · Aman Kaur · Aman Kaur · Amanda Bell · Amanda Gilbert · Amanda Ladd · Amanda Loversidge · Amandeep Kaur · Amandeep Kaur · Amandeep Kaur · Amar Kaur · Amber Donald · Amber Howard · Ambily
Abraham · Amelia Baleirewa · Amelia Denzel · Amelia McMahon · Amelia Van Rhyneveld · Amendra Samantilake · Amita Ahluwalia · Amita Prasad · Amita Vyas · Amitha Sivaraman · Amor Reyes · Amrit Kaur · Amrit Kaur
· Amrita Raj · Amy Amtman · Amy Bishara · Amy Brown · Amy Fifita · Amy Mian · Amy Morrison · Amy Reive · Amy Yin · Amy Gagasa · Amy McNeil · Ana Fangupo · Ana Hintay · Ana Hollands · Ana Leite · Ana Sands · Ana
Savou · Ana Marie Salibay · Anabel Konigstorfer · Analyn Irorita · Anan Du · Ancy Yohannankutty · Andre Battrick · Andre Hechter · Andrea Adams · Andrea Ansell · Andrea Burgos · Andrea Butler · Andrea Felipe · Andrea
Hall · Andrea Latoa · Andrea Manuel · Andrea Parsons · Andrea Rod · Andrei Pirlea · Andrew Crerar · Andrew Gibson · Andrew Hall · Andrew Heels · Andrew Inch · Andrew Jones · Andrew Knewstubb · Andrew Leith ·
Andrew Maglangit · Andrew Mitchell · Andrew Quezon · Andrew Searancke · Andy Clarke · Andy Heap · Andy Peters · Ane Pulou · Ange Dickson · Ange Knibb · Angel Montanez · Angel Perez · Angela Barraclough · Angela
Ferguson · Angela Lindup · Angela O’Connor · Angela Porritt · Angela Punchihewa · Angela Ravlich · Angela Redgewell · Angela Simpson · Angela Stewart · Angelica Araiza · Angelica Ona · Angelina Adams · Angelina
Bostrouas · Angelina Taiaroa · Angeline Chand · Angelique Capulong · Angelique Malabo · Angelo Trabado · Angie Cope · Angie Sidhu · Ani Veve · Anika Lewisham · Anish Anto · Anishma Raj · Anit Dominic · Anita Bhusal
Banjade · Anita Chapman · Anita Dayal · Anita Devi · Anita Devi · Anita Farmer · Anita Smith · Anitha Paul · Anitha Shijan · Anitha Varadhan · Anitta Shaju · Anjali Mitra · Anjana Lama · Anjana Poojary · Anjani Chaudhary
· Anjani Suresh · Anjelyn Pocession · Anjita Acharya · Anjo Francis · Anju Catherine · Anju Malakunnel Isac · Anju Sajan · Anjumol Saju · Ankitaben Patel · Ann Arun · Ann Beom · Ann Brady · Ann Cuaresma · Ann Dickason
· Ann Dombroski-Scheliin · Ann Escares · Ann Fernando · Ann Joy · Ann Mongcal · Ann Moorman · Ann Olbinado · Ann O’Neill · Ann Santos · Ann Varunny · Anna Benadie · Anna Carandang · Anna Emboido · Anna George
· Anna Haines · Anna Jalop · Anna Johnson · Anna Lai · Anna Lim · Anna Matulino · Anna McCorkindale · Anna Nosal · Anna Roberts · Anna Scott · Anna Smith · Anna Thomson · Anna Tufui · Anna Von Kimmer · Annabel
Sharp · Annabel Wheelans · Annabelle Urquhart · Anna-Lee Fitzgerald · Annalise Dixon · Annamay Toa · Anne Brittenden · Anne Cameron · Anne Cantos · Anne Flint · Anne Hall · Anne Hovell · Anne Kenna · Anne Larita
· Anne Ledesma · Anne Ngawati · Anne O’Donnell · Anne Streatfeild · Anne Verano · Annette Adams · Annette Bryson · Annette Holdaway · Annette Hollis · Annette Parsons · Annette Rains · Annie Bruce · Annie Craike ·
Annie Eunson · Annie Pascua · Anni-Jo Mandario · Annika Lindquist · Ann-Marie Innes · Anoma Gunaratne · Anshu Singh · Ansu Anna Varkey · Ant Williams · Anthea Gernetzky · Anthea Lemberiadis · Anthony Clyne ·
Anthony Healy · Antionette Kiddle · Antoinette Morgan · Antonette Asuncion · Antony Lonappan · Anu Aloysius · Anu Baby · Anu Gill · Anu Karthika Reghunathapanickar · Anu Kumar · Anu Mathews · Anu Pathirage · Anu
Paul · Anu Samuel · Anuja Kunwar · Anuja Shrestha · Ao Fuifui · Aoleen Heni · Aparna Surendran Vayackal · Api Lacanivalu · Apple Cuarton · Apple Ladia · Apple Uy · Appu Boora · Aprelle Aldaya · April Bulayungan · April
Deraja · April Lacson · April Mahuika · April Morillo · April Nino · Arahia Wilson · Archie Evans · Areita Bebenisala · Argie Forteza · Argielyn Sanchez · Ari Harper · Ariana Guerin · Ariana Hessell · Ariane Torreliza · Arianne
Alzaga · Aribo Timaai · Arieta Anderson · Arieta Faalau · Aris Seva · Arj Lozada · Arjun George · Arlene Macalalag · Arlene Pinote · Arlene Rodgers · Arlene Simadari · Arlet Anastasia · Armie Magcale · Arneka De Vries ·
Aroha Blythe · Aroha Te Huia · Arpanpreet Arpanpreet · Arraminda Ariate · Arthur Keane · Arti Devi · Arti Karan · Arti Patel · Arti Prakash · Artika Lata · Artika Naidu · Aruna Prakash · Aruna Reddy · Arunee Peterson ·
Arvin Treebhowan · Asa Porter · Ash Devi · Ash Prasad · Asha John · Asha Kiran · Asharif Rahman · Ashika Chand · Ashika Mandri · Ashika Singh · Ashlee Ferguson · Ashlee Tainui · Ashlee Thompson · Ashleigh Dixon ·
Ashleigh Shields · Ashley Gray · Ashley Jamieson · Ashley Joe · Ashley Quensell · Ashley Willis · Ashlin Freear · Ashmita Lata · Ashupreet Kaur · Ashvin Mendonca · Ashween Singh · Ashwina Ashwina · Ashwindar Kaur ·
Ashwini Naicker · Asmita Elliot · Asmita Hirachan · Asset Galeno · Asti Suliastari · Aswathy Padmanabhan · Aswathy Sreedas · Aswathy Thulaseedharansheela · Atakura Carson-King · Atawhai Reweti · Ateliana Ah Kuoi
· Athena Tangonan · Athulya Thankappan · Audrey Filgate-Davis · Audrey Moffett · Audrey Rigby · Auds Mendoza · Aura Maranan · Aurora Orogo · Ava Bahari · Ava McFadgen · Averil Taylor · Avrill Burchell · Awanui
Tangiia · Awhina White · Axl Funtila · Aya Takahashi · Ayesha Bashir · Aymee Cropp · Ayu Hardy · Ba Sigola · Baeua Mackenzie · Baljit Kaur · Balpreet Kaur · Bano Tasheem · Barbara Barker · Barbara Fay · Barbara Federico
· Barbara Kirk · Barbara Large · Barbara Reynen-Rose · Barbara Salele · Barbara Wilson · Barbie Bickerton · Barry Delamore · Barry Ria · Beate Smirek · Beatrice Salera · Beauty Chua · Bebien Montecillo · Bec Hall · Bec
Boyd · Becca Thomas · Beck Little · Beck Wilkins · Becki Hyde · Beckie Goodhead · Becks Dell · Becky Gillanders · Becky Moore · Becky O’Sullivan · Becky Payne · Bee Weiss · Bekah Cousins · Belinda Bargh · Belinda
Gosling · Belinda Madriaga · Belinda Ycong · Bella Jabat · Ben Bowles · Ben Chen · Ben Dass Shrestha · Ben Hungerford-Morgan · Ben Nicholls · Ben Poothuran · Ben Van Heerden · Benita Alexander · Benita Prasad ·
Benjamin Cavanagh · Benson Mejorada · Berbs Veloso · Bernadette Bancroft · Bernadette Forsdyke · Bernadette Lerios · Bernadette Palmer · Bernard Cagalawan · Bernard Nanai · Bernard Philpott · Bernardette Oliveiro
· Berni Chinyanganya · Bernie Hastie · Bernie Lidiard · Bernie Liu · Bernie Pask · Beryl Ahie · Beryl Ryan · Beth Aseniero · Beth Capistrano · Beth Frith · Beth Gerbes · Beth Haryett · Beth Kampen · Beth Po · Beth Reaney ·
Bethany Douglas · Bethany Edie · Bette Baldwin · Betty Agdeppa · Betty Clark · Betty Groves · Betty Lamb · Bev Fockenga · Bev Todd · Bev Toms · Bev Walker · Bevan Harris · Bex Abel · Bex Coster · Beza Esclamado ·
Bhakti Todi · Bharti Bedi · Bhavishna Chandrani · Bhavneet Kaur · Bheng Escano · Bhumi Jain · Bhupinder Kaur Chana · Bibin Vijayan · Bien Padilla · Bijo Mathew · Bill Doherty · Bill Temanel · Bimal Roshni · Bina Limbu ·
Bini Gurung · Bini Eldhose · Binky Marsh · Binuska Ranaweera · Bisomenike Dissanayaka · Blake Jackson · Blake Smith · Blanch Laroga · Blanche Nugas · Blessie Lintag · Blint Varghese · Bobby Abhilash · Bobby Beck ·
Bobby-John Crouch · Bobin Pullikkattil Jose · Brad Thomas · Brandi Ireton · Brando Bartolome · Bre Earl · Brechell Dela Vega · Bren Whitaker · Brenda Dudson · Brenda Hobbs · Brenda Paul Corera · Brenda Schroeder
· Brent Morfett · Brian Bark · Brian Robinson · Brian Tidey · Brian Ward · Brian Villaverde · Briana Reweti · Bridgette des Landes · Bridie Paul · Brin Downie · Brittany Cottam · Brittany Jeffcott-Moore · Brittany Kerebs ·
Brittney Ross · Bronnie Carston · Bronte Hermansson · Bronwen Steere · Bronwyn Barry · Bronwyn Hancock · Bronwyn Moodie · Brooke Carman · Brooke Roberts · Brooke Tyler · Bruce Hudson · Bruce Little · Bruce
Court-Patience · Bruno da Silva · Bryan Manlangit · Bryni Waldron-Lemon · Brynn Howe · Byron Young · Caitlin Brown · Caitlin Fleming · Caitlin Peirse · Caitlin Robertson · Caitlin Wallace · Caitlin Young · Caleb Lepper ·
Calin Henderson · Callum Morrish · Cam Yovich · Cameron Scott · Cameron Wootton · Camila West · Camille Lacadin · Camille Reyes · Camille Santos · Campbell Elliott · Candice Rusia · Cardona Castro · Careen
Bayoneta · Carina Birondo · Carl Arnst · Carl Dela Cruz · Carla Dela Cruz · Carla Elliott · Carla Ereneta · Carla Jones · Carla Lofredo · Carla Metti · Carlo Rufin · Carlos Toledo · Carmel Marino · Carmie Demesa · Caro
Swanston · Carol Andutan · Carol Bothamley · Carol Bunting · Carol Luttrell · Carol Mathias · Carol Power · Carol Toohill · Carol Wesley · Carol Galazo · Carola Acevedo · Carole Quickfall · Carolin Bijju · Caroline Brotherson
· Caroline Hart · Caroline Ludford · Caroline Potgieter · Caroline van Tulder · Caroline Wharengaro · Carolyn Adler · Carolyn Bovey-Brown · Carolyn Faloon · Carolyn Greenaway · Carolyn Herbert · Carolyn Lennox ·
Carolyn Morrison · Carolyn Mulder · Carolynn Aicken · Carrie Duncan · Carroll King · Casey Cowley · Cassandra Osborne · Cassandra Wallis · Cassie Chen · Cassie Scaife · Cassie Valdez-Abarro · Cath Magbaton · Cath
Seguan · Cath Swain · Catherine Bunting · Catherine Cordwell · Catherine Haren · Catherine Jalbuena · Catherine Kennedy · Catherine McKellar · Catherine Scullin · Catherine Veloso · Catherine Wright · Cathley Balaan
· Cathrina Singco · Cathy Andrews · Cathy Burton · Cathy Hassan · Cathy Hiku · Cathy Lata · Cathy Lippitt · Cathy Malone · Cathy Morris · Cathy Salcedo · Cathy Yang · Catie Phillips · Cecelia McLaren · Cecelia Williams
· Cecilia Hansson · Cecille Winspear · Cel Padayogdog · Celia Henare · Celia Ingerson · Celina Bulaga · Celly Nicer · Celthea Yu · Centuri Chan · Cha Bishop · Cha Juco · Chakri Siluveru · Chamara Hettiarachchige ·
Chandrika Ganepola · Chani Soper · Chantal Kennedy · Chantel Pilcher · Chantelle Ellery · Chantelle Hand · Charies Padua · Charith Ruwanpathirana · Charlene Serino · Charlene Tabigne · Charles Han · Charles
Hannaford · Charlotte Bullock · Charlotte Coomber · Charlotte Senining · Charmae Golosino · Charmagne Castillo · Charmaine Infante · Charmaine Julian · Charmaine Smith · Charmaine Staines · Charmaine Volschenk
· Chea Fraser · Chell Biato · Chelsea Cooper · Chelsea Hayler · Chelsea Hill · Chelsea Richdale · Chelsie Grindlay · Cherie Brosnan · Cherie Eddy · Cherry Casama · Cherry Gallego · Cherry Lagare · Cherry Mayo · Cherry
Quiros · Cherry Ramel · Cherry Venegas · Cherry Fabon · Cherryl Bauzon · Cherryl Marquez · Cheryl Alba · Cheryl Buchanan · Cheryl Damatac · Cheryl Jackson · Cheryl Rom Liu · Cheryl Shepherd · Cherylynn Stevenson
· Chessie Yap · Cheyanne Nuku · Cheyenne Peek · Chhiring Lama · Chi Zhao · Chidimma Aham-Chiabuotu · Chikaina Makatea · Chinchu Boban · Chinchu Augustin · Chit Escalon · Chitra Wratt · Chitt Fajardo · Chloe
Aitken · Chloe Bullimore · Chloe Hollows · Chloe Fitzgibbon · Chris Ashton · Chris Beckett · Chris Camm · Chris Church · Chris Corriea · Chris Daykin · Chris Dias · Chris Dombroski · Chris Grice · Chris Hall · Chris Harwood
· Chris Henry · Chris Hodge · Chris Jobe · Chris Keilty · Chris Ngataierua · Chris Parker · Chris Preston · Chris Saxon · Chris Shirer · Chris Simmonds · Chris Sinclair · Chris Sutton · Chris Tunbridge · Chris Turnbull · Chris
Wright · Chris Balanci · Chris Downes · Chrissy Mathews · Chrissy Smith · Chrissy Stanton · Chrissy Thompson · Chrissy Toa · Chrissy Villanos · Christelle Sazon · Christina Brenton · Christina Ioane · Christine Alcoseba
· Christine Besseling · Christine Buck · Christine Clarke · Christine Cleaver · Christine De Leon · Christine Dhariwal · Christine Erespe · Christine Grant · Christine Hill · Christine Kwiatkowski · Christine Langford · Christine
Langley · Christine Larking · Christine McCurdy · Christine Pauling · Christine Tweedie · Christine Han · Christine Labiton · Christine Sutton · Christine Ann Elizalde · Christopher Singer · Chu Templa · Chuck Navarra ·
Chummy Madarieta · Chyna Bourne · Cindy Cao · Cindy Evangelista · Cindy Le Hur · Cindy Phillips · Cindy Santillana · Ciska McGrath · CJ Jethwa · Claire Bate · Claire Crossen · Claire Daunivavana · Claire Davies · Claire
Farrell · Claire Harris · Claire Herbert · Claire Heyns · Claire Leef · Claire Rogers · Claire Sagcal · Claire Whitfield · Clara Tan · Clara Noveda · Clarace Codyre · Clare Burgess · Clare Glasspool · Clare Manders · Clarence
Picardo · Clarissa Alojado · Claudele Mangos · Claudete Silva · Claudeth Regidor · Claudia May · Claudia Rueda De La Serna · Claudia Farrell · Claudine Nair · Clauren Lim · Clem Von Ellerts-Martinoli · Cliff Cochrane ·
Cliff Lasmarias · Coco Fahey · Colin Whakatutu · Colleen Church · Colleen McHugh · Colleen Watson · Collette Gordon · Colm Boyle · Comaneci Ong · Comfort Siaw · Con Ciobanu · Con Van Niekerk · Conie Tiongson ·
Connie Tagle · Connie Vining · Connor Peirse · Connor Sim · Cora Jambalos · Cora Van der Heul · Coralea Potgieter · Coralie Vine · Cornelia Chin · Correen Steyn · Corrine Gillan · Corrinne Cooper · Cory Bryan · Court
Sheppard · Courtenay Colligan · Courtenay Reid · Courtney Gibson · Courtney Pillar · Craig Buist · Crestha Dumpa · Cris Ondong · Cris Viernes · Criselda Agbayani · Crish Landiza · Cristel Carter · Cristina Alejandro ·
Cristina Corre · Cristina Oliquiano · Cristina Uy · Cristine Bayliss · Cristy Pagaduan · Crystal Jugo · Crystal Saldanha · Crystelle Bewley · Csilla Feherne Kincses · Cy De Leon · Cym Seguan · Cynthia Bunag · Cynthia Coop
· Cynthia Humphreys · Cynthia Mercado · Cyril Balloso · Czhanna Dayo · Dainah Magonde · Daisy Duka · Dale Bell · Dale Whearty · Daljeet Khosa · Daly Anna Devasia · Daman Kaur · Damien Meehan · Dan Bromley · Dan
Parris · Dan Smith · Dan Torreja · Danae Shipston · Danelle Franklin · Dani Steer · Daniel Halengo · Daniel Lau · Daniel McLennan · Daniel Papina · Daniela Diederichs-Ronberg · Danielle Jeffery · Danielle Murphy · Danielle
Stroud · Danielle Tweed · Dara Penones · Darnell Bonita · Darren Fisher · Darren Hicarte · Darrin Findlay · Darsana Ram Bindu · Daryl Dominguez · Dashan Kaur · Dave Bennett · Dave Cooper · Dave Hawke · Dave Ingram
· Dave Murrell · Dave Pelham · Dave Robertson · Dave Sevilleno · Dave So · Dave Wand · Dave Cronin · David Bennett · David Cantell · David Datoy · David de Veth · David Easton · David Fisk · David Fulton · David Gibson
· David Jordan · David Kamande · David King · David Macdonald · David Main · David McKearney · David Nevin · David Oldham · David Ravenscroft · David Swan · David Townsend · Davis Thadathil · Dawn Griffiths · Dawn
Hunt · Dawn Philip · Dawn San Diego · Dawn Yrigollen-Hammond · Dawny Thomas · Dean Jackson · Deanna Glasson · Deanna Randell · Deb Hodges · Deb Robertson · Deb Ray · Debbi Fairlie · Debbie Austin · Debbie
Bontuyan · Debbie Bridger · Debbie Dixon · Debbie Edwards · Debbie Fred · Debbie Gemmell · Debbie Gray · Debbie Hartley · Debbie Kennedy · Debbie Komarkowski · Debbie Lim · Debbie McClure · Debbie Ogden ·
Debbie Potaka · Debbie Quennell · Debbie Rauhihi · Debbie Rountree · Debbie Sayrin · Debbie Smith · Debbie Sunckell · Debbie Wells · Debbie Hicks · Deborah Forde · Deborah Hayward · Deborah Ibale · Deborah Logt-
Osborne · Deborah Reynolds · Deborah Swingler · Debra Goodman · Debra Rowley · Debra Stone · Declan Rhodes · Dedeh Karyati · Dee Broad · Dee Mantell-Harding · Dee Repko · Dee Sharma · Deepa Sudhakaran ·
Deepani Hewa Batagodage · Deepika Deepika · Deepu Antony · Deidre MacGregor · Del Wellington · Del Whitehouse · Den De Paula · Denice Jamieson · Denis Goodwin · Denis Marra · Denise Boese · Denise Clevis ·
Denise Cunniffe · Denise Graham · Denise Greenbank · Denise Hutchison · Denise Laney · Denise Martin · Denise Mason · Denise Scott · Denise Thompson · Denise Fink · Dennis Frazer · Dennis Prendiville · Dennis Pura
· Denver Houston · Denzel Bonifacio · Deo Glovasa · Derek Greening · Des Aunese · Desiree Andriessen · Devi Nagalingam · Devika Naidu · Devika Reddy · Devon Maurice · Devon Melrose · Dewi Astuti · Dezaray Coutts
· Dhana Reddy · Dhang Navarro · Dhanju Rana · Dhanya Lukose · Dhara Patel · Dhorey Gabinete · Dhruvi Shah · Di Drought · Di George · Di Lister · Di McKenzie · Di Sinclair · Di Tahi · Di Tarling · Diana Brown · Diana
Cleveland · Diana Hanafin · Diana Jones · Diana Maiquez · Diana Nicolescu · Diana Plesovs · Diana Sian · Diana Te’o · Diane Brown · Diane Headifen · Diane Johnson · Diane Lloyd · Diane Mens · Diane Smith · Diane Taylor
· Diane Vergara-Galang · Dianne Burgess · Dianne Casimiro · Dianne Dona · Dianne Durham · Dianne Irvine · Dianne McIntosh · Dianne Melhuish · Dianne Newton · Dianne Rosado · Dianne Thompson · Dianne Villasenor
· Dianne Visda · Dianne Amolong · Dibi Raju · Didi Muncaster-Wright · Diksha Mainh · Dileep Sebastian · Dilum Jayasuriya · Dina Garcia · Dina Reid · Dina Fitria · Dinesh Nandakumar · Dionne Tuhou · Disha Ghandi · Divina
Cruz · Divina Lubrica · Divine Medina · Divya Chauhan · Divya Mannayath · Divya Sebastian · Dolly Alekar · Dominique Pagani · Don MacKay · Donah Cagalawan · Donald Ferguson · Donald Pool · Dondi Delgado · Donna
Barnes · Donna Bradford · Donna Campbell · Donna Dael · Donna Dungey · Donna Flaws · Donna Gonzales · Donna Jones-Smith · Donna Lewis · Donna Munoz · Donna Summerfield · Donna Bower · Donna Rose · Dora
Martinez-Velandia · Doreen Dacanay · Doreen Kumar · Doreen Lata · Doreen Maha · Doreen Narayan · Dorien Preston · Dorothy Harris · Dorothy Musosa · Dorothy Suario · Dorothy Withers · Dot Bax · Dot Wright · Dottie
Abuyabor · Dovie Villalobos · Dronah Villarino · Dulari Withana Ranasinghe · Duncan Phillips · Durham Quigley · Dustin Dominic · Dyanne Smith · Dynah Manota · Earl Te · Eda Galias · Eddie Deo · Eddie Ovansian · Edgar
Mamaril · Edilenson Igot · Eduard Bradley · Edwina Hutchings · Edz Botangen · Eileen Kielty · Eileen Welford · Eileen Wu · Eina Campos · Ekta Sharma · Elaine Galbraith · Elaine Hubbard · Elaine Marsh · Eldho George ·
Eldho Varghese · Eldo George · Ele Bibby · Eleanor Gaffley · Eleanor Lee · Eleanor Reo · Eleen Kee · Eleeza Jilson · Elena Braza · Elena Delector · Eleni Heaven · Eleni Meimaris · Eleonor Moral · Elina Rajie · Elisel Valoria ·
Eliseo Lapus · Elisha Gautam · Elisha Granada · Elizabeth Caboverde · Elizabeth Hunter · Elizabeth Okanga · Elizabeth Okpaleke · Ella Heeren · Ella Brown · Ella-Rose Knowles · Elle Coker · Ellen Cribb · Ellen Li · Ellie Price
· Ellora Santos · Elmer Carreon · Eloisa Obnial · Eloise Viscarra · Elona Walker · Elsa Boyd · Elsa Theron · Elsie DelosReyes · Elsie Pablo · Elsie Warriner · Elva Latonio · Elvi Tangonan · Elvira Gomez · Ema Clarke · Emalyn
Prosia · Emelita Cagas · Emily Blackmore · Emily Chen · Emily Goldsmith · Emily Joyce · Emily Narawa · Emily Palamountain · Emily Truong · Emily Xi · Emily Keenan · Emily White · Emma Anderson · Emma Hanley · Emma
Laing · Emma Lewis · Emma Peterson · Emma Poni · Emma Reardon · Emma Sanders · Emma Saquiban · Emma Scott · Emma Scrimgour · Emma Shepherd · Emma Singh · Emma Tarunge-Wasi · Emma Tumarae · Emma
Waetford · Emma Holder · Emmy Dolotina · Ena Pastrana · Enrique Vanegas · Eric Demo · Eric van Diggele · Erica Turner · Erica Sinclair · Erick Abille · Ericka Esteban · Ericka Sauquillo Adoyo · Ericka Vergara · Erik
Homena · Erika-Jean Searle · Erin Hume · Erin Pole · Erin Woodcraft · Erlan Lipata · Erwin Enriquez · Escher Kenny-Racey · Estela Garcia · Estella Quinto · Estelle O’Neil · Estelle Ramtano · Estelle Van Standen · Ester Da
Rosa · Ester Pugosa · Esther Cole · Esther Curtis · Esther Gupana · Esther Hukui · Esther Lawangen · Esther Simpson · Esther Smith · Esther Zvenyika · Estrella Rom · Ethel Mondarte · Eti Aunese · Eugene Ortile · Eurita
Balazo · Eusenia Tualasa · Eva De Jong · Eva Schilder · Eva Dodd · Eve Espanta · Eve Ojales · Evelyn Booth · Evelyn Cadzow · Evelyn Calaunan · Evelyn Doropa · Evelyn Espina · Evita Hariman · Faaiu Nielsen · Faamanu
Simeona · Faeona Wallace · Fair Rupal · Faith Fawcett · Faith Sakalia · Fallon Eynon · Fana Raveora · Fang Zhou · Fara Naicake · Farida Shilpi · Faridun Joya · Farisha Begum · Farishta Samadi · Farron Moke · Farzana Bi ·
Fay Lilley · Faye Pinpin · Fe Asinas · Fe Cuevas · Fe Taganas · Fefiloi Tausi · Felicity Mills · Felis Pael · Felix Lacerna · Femi John · Fhey Bayno · Finau Kafoa · Fiona Dube · Fiona Justine · Fiona Kingi · Fiona Le Gros · Fiona
Rolland · Fiona Scotland · Fiona Quinn · Fiona Te Haara · Fipe Lama · Fleur Cooper · Flo Hamilton · Floey Limjoco · Flor Anasarias · Flor Casas · Flora Casilang · Flora Torres · Florance Nikeeta · Florence Taylor · Fonda
Burt · Fraan Quirk · Fraenzi Gloor · Fran Chousal · Fran Malcolm · Fran Meireles Da Rosa · Fran Spitzer · Franca Phillips · Frances Lewis · Frances Luckin · Frances Schuster · Frances Twaalfhoven · Francis Deferia · Francis
Delia · Francisca Venegas · Frank Ryan · Frank Wang · Fred Agliam · Fred Cleaver · Freda Chase · Freda Van Schouten · Freddy Akkara · Frederick Chin · Freyja Dixon-Brazier · Fritz Lozano · Gabby Barnett · Gabby Da
Rosa · Gabby Whall · Gabe Stewart-Murray · Gabriel D’Alberto · Gabriella Schulz · Gabrielle Mann · Gael Coory · Gagan Kaur · Gagan Kaur · Gagandeep Kaur · Gail Beard · Gail Brown · Gail Castro · Gail Enriquez · Gail
Forsyth · Gail Miller · Gail Sangiorgio · Gail Te Au · Gail Wildbore · Galina Mandich · Galina Shipina · Ganga Mati · Gareth Bulliff · Gareth Salt · Garry Bott · Garry Singh · Gary Bacod · Gary Cox · Gary Robinson · Gavin Lucas
· Gavin Till · Gay Benabaye · Gay Libatog · Gay Ordonio · Gayani Welikala · Gayathri Kahawidanalage Dona · Gaye Hansen · Gaylene Allen · Gaylene Downs · Gaylene Graham · Gaylene Hutcheson · Gaylene White · Gee
Kaur · Geeta Chandra · Geeta Seghal · Geethu Babu · Geffrey Ayres · Gem Evans · Gemma Ballantyne · Gemma Fernandez Duck · Gemma Rolland · Gen Baoa · Gen Bautista · Gen Seeburrun · Gen Suerte Felipe · Gen
Yotoko · Gena Agnes · Genalyn Arca · Genelil Gonzales · Genell Dunn · Geneveve Van Dooren · Geoff Murton · George Garbutt · Georgekutty Joseph · Georgia Butler · Georgia Lusty · Georgia Ritchie · Georgia Scott ·
Georgia Smaill · Georgia Taylor · Georgie Hamilton · Georgina Aitken · Georgina Mashlan · Geraldine Kevill · Gerlie Navaja · Gerlie Sebastian · Germaine Dixon · Ghela Domalanta · Gigi Major · Gigi McMahon · Gihani
Chathurika · Gil Fielding · Gilanne Natividad · Gilar Merto · Gilbert Alolor · Gilda Testa · Gill Dyer · Gina Parkinson · Gina Reid · Gina Salt · Gina Schenkel · Gina Villanueva · Ginella Baldovino · Giovanna Falchi · Girley Pingol
· Girlie Stevens · Giroma Labradores · Gisha Chandy · Gizelle Quinola · Gladys Gaspar · Glaiza Alwit · Glaiza Bernardo · Glen Stanger · Glen Thomson · Glenda Corne · Glenda Hunter · Glenda Porter · Glenn McNickle ·
Glenn Perkins · Glenn Scott · Glenys Percy · Glenys Popenhagen · Glenys Stewart · Glenys Malone · Gloria Kavanagh · Gloria Kawadza · Gloria Wardle · Gloria Potier · Glynn Pussell · Goodwin Samuel · Gopi Muduthan ·
Gordon Lambagan · Gordon McKenna · Gordy MacLeod · Gorica Brasic · Goswin Kanta · Govind Yelagani · GR Taala · Grace Anacleto · Grace Arbitrario · Grace Blake · Grace Boyle · Grace Crawford · Grace Dalzell ·
Grace Francis · Grace Jaring · Grace Kamuhangire · Grace Kim · Grace Lubos · Grace Martinez · Grace Nathan · Grace Rennie · Grace Samuel · Grace Shen · Grace Tabut · Grace Wilson · Grace Bayes · Grace Wei ·
Gracie Ravago · Gracie Roberts · Graeme Muir · Graeme Thomson · Graeme Wilson · Grant Costello · Grant Duce · Grant Eggers · Greece Tade · Greema Paul · Greeshma Susham · Greg Conquest · Greg Evans · Greg
Giles · Greg Lapwood · Greg Small · Greta Hernandez · Greta Kennedy · Gretch Tacuyan · Greville Savage · Guin Diaz · Gunpreet Tiwana · Gurinder Atwal · Gurjeet Kaur · Gurpreet Dhillon · Gurpreet Gill · Gurpreet Kaur ·
Gurpreet Kaur-Gill · Gursharan Kaur · Gursharan Kaur · Gus Finlayson · Gwen Cajigas · Gwen Flynn · Haara Ria · Habiba Neniel · Hadrian Sultan · Hailey Byun · Hailey Smith · Haley Crimp · Hamida Khan · Hamish Keast ·
Hamish O’Neill · Hana Lee · Hanan Danyour · Hani Fatu · Hannah Baker · Hannah Barlow · Hannah Barry-Goss · Hannah Bryan · Hannah Calder · Hannah Carter · Hannah Debreceny Brazier · Hannah Espanola · Hannah
Hayes · Hannah Hekelaar · Hannah Ibale · Hannah Miles · Hannah Orlowski · Hannah Riches · Hannah Undan · Hannah Manalaysay · Hannah Wilson · Happy Nijjar · Harbhajan Kaur · Hardeep Kaur · Harianne Canoy ·
Harinder Kaur · Harjeeet Kaur · Harjinder Kaur · Harleen Gill · Harleen Johal · Harman Kaur · Harmonee Scott · Harper Connelly · Harpinder Kaur · Harpreet Kaur · Harpreet Kaur · Harpreet Kaur · Harpreet Kaur · Harpreet
Kaur · Harpreet Kaur · Harrie Geraets · Harriet Cairns · Harriet Ndukwe · Harriett Murray · Harry Chapman · Harry Sampson · Harsha Aiyappa · Harsha Kottarathil · Harshal Patil · Harvie Samra · Harwinder Kaur · Hashini
Ekanayake · Hasini Wadduwage · Hassel Sapanta · Hayden Beaton · Haylee Syverston · Hayley Berriman · Hayley Brown · Hayley Evis · Hayley Hendra · Hayley House · Hayley Kluytmans-Smith · Hayley Mackintosh ·
Hayley Rees · Hayley Sharp · Hayley So’oa · Hayley Jenkinson · Hazel Baliza · Hazel Dodunski · Hazel Grande · Hazel Guillen · Hazel Magar · Hazel Watene · Heather Barnett · Heather Jury · Heather Maynard · Heather
Parnell · Heather Robinson · Heather Seddon · Heather Sharp · Heather Simmonds · Heather Turner · Heather Turney · Heather Wilson · Heather Wooles · Hedda Viray · Heena Heena · Heide Barkman · Heidi O’Reilly ·
Heidi Qu · Heidi Reece · Heinrich Pretorius · Helen Bridge · Helen Burnley · Helen Danielsen · Helen Davy · Helen Francis · Helen Hayes · Helen Higgins · Helen Kent · Helen MacDonald · Helen Mason · Helen McKinnel ·
Helen Pedersen · Helen Small · Helen Van Der Meys · Helen Van Wijk · Helen Wehipeihana · Helen Weston · Helen Xu · Helen-Mary Foley · Hellen Grenfell · Helloise Tan · Henny Villaverde · Henry Dunford-Baker · Henry
Neo · Hermie Nuqui · Hermie Pabulario · Herminia Thompson · Hilary Ward · Hilary Westley · Hilary West · Hildah Muthui · Hima Pauly · Himshikha Paneri · Hina Veituna · Hine Kameta · Hiromi Mizushima · Hohaia Brown
· Hollie Emmett · Hollie Ruddick · Hollie Thomlinson · Holly French · Holly Gillett · Holly Grant · Holly Nicholas · Holly Wilson · Holly Palmer · Honey Chahal · Honey Duque · Honey Ebarle · Honey James · Honey Neilson ·
Honey Pagtanac · Honeylane Bautista · Hope Sakalia · Hua Chen · Hugh Maffey · Huiling Lu · Iain Doody · Ian Corry · Ian Hill · Ian Le Grange · Ian Whyte · Ike Abellana · Ilaisaane Ofa · Ilthon Tomo · Ima Donu · Imee Dalis ·
Imelda Borlas · Indika Abeykoon · Indu Gounder · Inge Rickards · Ingrid Cagalawan · Ingrid Loper · Inigo Holmes · Inno Chiu · Iosefo Bahn · Ira Indino · Irene Allen · Irene Lee · Irene Morgan · Irene Canonigo · Iresha Jahinge
· Irina Davis · Irish Clavecillas · Irish Pelegren · Isaac Bright · Isabel Jimenez · Isabel Seville · Isabelita Dizon · Isabella Wild · Ishan Kolothodi · Ishina Adhikari · Isi Uata · Isla Jean Tregonning · Issac Gould · Ita Living · Italia
Taka · Italo Martins · Ivane Parba · Ivory Ramoneda · Ivy Carreon · Ivy Chatterjee · Ivy Liza · Ivy Busran · Izak Luther · Izel Martinez · Izzy Hutcheson · Jabeline Obra · Jabul Shofi Rahman · Jacinta Afamasaga · Jack Foster
· Jack O’Meara · Jackie Batoy · Jackie Hotter · Jackie Miller · Jackie Scanlon · Jacky Adam · Jacky Basongit · Jacky Fitzsimon · Jaclyn Aitken · Jaco Malan · Jacob Boerman · Jacob Bowie · Jacob Cherian · Jacque
Manzano · Jacqueline Almosara · Jacqueline Chua · Jacquelyn Arao · Jacquelyn Cottam · Jacqui Clarke · Jacqui Comerford · Jacqui Davies · Jade Cook · Jade Hemi · Jade Rogerson · Jade Washbourn · Jade Te Awhe
· Jadi Cubita · Jadon Modlin · Jaime Clews · Jaime Douglas · Jaime Martin · Jaimeleigh Paaka · Jaimie Rees · Jaina Varghese · Jaka Payot · Jallah Barber-Coffey · James Alolor · James Aoys · James Clarijs · James Jose
· James Macaraeg · James Weight · Jamie Roberts · Jamie Rumbold · Jamie Sheary · Jamie-Leigh Robinson · Jamil Escalera · Jamila Khaled · Jan Bandala · Jan Corbett · Jan Le Roi · Jan Low · Jan McCann · Jan
McClelland · Jan Morrell · Jan Smith · Jan Thomson · Jana Dinusova · Jandy Taclob · Jane Baker · Jane Carver · Jane Elle · Jane Escalera · Jane Garner · Jane Gordon · Jane Hockey · Jane Jordan · Jane Lawrence · Jane
Magan · Jane O’Connell · Jane Paredes · Jane Pow · Jane Sun · Jane Van Daatselaar · Janelle Broughton · Janelle Reade · Janessa Baltazar · Janet Coutts · Janet Jesen · Janet Ngamaru · Janet Puna · Janet Scanlan ·
Janet Spaabaek · Janet Stacey · Janet Zanich · Janette Castroverde · Janette Valle · Jani Treesa · Janice Marban · Janice Munro · Janice Rothwell · Janice Salmons · Janice Stent · Janice Walsh · Janice Wright · Janie
Nolan · Janina Altoveros · Janine Aitken · Janine Amacio · Janine Fredric · Janine Lipsys · Janine Snape · Janine Waugh · Janith Fernando · Jan-Marie Houliston · Jannel Baldivas · Jannel Estrellado · Jannise Taylor · Jans
Amuwala Mesthrige · Jared Colwell · Jared Dickson · Jared Kemsley · Jas Bhotea · Jas Taala · Jasal Kolothumthodi · Jasbir Kour · Jash Jattana · Jasmeet Kaur · Jasmeet Virk · Jasmin Raju · Jasmine Dalkie Drummond
· Jasmine Lee · Jasmine Mcilraith · Jasmit Kaur · Jason Adam · Jason Browne · Jason Kenna · Jason Mack · Jason Van der Hulst · Jason Zhao · Jason Hopkins · Jaspinder Kaur · Jaspreet Brar · Jaspreet Kaur · Jaspreet
Kaur · Jaspreet Kaur · Jasprit Kaur · Jass Kaur · Jass Kaur · Jass Reddy · Jasvir Kaur · Jay Borromeo · Jay Kang · Jay Parag · Jay Pascua · Jay Payot · Jaya Mohan · Jayde Aung · Jayde Galbraith · Jayden Brown · Jayla
Bosley-Brown · Jayn Baker · Jayne McIlroy · Jayne Money · Jaz Spicer · Jazz Phillips · Jean Daug · Jean Galicia · Jean Louw · Jean Matias · Jean Raga · Jean Rigor · Jean Villarin · Jeanafe Abelarde · Jeanel Gutong · Jeanet
Bagares · Jeanette Erestingcol · Jeanette Tebbutt · Jeanette Trueman · Jeanie Gamboa · Jeanie Salcedo · Jeanne Paterson · Jeanne Walker · Jeannie Bautista · Jeannie Sales · Jeannie Wang · Jee Manipis · Jeena
Joseph · Jeeva Vakkachan · Jeff Parkins · Jehnille Sacriz · Jeli Howes · Jemima Pratt · Jemimah Curtis · Jen Badrudin · Jen Candia · Jen Davids · Jen Garcia · Jen Kim · Jen Magrath · Jen Marsh · Jen Rea · Jen Segundo
· Jen Tabuac · Jenelyn Ragadi · Jeni Keogh · Jenice Williams · Jenn Valavala · Jenni Harris · Jenni Mackay · Jenni Stevenson · Jenni Thompson · Jennie Abuan · Jennie Lloyd · Jennie South · Jennifer Dela Cruz · Jennifer
Ferrier · Jennifer Gonzalo · Jennifer Johnston · Jennifer Lasquite · Jennifer Roberts · Jennifer Trasmil · Jennifer Wong · Jennilyn Gonzales · Jenno Obando · Jenny Abalos · Jenny Achilles · Jenny Bain · Jenny Bongcog ·
Jenny Buhat · Jenny Campbell · Jenny Campbell · Jenny Cates · Jenny Chang · Jenny Christmas · Jenny Coleman · Jenny Crutchley · Jenny del Carmen · Jenny Griffiths · Jenny Guanco · Jenny Lane · Jenny Lee · Jenny
Magsilang · Jenny Merrett · Jenny Parker · Jenny Roux · Jenny Simons · Jenny Sommers · Jenny Thiele · Jenny Whale · Jenny Wilson · Jenny Wood · Jenny Bower · Jenny de Peralta · Jenny Dominguez · Jep Anacleto
· Jerald Isleta · Jerald Sunto · Jeremy Moore · Jeremy Wood · Jeremy Herradura · Jerica De Villa · Jerica Enriquez · Jermae Aguilon · Jerome Wong Yit · Jerrie Mallon · Jeseena Varghese · Jesilyn Delgado · Jesna Jose ·
Jesreel Cajeles · Jess Adams · Jess Bonustro · Jess Boxall · Jess Hatfield · Jess Jacques · Jess Jellyman · Jess Jewell · Jess Kehoe · Jess Lewis · Jess Ross · Jess Smith-Street · Jess Malaque · Jessa Cabe · Jessen
Ramtano · Jessica Cuttle · Jessica Matheson · Jessica Taningco · Jessica Tonacao · Jessica Beer · Jessica Csengo · Jessie Dennis · Jessie McKay · Jessie Tang · Jessy Arthur-Worsop · Jesty Nelson · Jevy Badilla · Jez
Balaba · Jha Tanio · Jhonaliza Detera · Jhong Solen · Jibin John · Jie Yu Zeng · Jiji Kashmiras · Jil Chua · Jill Bailey · Jill Clark · Jill Gregson · Jill Hague · Jill Turner · Jill White-Northcroft · Jill Munro · Jillian Cole · Jilsy Joy
· Jim Naoe · Jim Otimi · Jima Ilagan · Jimaima Naikatini · Jimmy Silich · Jimmy Wei · Jimy John · Jince Jose · Jinell Fernandes · Jingyi Yin · Jini Joy · Jini Joy · Jinky Romero · Jinson Abraham · Jinu Thomas · Jiny Johny
· Jisna Poulose · Jit Chhetri · Jittisak Chammanee · Jizza Lumantad · Jo Anam · Jo Cant · Jo Clare · Jo De Alday · Jo Dickson · Jo Goode · Jo Hendry · Jo Hunt · Jo Kitson · Jo Luijk · Jo Nelson · Jo Oakden · Jo Seed · Jo
Tasker · Jo Turner · Jo Villaester · Jo Wix · Joan De Guzman · Joan Erceg · Joan Lagman · Joan Rubio · Jo-An Alipin · Joana Matias · Joanna Forbes · Joanna Nituma · Joanna Taylor-Spedding · Joanne Batara · Joanne
Eaton · Joanne Hart · Joanne Lata · Joanne Manger · Joanne Ramirez · Joanne Robinson · Joanne Steele · Joanne Wang · Jo-Anne Buhler · Jobi Paul · Jocelyn Enad · Jocelyn Forster · Jocelyn Infante · Jocelyn Josue ·
Jocelyn Lines · Jocelyn Taylor · Jock Rasmussen · Jodie Robb · Jody Keating-Gorton · Joe Blair · Joe Nio-Aporo · Joe Schuchmann · Joe Suedad · Joe Vas · Joelle Whipp · Joenita Florendo · Joey Bawas · Johan Barnard
· Johanna Wood · John Bland · John Caballero · John Daniels · John Entice · John Gavin · John Jenkins · John Liceralde · John Miller · John Munro · John Nayga · John Nguyen · John Poral · John Tate · John Taylor · John
Van Turnhout · John Walton · John Young · John Anggot · John Morris · Johncy Joseph · Joiemaia Lubrica · Jojo Archer · Jojo Diquit · Jolenie Zomil · Jomarie Guarnes · Jomy Jose · Jon Agtuca · Jon Northway · Jona
Arganda · Jonabelle Dulap · Jonah Llamas · Jonald Laurico · Jonathan Ball · Jonathan Santamaria · Jonathon Hean · Jone Seniceva · Jonelyn Valeroso · Joni-Lou Arcelo · Jonna Mangahas · Jono Burch · Jordan Elvy ·
Jordan Lapish · Jordan Smart · Jordan Wilson-O’Brien · Jordyn Clarke · Joris Bolijn · Jose Palathunkal · Joseph Domingo · Joseph Go · Josephine Cunado · Josephine Slater · Josh Begley · Josh Brazier · Josh Dench ·
Josh Jones · Josh Kelleher · Josh Ladowsky · Josh Lamont · Josh Ting · Josh Walker · Josh Escalera · Joshua Smith · Joshua Waine · Josie Dionisio · Josie McCrone · Josie Placino · Josmin Jose · Josy Jose · Joti Chand
· Joti Kumari · Joti Reena · Journey Komene · Jova Marquez · Jovi Obias · Joy Abellar-Sinha · Joy Albano · Joy Breward · Joy Campo · Joy Duran · Joy Murray · Joy Napalan · Joy Notman · Joy Wagtingan · Joy Harrison
· Joy Mason · Joyce Dixon · Joyce Kydd · Joyce O’Connell · Joyce Philiph · Joyce Reniedo · Joyce Roa · Joyce Srikantharajah · Joyce Stone · Joycelin Panganiban · Juan Coffey · Jucelia Da Silva · Jude Faulknor · Jude
Kerr · Judette Froilan-Algodon · Judi Wetere · Judith Ditablan · Judith Polkinghorne · Judith Rutledge · Judith Taylor · Judith Worsley-Taylor · Judy Aitken · Judy Campbell · Judy Campbell · Judy Chapman · Judy Jaropillo
· Judy Patterson · Judy Petersen · Judy Sequeira · Judy Sutton · Juffin Koshy · Jules Mudford · Jules Tungatt · Julia Charteris · Julia Evans · Julia Hamilton · Julia Murphy · Julia Prentice · Julia Walker · Juliana Agudelo ·
Juliana Joseph · Juliana King · Julie Akinyele · Julie Ballinger · Julie Baron · Julie Collings · Julie Corkill · Julie Crayford · Julie Crofts · Julie Deticio · Julie East · Julie Enriquez · Julie George · Julie Gumban · Julie Hansen ·
Julie Horopapera · Julie Hoskin · Julie Madden · Julie Mallia · Julie Morrish · Julie Pinzon · Julie Ryan · Julie Seymour · Julie Simpron · Julie Todd · Julie Toevai · Julie Wallis · Julie Camay · Julie Khor · Julie-Ann Beattie ·
Julieanne Stephens · Juliet D Souza · Juliet Findlay · Juliet Smith · Juliette Brownlow · Julius Ajoc · Juls Winter · Julyn Cancino · Jun Fernandez · Jun Montajes · June Gledhill · June Hare · June Savage · June Siakia · June
Wano · Junior Toaisi · Justin Regidor · Justin Reinecke · Justine Anderson · Justine Brigoli · Justine Michel · Jyan Agngarayngay · Jyoti Bhanot · Jyoti Kunwar · Jyoti Naidu · Jyoti Phuyal · Kaden Ko · Kae Tayong · Kael Fallu
· Kaelan Healy · Kaitlyn Caldwell · Kal Sherchan · Kaleb Dunstan · Kaleshni Devi · Kalisi Funaki · Kalisi Savu · Kalpa Kumarasinghe · Kalpana Negi · Kalvi Selvaraj · Kamal Dhaliwal · Kamal Kaur · Kamal Pandher · Kamala
Phuyel · Kamini Prasad · Kanchan Dangol · Kane Jones · Kanika Singh · Kanta Mani · Kanti Karan · Kaori Ikushima · Kapri Gudgeon · Kara Turvey · Kara Belcher · Karam Kaur · Karan Senger · Kareen Galang · Karen
Andersen · Karen Bacani · Karen Bensemann · Karen Borland · Karen Calder · Karen Castel · Karen Chavez · Karen Clark · Karen Currie · Karen Dillon · Karen Fuhrmann · Karen Jackson · Karen Jellyman · Karen Jenkins
· Karen Lake · Karen Mabao · Karen Merrilees · Karen Moriyama · Karen Nasser · Karen Parata · Karen Prothero · Karen Ramos · Karen Reid · Karen Rodger · Karen Sears · Karen Shaw · Karen Sirot · Karen Wellington ·
Karen Wells · Karen Williams · Karen Wilson · Karen Zhang · Karenne Melo · Karin Odendaal · Karin Reinecke · Karin McDonald · Karina Misterio · Karl Rosales · Karl Royo · Karl Holden · Karla Davis · Karla Marrs · Karm
Kaur · Karnjot Benipal · Karolyne Boynton · Karuna Maharaj · Karuna Neupane · Karuna Singh · Karyn Marshall · Karyn Nobilo · Karyn Porter · Karyn Small · Kasa Palefau · Kase Woolley · Kasey Livioco · Kat Atkins · Kat
Hanson · Kat Patron · Katalina Aitaua · Katalina Kisina · Katarina Biaukula · Kate Anderson · Kate Carr · Kate Ensor · Kate Kennedy · Kate Morgan · Kate Pitcaithly · Kate Sharples · Kate Spiller · Kate Waldock · Kate Wood
· Kate Arsenio · Kath Abelligos · Kath Arillo · Kath Collett · Kath Daveis · Kath Dwyer · Kath Morgan · Katherine Smith · Katherine Urquhart · Kathie Dimock · Kathleen Corcuera · Kathleen de Gracia · Kathleen McMillan ·
Kathleen Parker · Kathlen Gingoyon · Kathrine Tan · Kathryn Francis · Kathryn Nieva · Kathryn Staples · Kathryn Ostapczuk · Kathy Bernados · Kathy Upton · Katie Bell · Katie Daykin · Katie Hilleard · Katie Japor · Katie
Miles · Katie Orr · Katie-Jane Knight · Katja Segeth · Katrina Armstrong · Katrina Boyd · Katrina Chinnery Allen · Katrina Ede · Katrina Mann · Katrina McLean · Katrina Stevens · Katrina Villanueva · Katy Blasdale · Katy
Hodder · Katy Van Nieuwenhuizen · Katz Melebo · Kavinder Kaur · Kavita Devi · Kavitha Sukumar · Kawalpreet Mattoo · Kay Jeffs · Kay Katene · Kay Merekula · Kay Sheppard · Kay Spick · Kay Zinhan · Kay Marfell · Kaycee
Borja · Kaye Francisco · Kaye Kaur · Kaye King · Kaye Nieva · Kaye Stoddart · Kayla Edwards-Fox · Kayla Myles · Kayla Te Ruki · Kaylene Brock · Kaylene Tipene · Kayley Taylor · Kaylyn Merrall · Keagan Modlin · Keann
Alojado · Kearny Royo · Kee Chan · Keiko Simpson · Keiran Steele · Keitha Riddle · Kelera Bourke · Kellie Hawkins · Kellie Hura · Kelly Barnes · Kelly Cooke · Kelly Dacanay · Kelly Jones · Kelly McHaffie · Kelsey Bone · Kelsey
Wilson · Ken Arceno · Ken Enriquez · Ken Go · Ken Wongsomboon · Ken Yeung · Kendall Johnson · Kendra Tate · Kennely Atilano · Kenneth Alo · Kenny Babajide · Kenny MacAskill · Keran Taylor · Keri Ladbrook · Kerri Batin
· Kerri Martin · Kerri Roberts · Kerri Taylor · Kerrie Christou · Kerrie Ekers · Kerrie Scott · Kerry Gall · Kerry Naidu · Kerstein Villareal · Kevin Butcher · Kevin Grimwood · Kevin Higgins · Kevin John · Kevin May · Kevin Selner
Maniego · Keysha Ericksen · Kharyn Baliola · Khina Neupane · Khush Pandher · Khush Soni · Kianna Wang · Kiely Buttell · Kieti Kalava · Kika Fosita · Kim Brougham · Kim Clarke · Kim Cunard · Kim Dongon · Kim Grundmann
· Kim Henry · Kim Housiaux · Kim Kim · Kim Manansala · Kim Nanscawen · Kim Peoples · Kim Shanly · Kim White · Kim Barwell · Kimberlee Robertson · Kimberly Bakian · Kimberly Libatog · Kimlea Howard · Kina Manuofetoa
· Kinu Nagaya · Kiran Bala · Kiran Dhillon · Kiran Gudopp · Kiran Joshi · Kiran Kaur · Kiran Lata · Kiran Basram · Kirandeep Kaur · Kirandeep Kaur · Kiri Henare · Kirk Lubos · Kirk Seratica · Kirn Brar · Kirsten Liggett · Kirsten
Merrett · Kirstin Charters · Kirstin Davis · Kirstin Jenkinson · Kirstin Murdoch · Kirsty Gledhill · Kirsty Morris · Kirsty Calder · Kirti Karishma · Kisa Faauli · Kisa Tanuvasa · Kishore Kurian · Kit Montilla · Kitty Arnold · Kitzy
Pandit · Klarissa Dacyon · Komal Kaur · Korin Unka · Korinna Dela Cruz · Koshala Waduwatta · Koshila De Silva · Kripa Gurung · Kris Ria · Kris Ingles · Krish Naicker · Krishma Singh · Krishna Malcampo · Krishna Nagalla ·
Krissy Burke-Luff · Krista Lee · Kristel Cagasan · Krister Borja · Kristie Limos · Kristie Newton · Kristin Cadavis-Khiathani · Kristina Bonsol · Kristina Thomas · Kristine Baring · Kristine Bello · Kristine Dalauidao · Kristine
Fegi · Kristine Jimenez · Kristine Llave · Kristine Singh · Kristine Talavera · Kristoff Bawayan · Kristoffer Dalman · Kristy Marment · Kristy Brown · Krystal Manson · Krystal McDonald · Krystyna Bostrovas · KT Taylor · Kuini
Tuala · Kulbhushan Kokate · Kuldip Singh · Kuljinder Kaur · Kumar Mekala · Kurt Hiller · Kushma Wati · Kyamala Magar · Kyla van Heerden · Kylah Pere · Kyle Thomson · Kylee George · Kylie Campbell · Kylie Humphrey ·
Kylie Martin · Kylie Thomas · Kym Faulkner · La Cikamatana · La Drew · Lachmi Kanta · Ladine Hobson · Ladonna De Asis · Lafi Lemana · Laiza Peters · Laiza Lambino · Lakshmi Gopi · Lamar Aspinall · Lami Taua · Lana
Boynton · Lana Fraser · Lance Alexandra · Lance Clendon · Lance Fletcher · Lancy Lawrence · Lanei Dimaano · Laney Tomkins · Lanie Mabale · Lanna Schnetler · Lanson Teura · Lara Corbishley · Lara Durand · Lara Giles
· Larissa Sedouch · Larissa Te Ao · Larry Montoya · Latchmi Murti · Latoya Brownlee · Launiu Tuiloma · Laura Blunsdon · Laura Carrington · Laura Gare · Laura Hawkes · Laura Hollenback · Laura Luague · Laura
MacDonald · Laura Manalaysay · Laura McCracken · Laura Moffett · Laura Ralph · Laura Thompson · Laura Walker · Laura Whicker · Laureen Roberts · Lauren Baldock · Lauren Beaumont · Lauren Beckett · Lauren Heyes
· Lauren Siemelink · Lauren Stafford · Lauren Tuirirangi · Lauren Wells · Lauren Wright · Laurence Alojado · Laurie Johnson · Lauriz Apuada · Lavinia Quinn · La-Vonia Edlin · Lawale Baigern · Lawrence Manohara-Seelan
· Lawrence Taylor · Lea Brown · Lea Mawson · Lea Valdez · Leah Butler · Leah Duffield · Leah Erasmus · Leah Hand · Leah Marechal · Leah Ouano · Leah Soliva · Leah White · Leah Bryan · Leanna Harding · Leanne Ansell
· Leanne Booth · Leanne Fabish · Leanne Hunter · Leanne McFarlane · Leanne Nukunuku · Leanne O’Meara · Leanne Paekau · Leanne Parkinson · Leanne Stewart · Leanne Watson · Leanne King · Ledina Dangol · Lee Gao
· Lee Murray · Leela Pathirannahelage · Leen Porathur · Leena Kumar · Leeza Stone · Lehanna Pio · Leia Bishop · Leigh Dixon · Leigh Pakome · Leilane Alforo · Leilani Loibl-Beach · Leisa Brown · Leizel Deligero · Len Galate
· Lena Gawler · Lena Te Miha · Leo Aguirre · Leo Canete · Leo Salac Jr · Leonie Bracewell · Leonie Johnson · Leonie Kebbell · Lera Baisheva · Leshika Arachchige · Lesley Crampton · Lesley Fulton · Lesley Harris · Lesley
McGarr · Lesley Nicolson · Lesley Pells · Lesley Rowe · Lesley Sime-Arthurs · Lesley Te Maiharoa-Sykes · Leslie Ortega · Lester Belanio · Lester Demabildo · Lester Salvosa · Letitia Corcoran · Leva Latu · Levao Fidow ·
Lewis Bradford · Lez Pencz · Li Hayman · Li Ma · Lia Pou · Liam Brown · Liane Kirwan · Lianne Woolford · Libby Allison · Libby Doran · Libertine Esguerra · Lie Fiu · Liesl Kruger · Ligi Johnson · Ligi Pailikutty · Ligy John ·
Likhwa Sigola · Lila Patel · Lili Latu · Lili Talega · Lilian Hulsbosch · Lilibeth Gapuz · Lill Wawatai · Lily Birkett · Lily Genet · Lily Isleta · Lily Nicolescu · Lima Ugapo · Lin McLaughlin · Lina Benedetti · Lina Tuimana · Lincy
Fransis · Linda Bennett · Linda Burnside · Linda Churchill · Linda Danga · Linda Duke · Linda Elleston-Wiliamson · Linda Maharjan · Linda McGill · Linda Mckee · Linda Morey · Linda Pettigrew · Linda Reid · Linda Richards
· Linda Sharrock · Linda Skelton · Linda Soloman · Linda Tafutu · Linda Warren · Linda Yu · Linda Russell · Lindsay Harrison · Lindsay O’Connor · Lionel Pillay · Lis Dawson · Lisa Crichton · Lisa Gilligan · Lisa Humphrey ·
Lisa Laforgia · Lisa Leger · Lisa Marr · Lisa Mazey · Lisa More · Lisa Petana · Lisa Petersen · Lisa Robinson · Lisa Ross · Lisa Walton · Lisa Whitcombe · Lisa Carr · Lisa Neiman · Lisa Raymond · Lisi Fifita · Lita Naude ·
Lit-Lit Lacerna · Liu Liu · Liyana Bandara · Liz Battersby · Liz Beresford · Liz Bradford · Liz Carmichael · Liz Close · Liz Cunningham · Liz Dilger · Liz Gill · Liz Hampton · Liz Hickling · Liz Keeman · Liz Penman · Liz Schofield
· Liz Thrush · Liz Wells · Liza Dong · Liza Hendry · Liza Ingeniero · Lizeth Monzalo · Lizz Read · Lizzy McKenzie · Lloyd Landiza · LLoyd Ross · Loa Tuiolemotu · Lobesia Bulicakau · Logan Carpenter · Logan Fairbairn · Loida
Malanyaon · Loida Sung · Loida Zarandona · Lois Battersby · Lois Chirume · Lois Lee · Lois Partridge · Lois Tooley · Lonita Tejano · Lordei Ledesma · Lorelle Krissansen · Loren Adolfo · Loren De Chavia · Lorenza Macayba
· Lori Christie · Lorie Anderson · Lormie Talape · Lorna Alcasabas · Lorna Carter · Lorna Jenkin · Lorna Sueta · Lorraine Barcibal · Lorraine Dawson · Lorraine Hulse · Lorraine Julia · Lorraine Knight · Lorraine Leigh ·
Lorraine Masters · Lorraine Parnell · Lorraine Tippett · Lotis Baldozano · Lotis Caranguian · Loto Foaese-Aiolupo · Lou Anisy · Lou Moyle · Louie Pagaduan · Louis Wolmarans · Louise Carr · Louise James · Louise Nicholas
· Louise Trilloe · Louise Waller · Louise Woods · Louise Davies-Collins · Lourdaelee Yude · Lourde Riotoc · Love Joy Battulayan · Lovely Chauhan · Lovely Sawal · Lovey Williamson · Lovi Lavulo · Lu Southern · Lua Tauaneai
· Luc Davenport · Lucia Aiga · Lucia Meyer · Lucky Schuster · Lucky Shakya · Lucy Banaba · Lucy Bothwell · Lucy Caldwell · Lucy Deng · Lucy Fan · Lucy Kamau · Lucy Mataki · Lucy Melchert · Lucy Plant · Lucy van Deursen
· Lucy Weir · Lucy Zengeni · Lucy Kawana · Luis Leh · Luisa Filimoehala · Luisa Rokotuiloma · Luisa Wilson · Luisa Elisara · Luke Flynn-Mackenzie · Luke Hutchinson · Lulu Harkness · Lupe Halafihi · Lupe Kaufusi · Luseane
Leota · Lusiana Khan · Lusila Perez · Luz Pinili · Lydia Lophus · Lydia Morintat · Lyn Aragon · Lyn Brown · Lyn Elton · Lyn Fellows · Lyn Jeffrey · Lyn Nickel · Lyn Nyenhuis · Lyn Smith · Lynda Clough · Lynda Dean · Lynda Van
den Bos · Lynda Hill · Lynda Schuler · Lynde DeAndres · Lyndsay Richards · Lyndsey Craig · Lyndy Direen · Lynette Darling · Lynette Neale · Lynette Pido · Lynette Polley · Lynette Taylor · Lynley Ballantine · Lynn Buist ·
Lynn Charlton · Lynn Garner · Lynn Kerekere · Lynn Matthews · Lynn Patel · Lynn Rollo · Lynn Tanner · Lynn Yang · Lynne Bretherton · Lynne Domigan · Lynne Johnston · Lynne Kane · Lynne Lepoidevin · Lynne Peirse ·
Lynne Jackson · Lynton Parkinson · Lyssa Whatarau · Ma Kriezl Mena · Maaimoa Latu · Maan Singh · Ma’ata Mesui · Mabel Mathews · Mackenzie Stuart · Mackenzie Van-Flupen · Maddi Brown · Maddi Eustace · Maddi
Hansen · Madeline Bedggood · Madelyn Premacio · Madhu Singh · Madi Taylor · Madusha Fernando · Madz Marana · Mae Abalajen · Mae Flores · Mae Macabuat · Maffy Coates · Mafi Manuhapai · Maggie Malone · Maggie
Roberts · Mahal Gabionza · Mahima Muralidharan · Mai Phetcharoen · Maia Clare · Maia Tagod · Maia Taylor · Maine Mercado · Mak Eketi · Makayla Adams · Malcolm Haliday · Maleesa Daniel · Malia Lutu · Malia Savelio ·
Malo Tauaneai · Mamta Joon · Mamta Kumar · Man Wai Fung · Manasa Mohan · Manda Ross · Mandeep Gill · Mandy Clutterbuck · Mandy Errington · Mandy Hemmingsen · Mandy Jiang · Mandy Kaur · Mandy Tipoki · Mandy
Uren · Mandy Zhang · Mandy Davie · Mani Kaur · Manish Gaur · Manisha Gurung · Manisha Mane · Manisha Sami · Manjit Mahi · Manju Bothara · Manjula Devi · Manmeet Kaur · Manohari Mendis · Manpreet Kaur · Manpreet
Kaur · Manpreet Kaur · Manpreet Sekhon · Manpreet Kaur · Manu Kaur · Manu Mathew · Manu Sherchan · Manvir Kaur · Manwinder Sangha · Mara Hernando · Marama Lomia · Marama Terakoro · Marcia Hawe-Akinwumi
· Marcus Cullen · Maree Crozier · Maree Hughes · Maree McCorkindale · Maree Morris · Maree Ockwell · Maree Parsons · Maree Ramanauskas · Maree Vaile · Maree Washbourne · Maree Kay · Mareike Bohte · Marella Tan
· Marg Vicente · Marg Vince · Margaret Chambers · Margaret Haami · Margaret Hamilton · Margaret King · Margaret Lethbridge · Margaret Manebona · Margaret Manson · Margaret McMellon · Margaret Mulloy · Margaret
Osage · Margaret Rakai · Margaret Whitehead · Margareth Cainto · Margie Ranjo · Margo Beale · Margo Fowler · Margot Boock · Mari Gomes · Maria Achari · Maria Amores · Maria Bautista · Maria Bentley · Maria Cavan ·
Maria Cuizon · Maria Flores · Maria Fuga · Maria Gopi · Maria Inocencio · Maria Jarkiewicz · Maria Jordan · Maria Kengen · Maria Mathieson · Maria McNeilly · Maria Molina-Dizon · Maria Neill · Maria Nuval · Maria Ralawa ·
Maria Ramos · Maria Restrepo · Maria Tamale · Maria Te Runa · Maria Walker · Maria Warriner · Maria Cudejkova · Maria Torralba · Marianel Miralles · Marianita Pelaez · Marianne Cobeldick · Marianne George · Marianne
Hernandez · Maricel Atienza · Marichel Cadavos · Marichelle Roxas · Marichille Bandales · Marichu Calpo · Marichu Siao · Maricris Mariano · Marie Aki · Marie Araneta · Marie Chandra · Marie Darling · Marie Deverell ·
Marie Domingue · Marie Gonzales · Marie Hodges · Marie Jenkins · Marie Kilby · Marie Kyle-Stevenson · Marie Rutherford · Mariel Ceballos-Loloya · Mariel Simblante · Mariela Durnhofer Rubolino · Marietjie Schoeman ·
Marievan Tan · Marife Patterson · Marife Galvez · Marika Laflamme · Marilou Callo · Marina John · Marina Orlova · Marina Turnbull · Marina Wildbore · Marion Jackson · Marion McManus · Marion Paquit · Marion Pawson
· Mariss Yamson · Marissa Hirawani · Marius Mostert · Marivic Sinio · Marizz Maneng · Marjan Aghakarimi · Marjo Engel · Marjorie Gomez · Mark Adams · Mark Cooley · Mark Cooper · Mark Florendo · Mark Gela · Mark
Jerkovich · Mark McDonald · Mark Paraiso · Mark Robinson · Marko Meingassner · Marlene Willems · Marmyl Robson · Marnie Castillo · Marta Manicia · Marta Ros Ruiz · Martha Peka · Martin Burns · Martin Greenfield ·
Martin Lau · Martin Westley · Martley Mitikulena · Martyn Osborn · Marvie Rongavilla · Mary Bautista · Mary Buford · Mary Condino · Mary Cyriac · Mary Dayto · Mary Domingo White · Mary Durban · Mary Freeman · Mary
Gialamas · Mary Gonzales · Mary Harborne · Mary Jacobsen · Mary Kasperski · Mary Kints · Mary Lusty · Mary Rosales-Shewring · Mary Tait · Mary Teei · Mary Thompson · Mary Vasaya · Mary Ybanez · Mary Ann Domingo
· Mary Ann Noquilla · Mary Jean Basilio · Maryanne Gilmore · Maryanne Marsters · Mary-Anne MacAskill · Maryanne Samson · Marybeth Perez · Mary-Jane Hackney · Maryvonne Gray · Masayo Burke · Mason Walker ·
Mason Woods · Matakeu Timms · Matelle Valmoria · Mathews Jose · Mati Fryer · Matt Bell · Matt Chen · Matt de Jong · Matt Deledio · Matt Fane · Matt Hutchinson · Matt Poskitt · Matt Smith · Matt Southwick · Matt Wright
· Matthew Brown · Matthew Gowdy · Matthew Somosot · Mauree Parker · Maureen Barron · Maureen Glentworth · Maureen Johnson · Maureen Parsons · Maurice Schroeder · Max Muscroft · May Carinan · May Pama ·
May Raquepo · May Sino-Ag Sargento · May Angeli De La Cruz · Maya Daniel · Maya Prasad · Maybel Bumanglag · Maychelle Bechayda · Mayda Bromley · Maye Agdigos · Meagan Leqakowailutu · Mealofa Faimalo ·
Meegan Potts · Meehee Kim · Meena Meenakshi · Meera Kakaraliya · Meg Wooller · Megadryl Atas · Megan Ashton · Megan Burns · Megan Coffey · Megan Fowlie · Megan Knight · Megan Willis · Meghan Blackwell-Hart ·
Mei Boderick · Mei Coates · Meidy Maza · Meise Misa · Mel Aspinall · Mel Bourk · Mel Corliss · Mel Jones · Mel Mackay · Mel Perrin · Mel Snyder · Mela Moceiwai · Melania Velterean · Melanie Asuncion · Melanie Dizon ·
Melanie Harrison-Shipton · Melannie Marasigan · Mele Ekenasio · Mele Palelei · Mele Sili · Mele Vi · Meliame Nimmo · Melina Palmer · Melinda Opray · Melinda Reside · Melis Casimiro · Melissa Aleta · Melissa Allan · Melissa
Caldwell · Melissa Carter · Melissa Cousins · Melissa Cross · Melissa Dean · Melissa Escretor · Melissa Fluit · Melissa Franklyn · Melissa Lloyd · Melissa Parrish · Melissa Wayland · Melita Lesiva · Melkame Kebede · Mellisa
Sione · Mellissa Page · Melvin Manglicmot · Mely Cruz · Memoree Wishart · Menaka Silva · Menali Weerasekara · Meng Meng · Mengyao Luo · Menik De Silva · Mennen Oebanda · Menno Theodooz · Mercy Olores · Mercy
Ponniah · Mere Caginiveisaqa · Mere Korotuku · Mere Mana · Mere Manukonga · Mere Tabataba · Mereani Boi · Mereani Naduva · Meredith Fricker · Merenaite Va’a · Merewalesi Rogasagasa · Merin Sabu · Merin Thomas
· Meriya Dias · Merlin Varghese · Merly Jacob · Merlyn Clarke · Merlyn Raciles · Merree Harris · Merrian Dundas · Merrin Jack · Merryl Espanol · Meryll Totanes · Meserat Mulegata Cherente · Meylen Leti · Mhel Bautista
· Mhern Hatosa · Mia Azogue · Mia Mia · Mia Wong Yit · Michael Aninon · Michael DePonte · Michael Galgo · Michael Ledama · Michael Masoe Milovale · Michael Teague · Michael Cummings · Michael Le Pine-Day · Michael
Pascual · Michaela Claridge · Michaela Reyes · Michaela Forgus · Michaella Faaita · Michele McAlinden · Michele Morrison · Michelle Abad · Michelle Barnard · Michelle Berridge · Michelle Blackler · Michelle Blanchard ·
Michelle Canning · Michelle Cowan · Michelle Eleno · Michelle Forgus · Michelle Forman · Michelle Garland · Michelle Greig · Michelle Houston · Michelle Kiel · Michelle Legaspi · Michelle Loader · Michelle Lord-Roper ·
Michelle Oelofse · Michelle Paget · Michelle Perkins · Michelle Priest · Michelle Rampling · Michelle Robertson · Michelle Robinson · Michelle Shaw · Michelle Sims · Michelle Stewart · Michelle Sutherland · Michelle Tan ·
Michelle Tidey · Michelle Van der Park · Michelle Vermeer · Michelle Wright · Michelle Lewis · Miho Tomoike · Mika Reid · Mikayla Miller · Mike Adair · Mikey Pantaleon · Mila Biaukula · Mila Slavinskaya · Mille Vette · Millie
Edwards · Millie McKernan · Min Cho · Min Choi · Min Kim · Min Lee Phang · Minty Walia · Miraina Rimon · Miranda Sargant · Mirasol Beattie · Miriam Johnston · Miriam Rogers · Miriama Johnston · Misa Patterson · Mitanshu
Devi · Mitchell Johnson · Mlete Asfaw · Moana Fifita · Moana Kouka-Ruhere · Moana Martin · Mohamad Bucua · Mohini Narayan · Mohini Olds · Moka Atamu-Watkinson · Molly Limpus · Molly Martin · Molly Steel · Momena
Begum · Momota Sikalu · Mona Sami · Mona Singh · Monette Angadol · Monica Cruz Arevalo · Monica de Jesus · Monica Keys · Monica Narasimalu · Monica Relucio · Monika Monika · Monika Prasad · Monima Thapa ·
Monique Awab · Monique Leeson · Monique Marshall · Monique Powe · Monique Villalobos · Monique Wilson · Monita Mala · Moose Roris · Moreen Kaur · Moreen Lata · Morgan Davis · Morgan Edge · Mouli Liyanaarachchi
· Mounata Shrestha · Mousmi Bhaggal · Mufida Nisha · Muhammed Khan · Muna Nonu · Munah Miller · Murray Bain · Murray Parkes · Mylah Morandarte · Mylen Lingaolingao · Mylene Bugo · Myra Attwood · Myra Gotz ·
Myra Tonks · Myrna Tulloch · Myrtle Brown · Naaz Hakim · Nadege Wan Riau · Nadia Heggland · Nadine Davis · Nafeeza Manga · Naise Palusa · Namiko Uehara · Namita Shyam · Namrata Joshi · Nancy Brown · Nancy
Hayden · Nancy Mitchelson · Nancy Taua · Nancy Watta · Nancy Wilson · Nandika Silva · Nandini Ram · Nani Rokotuisuva · Nao Osato · Naoko Matsuo · Naomi Kaba · Naomi Kato · Naomi Silva · Naomi Tulaga · Naomi
Keegan · Narmadha Dissanayake · Narumon Murray · Nasib Kaur · Nasiya Jarish · Nat Shackleton · Natalia Krouchinskaia · Natalia Mazive · Natalie Elliott · Natalie Finn · Natalie Fox · Natalie Saunders · Natalie Thomson ·
Nataliya Tretyakova · Natalya Holley · Natana Gisma · Natasha Carson · Natasha Fitzpatrick · Natasha Henderson · Natasha Mileva · Natasha Montagu · Natasha Rattray · Natasha Ball · Nathan Brown · Nathan Ellis ·
Nathan Monaghan · Nathan Salanoa · Nathan Tahi · Natnicha Sangsorn · Naumai Taitumu · Nav Hehar · Nav Kaur · Nav Kaur · Nav Singh · Navdeep Kaur · Navjeet Multani · Navjot Brar · Navjot Kaur · Navneet Kaur · Navneet
Navneet · Neal Barkell · Neethu Joseph · Neethu Maxin · Neethu Sebastian · Neethu Tony · Neetu Kaur · Neha Neha · Neha Neha · Neil Davies · Neil Sadlier · Neil Sears · Nela Sepuloni · Neli French · Nelly Chand · Nemo
Arriola · Nena Balbis · Neneh Martin · Neneth Alicamen · Nerin Anoop · Neslyn Baglan · Nessa Ojales · Nethmi Amarasinghe · Nette Gabriel · Neville Parkinson · Ng Faron · Ngahuia Wetere · Ngaire Harris · Ngaire Moreton
· Ngaire Ria · Ngas Gideon · Ngosi Smith-Licorish · Ngun Heh · Nhes Coroza · Nibin Antony · Nic Thorpe · Nicha Prachankhet · Nichola Smyth · Nicholas Kisina · Nicholas Morris · Nick Male · Nick Tully · Nick Frische · Nicki
Kay · Nicki May · Nicky Anderson · Nicky Crawford · Nicky Hudson · Nicky Morse · Nicky Phillips · Nicky Smith · Nicky Bercich · Nicola Bowick · Nicola Keast · Nicola Martin · Nicola Mitchell · Nicola Price · Nicola Steel ·
Nicola Tarleton · Nicole Duncan · Nicole Dunn · Nicole Forster · Nicole Kearney · Nicole Ladino · Nicole Langman · Nicole Mills · Nicole Nation · Nicole Rodgers · Nicole Toomey · Nicole Uy · Nicole Yeatman · Nicole Serrano
· Nicole Tayles · Nicy Abraham · Nidisha Shetty · Nig Eccles · Nigel Keane · Nigel Megaw · Nik Ekdahl · Nika Lafaele · Nika Siania · Niki De La Harpe · Niki Veeran · Nikita Horan · Nikita Van Niekerk · Nikka Bermejo · Nikki
Babbington · Nikki Barringer · Nikki Bonus · Nikki Deang · Nikki Harrington · Nikki Johns · Nikki Kirner · Nikki Millar · Nikki Mills · Nikki Yamson · Nikolai Balanski · Nikole Henderson · Nilda Pagba · Nileshni Devi · Nili Gyawali
· Nilmini Rajapaksa · Nilsane Rosales · Nima Joseph · Nimfa Nanales · Nimi Jacob · Nimmy Thomas · Nina Kluge · Nina Melocotones · Nina Sharples · Nina Wozniak · Nina Zhang · Ninja Chahal · Nirmala Karki · Nirmala
Sharma · Nirosa Perera · Niru Chouhan · Niru Barot · Nisha Ismail · Nisha Kalathil · Nisha Thapa · Nishantha Jinadasa · Nita Yu · Nithila Thangamony · Nizar Gilani · Nizar Virani · Nochelle Visitacion · Noeline Plowman ·
Noella Farrell · Noema Leota · Noemie Flores · Nolene Percy · Nona Chase · Nora Arango Bedoya · Nora Esplago · Nora Hankey · Norma-Jean Wilson · Norman Beattie · Norman Tadique · Nova Santiago · Nyzza Gabor ·
Oakley Miller · Odessa Abellana · Odette Whitter · Ofa Lolohea · Olive Balli · Oliver Bones · Oliver Konigstorfer · Oliver Korunic · Oliver Neal · Olivia Clover · Olivia Ferrer · Olivia Gilmore · Olivia Hamilton · Olivia Lennox ·
Olivia Roth · Olivia Van de Klundert · Olivia Yan · Om Prasad · Omar Damatac · Omar Dumaquita · Ondene Te Kahika · Orada Wisatwongsa · Ossie Wiggill · Otep Sacristan · Otto Otto · Pabitra Gautam · Paewai Tume ·
Paige-Ellen Field · Pam Harliwich · Pam McCreedy · Pam Mino · Pam Mirk · Pam Poonam · Pankti Modh · Paola Adolfo · Paola Beltran · Paolo Robles · Param Kaur · Paramjeet Buttar · Pardeep Brar · Parmjit Kaur · Parvathy
Nair · Parvati Lal · Parveen Brar · Parveen Chohan · Parvinder Kaur · Parwati Kriletich · Parwinder Kaur · Pasepa Veilofia · Pat Mabunga · Pat McKee · Pat More · Pat Sleeman · Pat Turner · Patricia Nand · Patricia Robles ·
Patty Khunkaew · Paul Bertelsen · Paul Child · Paul Clark · Paul Delamain · Paul Dyack · Paul Francis · Paul Guy · Paul Korunic · Paul Lenette · Paul Martillana · Paul Morunga · Paul Purnell · Paul Sutcliffe · Paul Sutton · Paul
Viernes · Paula Cathcart · Paula Fa’aoso · Paula Franklin · Paula Kennard · Paula Moyles · Paula Panckhurst · Paulette Sheehan · Paulina Woch · Pauline Cody · Pauline Field · Pauline Gordon · Pauline Groves · Pauline Hillis
· Pauline Linton · Pauline Murray · Pauline Nickson · Pauline Patterson · Pauline Robinson · Pauline Rousseaux · Paulo Moreira · Pawan Kaur · Paz Chan · Paz Checchecan · Peachy Wee · Peak Prompim · Pearl Ranui · Pearl
Sharman · Peggy Chao · Pele Vaaga · Pelise Muiaa · Penelope Stark · Peni Raroa · Pepa Memea · Pepe Tamapeau · Pepe Toe · Percy Segarra · Perla Torreja · Persis Chavan · Peta McGregor · Peter Alesana · Peter Erian ·
Peter Hollins · Peter Macintosh · Peter Meilink · Peter Prins · Peter Shaw · Peter Smith · Peter Whelan · Peter Small · Petra Bulandova · Petra Klingbeil · Pha Taylor · Phil Bang · Phil Haynes · Phil Quartly · Philip Hanson · Philip
Jackson-Cox · Philip Mealings · Philippa Campbell · Philippa White · Phill Larner · Phillipa A’Court · Phoebe Laureano · Phoebe Markham · Phoebe Premacio · Phoebie Wesche · Phyl Balogo · Pieta Valentine · Pieter Kruger
· Pilar Merino Neyra · Pinal Parmar · Pinchu Reghunadhan Nair Jayasree · Ping Liu · Pinki Thapa · Pinky Evangelista · Pinky Kurian · Pinky Paulino · Pip Griffin · Pip Smith · Pip Wayne · Pippa Spencer · Pita Bhattarai · Polly
Maxwell · Pooja Khokra · Pooja Patel · Poonam Jyoti · Poonam Kumar · Poonam Rani · Poonam Rani · Poppy Griffin-King · Prabath Meegoda Gamage · Prabhjot Kaur · Pracey Cheriyan · Prachi Didmishe · Pradip Khadka
· Prajith Ramakrishnan · Prakash Singh · Praneel Singh · Prateek Sharma · Pratima Sharma · Pravin Singh · Precy Bond · Prema Gavarriah · Premitha Silva · Preshmeen Reddy · Prince Gill · Princess Tabay · Priscila Van
Den Bemt · Priscilla Francis · Priscilla Mihaere · Pritee Gurung Lama Lopchan · Priti Devi · Pritika Chand · Pritika Devi · Privitha Sivanesan · Priya Drummond · Priya Goundar · Priya Prakash · Priya Reddy · Priya Sharma ·
Priya Sharma · Priyanka Joshi · Priyanka Rai · Priyanka Tandon · Priyanka Gamit · Priyanthi Perera · Priyeta Priyadarshni · Prox Tiwari · Prudy Macdonald · Prue Langdon · Pryanka Biswas · Purissa Abalo · Purnima Devi ·
Pushpa Rao · Qalo Kolinisau · Qin Xueqin · Rabyn Reveche · Rach Neill · Rach Wates · Rachael Condon · Rachael Hearn · Rachael Mason · Rachael Roberts · Rachael Seyb · Rachael Van Aalst · Rachael Hanrahan · Racheal
Trinidad · Rachel Ang · Rachel Beattie · Rachel Binnie · Rachel Cadzow · Rachel Clark · Rachel Garrard · Rachel James · Rachel Lalor · Rachel Lim · Rachel Llido · Rachel McIvor · Rachel Papo · Rachel Robertson · Rachel
Smedley · Rachel Smith · Rachel Stansbury · Rachel Turner · Rachel Wangui · Rachel Williams · Rachel Alford · Rachelle Jones · Rachelle Nuevo · Radha Wagle · Radhika Lingam · Radhika Reddy · Rae Austin · Rae Cruz
· Raewyn Flyger · Raewyn Greene · Raewyn McLachlan · Raewyn Sides · Raewyn Taylor · Raewyn Ward · Raewyn Wright · Raewyn Bishop · Raewyn Redfern · Raewynne Daly · Raf Lachica · Ragni Narayan · Ragni Lata ·
Rahat Arif · Rahul Suresh · Rahul Singh · Rain Timalsina · Raissa Manicad · Raj Balamysi · Raj Grewal · Raj Sundararajan · Raj Velumula · Raja Thirumugam · Rajan Kumar · Rajani Acharya · Rajeev Kumar · Rajneel Shankar
· Rajni Punia · Rajvir Kaur · Rajwinder Kaur · Rajwinder Kaur · Raken Abiteti · Ralph Lee · Ram Martir · Rama Niroula · Raman Brar · Raman Gill · Raman Kaur · Raman Singh · Ramandeep Sharma · Ramanpreet Dhillon ·
Ramanpreet Ramanpreet · Ramanpreet Syal · Rami Brar · Ramya Bellam · Randeep Kaur · Randeep Kaur · Randeep Kaur Parihar · Ranga Mahere · Rani Kuriakose · Rani Pillay · Ranjana Gurung · Ranjanie Dhanapala ·
Ranjeeta Krishna · Ranjit Kaur · Ranjit Kaur · Ranjita Poudel Mahat · Raola Sayer · Raquel Bibal · Raquel Rapp · Rasanjana Kumarasinghe · Rata White · Raven Bitancor · Ravinder Binning · Rawinia Tahi · Ray Fairbairn ·
Thank you
Raya Aganon · Raymond Laws · Rayu Agcopra · Raziya Nisha · Razyl Canlas · Rebecca Ducre · Rebecca Dunn · Rebecca Fieldhouse · Rebecca Fielding · Rebecca Hart · Rebecca Hill-Van Der Merwe · Rebecca Kavugho
· Rebecca Keen · Rebecca Knell · Rebecca Little · Rebecca Lomax · Rebecca Malaki · Rebecca Mansell · Rebecca McMillan · Rebecca Schumacher · Rebecca Thwaite · Rebecca Waine · Rebecca Wells · Rebecca Wethey
· Rebecca Burgess · Reega Tholath · Reema Devi · Reena Chandar · Reeta Singh · Reetika Sharma · Regina Gounder · Rehana Sharif · Reina Manten · Reina Saludares · Reina Bonaobra · Reinz Caduhada · Rejena Lazar
· Rekha Ramanath · Remya Kariyapurayidom Thomas · Remya Rajagopal · Ren Abarca · Rena Allen · Rena Hawe · Rene Bryant · Rene Lagahit · Renee Perreau · Renee Tume · Renestien Paracha · Renisha Senchyury ·
Renjith Pariyarath Raveendran Nair · Renuka Gounder · Reshma Mala · Reshma Mathew · Reshma Moolayil · Reshmi Lata · Reshmi Narayan · Reshmy Remanan · Reshnee Cabunilas · Ressa Larkin · Reta McCleery · Reti
Hema · Reuben Andrew · Reuben Mahendran · Revlin Ratishma · Rewa Stewart · Rey Pugosa · Reydun Kihi · Reyn Dilag · Rhea Canada · Rhia Le · Rhianne Overell · Rhona Miranda · Rhonda Evans · Rhothia Swart · Rhyarna
Batchelor · Ria Grewal · Ria Jamin · Riana van Niekerk · Ricardo Onate · Ricardo Pureza · Richa Ghimire · Richard Batt · Richard Bennett · Richard Chisholm · Richard Crump · Richard Sherrell · Riche Campaniel · Richelle
Martin · Richelle Villanueva · Richie Cronin · Richie Ouano · Richie Sabulao-Tablate · Rick Anderson · Ricky Bruining · Ricky Ciobanu · Riffy Jahan-Khan · Riji Johny · Rika Kawakami · Rikka Ly · Riley Leonard · Rimal Ram
· Rina Situmorang · Rini Sochidin · Rishi Mangalat Kokkodan · Rita Aballog · Rita Connolly · Rita Neves · Ritty Abraham · Ritu Devi · Riya Augustian · Riya George · Riya Mahna · Rizel Delay · Rizza Moron · Ro Nazari · Rob
Carter · Rob Miller · Rob Simpson-Burn · Robbie Blair · Robbie Muller · Robert Cradock · Robert Gallagher · Robert Honoridez · Roberta Baxendale · Roberta Campbell · Robyn Elder · Robyn Kereone · Robyn Kerr · Robyn
Lever · Robyn McCracken · Robyn O’Regan · Robyn Sullivan · Robyn Thompson · Robyn Tomkins · Robyn Tutton · Rochelle Bibal · Rochelle Cohen · Rochelle Craigie-Whitta · Rochelle Davis · Rochelle Hart · Rochelle Kara
· Rochelle Li · Rochelle McIntyre · Rochelle Taylor · Rochelle Concha · Rocky Atendido · Rod Flemming · Rodela Caldea · Rodney Gopal · Rody Abuan · Rogelyn Parcon · Roger Nuttall · Roger Rolls · Roger Sales · Roger
Sillars · Roger Thorpe · Rohan Natekar · Rohini Devi · Rohini Gayakwad · Rohini Gurung · Rohini Lal · Rohini Lata · Rohini Lata · Rohini Namuni · Rois Gracia · Roisin Phillips · Roma Tarranza · Romane Mouillon · Romeo
Villanueva · Romina Carangalan-Rosales · Rommel Marcelo · Roms Ungab · Ron Ente · Ron Llanera · Rona Mendoza · Ronald Damian · Ronalyn Alolor · Ronee Kumar · Roni Lamsen-Castillano · Roni Mathew · Roni Mathew
· Ronita Prasad · Ronitta Philip · Ronny Liew · Ronny Taane · Roop Bhullar · Roopa Roopa · Roopa Shetty · Rory Edwards · Rory Tai · Rosa Korneliussen · Rosalie Watson · Rosalind Hayhoe · Rosaria Manjala · Rose Avery
· Rose Cable · Rose Coulson · Rose Gabatan · Rose Lawlor · Rose McSkimming · Rose Noval · Rose Sacay · Rose Shepard · Rose Tabasan · Rose Taylor · Rose Tom · Rose Velilla · Rose Beals · Rosecilla Saulon · Roselee
Mudalige · Roseline Sharma · Roselle Camatis · Roselle Plata · Rosemary Deane · Rosemary Henson · Rosemary Joy · Rosemary Maligsay · Rosette Vocal · Roshana Taylor · Roshila Cherman · Roshmen Hussain Ali ·
Roshni Hicks · Roshni Jeet · Roshni Raja · Rosie Butler · Rosie Ireland · Rosie Malone · Rosie Neilson · Rosie Williams · Rosie Wong · Rosmi Mathew · Rosmin George · Ross Bulling · Ross Howes · Ross Ireland · Ross
Sutherland · Ross Whiteside · Roula Yianakis · Rowena Birch · Rowena McCutchie · Rowena Newport · Rowena Poroa · Rowena Wood · Roxanne Balidio · Roxy Saltmarsh · Ruben Kumar · Ruby Beresford · Ruby Briede ·
Ruby Galviz · Ruby Kanwar · Ruby Kaur · Ruby Mitchell · Ruby Brar · Rupa Sherma · Rupi Kaur · Rupinder Dhaliwal · Rupinder Kaur · Rupinder Kaur · Ruselle Surell · Rushita Dave · Russell Dobson · Ruth Donnelly · Ruth
Donoghue · Ruth Gavey · Ruth Mackay · Ruth Makin · Ruth Murray · Ruth Waterhouse · Ruthy Manu · Ruthy Van Heerden · Ryan Evans · Ryan Junaid · Ryan Patron · Ryan Verbo · Ryanna Cabunilas · Saakshi Sunnaina ·
Sabira Khan · Sabita Bhattarai · Sabitri Gajurel · Sabnam Pun · Sabrina Lamvohee · Sacha Young · Sadhana Devi · Sadhana Wati · Sadhna Reddy · Sadia Farzana · Safaira Koto · Saffron Shield · Saggita Devi · Sai Huang ·
Saifun Nisha · Saisamon Hongbin · Sajana Shabin · Sajeeve Rajasuriya · Sala Manase · Saleshni Maharaj · Salie Alcartado · Sally Abarquez · Sally Haslam · Sally Hayashi · Sally Johanson · Sally Mulitalo · Sally Rodgers ·
Sally Veng · Sally Waldek · Salochana Naidu · Salosh Singh · Salote Tuivakano · Salote Salailagi · Sam Abrham · Sam Ahn · Sam Carryer · Sam Cassidy · Sam Hibbs · Sam Hines · Sam Jakes · Sam Kingi-Te Purei · Sam
Kingsbury · Sam Mahapure · Sam Mathew · Sam Nicholls · Sam Pewhairangi-Stok · Sam Rusden · Sam Shirkey · Sam Singh · Sam Taylor · Sam Te Nahu · Sam Tobias · Sam Trotter · Sam Wheeler · Sam Woolford · Samantha
Smart · Samara Hodges · Sami Adhikari · Sami Chinnock · Samiksha Dhakal · Samira Khan · Samista Subedi · Sammi Nelson · Sammi Zhang · Sammy Caffell · Sammy Cook · Samool Yadav · Samuel Samuel · Samuel Shijo
· Samuel Julian · Sandamali Karalin Gamage · Sandeep Kaur · Sandeep Kaur · Sandeep Sidhu · Sandeep Waraich · Sandi Keen · Sandie Campbell · Sandie Eddy · Sandra Batten · Sandra Chapman · Sandra Duckworth ·
Sandra Hendriks · Sandra Hodson · Sandra Houston · Sandra Kennedy · Sandra McGlade · Sandra Naea · Sandra Officer · Sandra Rogers · Sandra Severinsen · Sandra Siakifilo · Sandra Stacey · Sandy Kaur · Sandy
Paterson · Sandy Patterson · Sandy Pihema · Sangeeta Lata · Sangeeta Shrestha · Sani Peter · Sanita Kumar Bai · Sanj Prasad · Sanjana Koroththazhekuni · Sanjay Rivera · Sanna McGavin · Santi Samuel · Sanumol Antony
· Sara Fearnley · Sara Hodgson · Sara Kaur · Sara Kaur · Sara Kuruvila · Sara McCunnie · Sara Newbury · Sara Taylor · Sarab Kaur · Sarah Affleck · Sarah Aloria · Sarah Ardill · Sarah Arps · Sarah Bennett · Sarah Campbell
· Sarah Creighton · Sarah Direen · Sarah Enverga · Sarah Farrell · Sarah Henderson · Sarah Henwood · Sarah Kim · Sarah Kitto · Sarah Laiz · Sarah Lomax · Sarah Louttit · Sarah Maxwell · Sarah Meek · Sarah Mondejar ·
Sarah Reid · Sarah Schmidt · Sarah Sinclair · Sarah Taylor · Sarah Tomas · Sarah Vivian · Sarah Walsh · Sarah Davis · Sarah Deal · Sarah Mae Micabani-Mueller · Saras Kumar · Sarath Kanuboina · Saravjeet Kaur · Sarda
Gounder · Sarika Asokan · Sarika Prasad · Sarila Devi · Sarina Hubber · Sarina Shrestha · Sarita Kumar · Saritha Baiju · Saritha Mathew · Saroj Chauhan · Sarojitharai Srikanthan · Sarojni Kumar · Sarojni Sarojni · Sashi
Hutchins · Sashi Lata · Sashi Prasad · Sashi Singh · Sasika Samarakoon · Saskia Hannink · Satbir Kaur · Sathish Kumar · Satinder Kaur · Satwinder Dhindsa · Savita Reddy · Savitri Naidu · Savitri Naidu · Sayo Pereppadan
· Scott Bignold · Scott Crawford · Scott McGregor · Scott Redmond · Scott Saunders · Scott Wallace · Sean Crosby · Sean Galbreath · Sean Jenkins · Sean Mortimer · Sean Ortuoste · Seekku Silva · Seena Sooraj · Seetha
Mwashomah · Seirosa Fakaofo · Selene Patterson · Senait Degfe · Senijiale Fuakulau · Seniya Sebastian · Senolita Vea · Sera Kaliopasi · Serema Saxe · Serge Hollis · Seu Silipa · Sha Bolivar · Sha Nonato · Sha Terrobias ·
Shabin Basheer · Shaby Wilde · Shah Silerio · Shahreena Kereopa · Shai Venkitachalam · Shain Begum · Shaira Ugay · Shairin Begum · Shaleeni Goundan · Shaleshni Kumari · Shalesni Kumari · Shalia Hussain · Shalika
Wijethilaka · Shalimar Bawayan · Shalini Shah · Shalom Ndukwe · Shalu Corro · Shaly Lazer · Shamie Zindoga · Shamshad Begum · Shamsun Partap · Shana Callaghan · Shane Bayang · Shane Fairbairn · Shane Grinter ·
Shane Vargas · Shani Rathnayaka · Shania Simpson · Shanika Mudiyanselage · Shanno Chand · Shannon Armishaw · Shannon Butler · Shannon Denham · Shannon Jackson · Shannon Ritchie · Shannon Scotney · Shanthi
Fernando · Shanthy Gopal · Shanti Prasad · Sharalyn Dockerty · Sharandeep Kaur · Sharanjit Kaur · Shareen Begum · Shareen Devi · Shareene McKinnon · Sharmila Prasad · Sharmila Sharma · Sharn Unka · Sharnie
Hagger · Sharon Armstrong · Sharon Balsom · Sharon Bonfield · Sharon Brown · Sharon Chapman · Sharon Denniston · Sharon Grogan · Sharon Hamlyn · Sharon Henderson · Sharon Jackson · Sharon McDonald · Sharon
McDonnell · Sharon Ritchie · Sharon Tainui · Sharon Chadwick · Sharon Wilton · Sharron Bourne · Sharron Lamb · Sharron Neale · Sharyn Kennedy · Sharyn Ward · Shashee Prasanna · Shashi Lata · Shashi Singh · Shaun
Bhondi · Shaun Kennedy · Shaun Steele · Shawn Duan · Shayal Naidu · Shayna Ingham · Shayna Moir · Shayne Macarubbo · Shazneen Bi · Sheen Reyes · Sheena David · Sheena Morgan · Sheena Taki · Sheena Villa · Sheena
Wiel · Sheenal Singh · Sheenly Tilos · Sheevey Quezon · Sheila Bascara · Sheila Gamboa · Sheila Opena · Shelby Marsh · Shelin Kumar · Shellden Kruyff · Shelley Austin · Shelley Ferguson · Shelley Harris · Shelley Williams-
Bennett · Shelly Mani · Shemery Sevilleno · Shenal Shivasani · Shenan Ranasinghe · Sheng Puguon · Sheniel Sen · Shequille Stewart · Sheree Tanner · Sheridan Searle · Sherine Megula · Sherlin Prakash · Sheron
McDermott · Sheron Perera · Sherree Wilson · Sherryl Sy · Sheryl Aguarilles · Sheryl Keen · Sheryl Morris · Sheryl Smith · Shey Landiza · Shiela Bendal · Shiela Molina · Shiella Alvarez · Shiena Atilano · Shija Koirala · Shikha
Shikha · Shikha Verma · Shinoy Abraham · Shirley Bakulich · Shirley Brown · Shirley Bucua · Shirley Goodall · Shirley Hampson · Shirley Karl · Shirley Krishna · Shirley Leith · Shirley Lin · Shiuli Bagchi · Shivangika Ashok ·
Shivangni Prusad · Shivani Gounder · Shiwani Devi · Shobna Kumar · Shola Olowoyeye · Shom Lata · Shon Frater · Shona Bayliss · Shona Cook · Shona O’Malley · Shoncey O’Brien · Shontelle Taylor · Shraddha Maharjan
· Shreta Chand · Shruti Sharma · Shuba Selvaraj · Shuvayi Mbewe · Shweta Devi · Shy Thomas · Shyji Sebastian · Shyna Boock · Shynal Singh · Shyrene Bechoo · Sia Anand · Sia Kutimeni · Sia Palusa · Sia Taualupe · Sia
Vave · Sianne Pinto · Siga Parker · Sigas Bose · Sigfred Lagajino · Sigin Pullemkunnel · Siliva Samuelu · Silva Evangelista · Silvy Thomas · Sim Bhondi · Sim Gurung · Simi John · Simi Verma · Simin Alipour · Simon Allan ·
Simon Emett · Simon Jantke · Simon Mravicich · Simona Wallwork · Simone Donahue · Simone Taylor · Simone Williams · Simran Kaur Sra · Sina Aaifou · Sina Afamasaga · Sini Jose · Sinto Davis · Siobhan Hotere · Siobhan
Solofuti · Sione Tonga · Sipa Kiko · Sirisuda Charoensak · Sisi Tawake · Siteri Kama · Siteri Nava · Siti Halim · Siu Tapaevalu · Siua Koae · Skye Stanley · Smitha Pulickakunnel Joseph · Smitha Vellattu · Snap Venturanza ·
Snower Singh · Sobin Stephen · Sofia Butler · Sofin Mohammed · Solly Joseph · Solo Tonga · Somkhit Lightbourne · Sonia Barrett · Sonia Bonaobra · Sonia Cuasito · Sonia McMartin · Sonia Peter · Sonia Searle · Sonia
Sharma · Sonia Vincent · Sonia Welch · Sonia Wilson · Sonika Kissun · Sonika Prasad · Sonika Sharma · Soniya Alex · Soniya Magar · Sonja Saumolia · Sony Kaur · Sony Paul · Sonya Brown · Sonya Denton · Sonya Field ·
Sonya Overy · Sonya Pama · Sonya Patey · Sonya Tikoduadua · Sonya Dunlop · Sookie Magallones · Sophia Climaco · Sophia Shan · Sophia Zhang · Sophie Devi · Sophie Koroniadis · Sophie Reade · Sorawit Songsataya
· Soraya Pu · Soumya George · Sova Nairoroi · Stacey Curd · Stacey Hancock · Stacey Wilson · Stacey Woollam · Stan Bickerton · Stan Williams · Starra Wood · Stef Dudek · Stef Monje · Steffy Thomas · Stella McConnochie
· Stella Wong Mok · Steph Cawte · Steph Flis · Steph Townshend · Steph Young · Steph Vallete · Stephanie Broadhurst · Stephanie Edwards · Stephanie Hechter · Stephanie Kara · Stephanie Vincent · Stephanie Weller ·
Stephen De Jonge · Stephen Denvers · Stephen Hand · Stephen Iraia · Stephen Radburn · Stephen Browning · Stephy Sinto · Steve Cotter · Steve Edwards · Steve Jennings · Steve Youn · Steven Lemon · Stevie Taiwhati
· Storm Raharuhi · Stu Oostdam · Stuart Korunic · Stuart Williams · Subhnam Khan · Subin Babu · Sudhakar Sudarsanam · Sue Adamson · Sue Allen · Sue Bovey · Sue Buchanan · Sue Clifton · Sue Coventry · Sue Gemmell
· Sue Hammond · Sue Healey · Sue Horan · Sue Hurcomb · Sue Kaur · Sue Kim · Sue Knight · Sue Liang · Sue Massie · Sue Miller · Sue O’Brien · Sue O’Malley · Sue Pham · Sue Sloan · Sue Stace · Sue Stothart · Sue Stott ·
Sue Su · Sue Taylor · Sue Wickham · Sue Williams · Sue Frew · Sui Lavea · Sujan Sapkota · Sujana John · Sukh Rai · Sukhpal Sandhu · Sultan Salauddin · Suman Lata · Sumi Nand · Sumi Renjith · Sumitra Shrestha · Sumnina
Poudel · Sunita Ghimire · Sunita Sobha · Sunny Choi · Sunny Sandeep · Sunpreet Mann · Supriya Shrestha · Suraj Maisuria · Suresh Unka · Surinder Sran · Susan Bacod · Susan Baird · Susan Bekker · Susan Brett · Susan
Brister · Susan Burgos · Susan Campbell · Susan Crozier · Susan Henderson · Susan Hughes · Susan Millington · Susan Newstead · Susan Potter · Susan Rae · Susan Sainsbury · Susan Smith · Susan Spittal · Susan
Edmonds · Susanne Boehm · Sushan Rijal · Sushila Kumari · Sushma Nepali · Susi Alefosio · Susie Alayne · Susie Cox · Susmita Chhetri · Suzanna Allan · Suzanne Elliott · Suzanne Gain · Suzanne Mason · Suzanne Wilkinson
· Suzanne Wells · Suzette Nuyda · Suzleen Lata · Suzy Stanek · Suzy Gibbs · Svetlana Gladkih · Swapna Talipineni · Swarn Kaur · Swastika Kumar · Swathy Dev · Swati Prasad · Swati Sharma · Sweety George · Syd Matunog
· Sylvia Consadine · Sylvie Borrett · Syvelle Baricuatro · Taff Lewis · Tagi Yabakirua · Tahani Grewal · Tahmina Rahman · Tai (Ther) Hooper · Taina Tuipulotu · Takoi Lopati · Tala Vea · Talai Ati · Talei Murray · Talia Bebeia ·
Tamara Bradford · Tamara Price · Tami Trow · Tammi Kerei · Tamsin Eldridge · Tamsyn Brown · Tangi Ohuka · Tania Boyd · Tania Lilley · Tania Papple · Tania Taylor · Tania Hapi · Tanya Mandeya · Tanya Newton · Tanya
Waters · Tanya Zdebliak · Tanya Swart · Tapa Vaofusi · Tapiwa Zengeni · Tara Berkett · Tara Clark · Tara Zhang · Tarien van Aswegen · Tarn Gardner · Tarns Adams · Tarnz Morrison · Taryn Eagle · Taryn Jonasen · Tash
Aherne · Tash Brightwell · Tash Richardson · Tatiana Nagorski · Tatiane Jacobs · Tau Faatoto Malaga · Tayla Beck · Tayla Whitehouse · Tayla Wiperi · Tayla Anderson · Taylah Williams · Taylar Coates · Taylor Allison ·
Taylor Lawson-Smith · Taylor Murphy-Peters · Te Rangi White · Tee Rakena · Teenu Skaria · Tehanie Azcona · Tek Namoori · Tekai Tuneti · Telma Tom · Temi Fayomi · Tenille Pickett · Teresa Bakewell · Teresa Churchill ·
Teresa Earl · Teresa Hewson · Teresa Jurkiewicz · Teresa Sinclair · Teresa Young · Terese Izquierdo · Teressa Matthews · Terikano Tentoa · Terri McKenzie · Terri Taylor · Terry Burling · Terry Taylor · Tess Canoy · Tess
Coronel · Tess Danganan · Tess Fitzgerald · Tess Mallari · Tessa Edwards · Thamara Fernando · Thara Prabhakar · Thavy Mey · Thea Robiso · Thelma Escobar · Thelma Littlejohn · Theresa Ada · Theresa McCarthy ·
Theresa Miagan · Theresa Rayner · Theresa Robiso · Theresa Te Whata · Thomas Goodhew · Thu Nguyen · Thushari Withanage · Thy Vuong · Tiana Kelbel · Tiana Pitolua · Tiau Itaaka · Tiffany Grant · Tiffany Hamilton ·
Tigi Thomas · Tillie Laufiso · Tim Garlick · Tim Goodwin · Tim Haworth · Tim Reihana · Tim Rickards · Tin Saladar · Tin Tagle · Tin Tin Borres · Tina Baricuatro · Tina Barnett-Peretini · Tina Castro Herrera · Tina Lutui · Tina
Mateo · Tina McNally · Tina Schwenke · Tina Soutar · Tina Strahl · Tina Thomson · Tina Healy · Tin-Tin Ladisla · Tintu Maria Thomas · Tinu Abraham · Tisa Gopal · Tish Dixon · Tita Diamante · Tittu Thomas · Tobias Philip
· Todd Clayton · Todd Weir · Toe Tuputupu · Toka Toawea · Tokasa Vakaloloma · Tom Allison · Tom Brownrigg · Tom Cadag · Tom Mason · Tom Saunders · Tomirose Dela Cruz · Tommy Quinn · Toni Bestow · Toni Borowicz
· Toni Cochrane · Toni McNamara · Toni Neels · Toni Pasco · Toni Walker · Tonia Shakhova · Tony Bell · Tony Howarth · Tony Killip · Tony Thomas · Tony Villanueva · Topsy Reynolds · Torika Warren-Peu · Tory Hamilton ·
Toto Ajawas · Towa Tawake · Tracey Busson · Tracey Campen · Tracey Cheshire · Tracey Chettleburgh · Tracey Clapp · Tracey Collier · Tracey Dewes · Tracey Doody · Tracey Dunn · Tracey Henricksen · Tracey Irvine ·
Tracey Lord · Tracey McCauley · Tracey McIndoe · Tracey Moncur · Tracey Saggers · Tracy Chen · Tracy Elliott · Tracy Kemp · Tracy Mahoney · Tracy McKay · Tracy McLeod · Tracy Webster · Tracy Wickman · Trang Le
· Travis Banes · Travis Cocks · Treeshi Chauhan · Trevor Gray · Trevor Simms · Trina Michelle · Trini Humphrey · Trish Butterworth · Trish Coker · Trish De Jong · Trish Harris · Trish Murray · Trish Tallott · Trish Warren ·
Trish Weke · Trish Windle · Trisha Valdrez · Trishna Chand · Troy Noronha · Trudi Martin · Trudi McNamara · Trudi Wilkinson · Trudy Royfee · Trudy Shepard · Trudy Stark · Tsana Cowling · Tsitsi Marimi · Tua Brown · Tua’a
Simone · Tui Duffull · Tuualii Finai · Tyla MacDonald · Tyler Williams · Tyra Jobe · Tyrah Aspinall · Tyran Van Ingen-Kal · Tyrone Healy · Ubbie Kooma · Udara Wickramaratne · Ula Rakai · Ulysses Patrick Estrellada · Uma
Kumar · Umesh Khiatani · Una Anderson · Una Osunwa · Ungatea Fakaosiula · Usha Adhikari · Usha Subba · Uzma Zaveeri · Vaisakh Bijukumar · Val Abarquez · Val Aitken · Val Calvert · Val Rangelova · Val Spalding · Van
Go · Vandana Kazal · Vandana Narayan · Vandana Pillay · Vanessa Capistrano · Vanessa Claridge · Vanessa Hallett-Free · Vanessa Jeng · Vanessa Jinayon · Vanessa Matson · Vanessa Navarro · Vanessa Neilson · Vanessa
Papa · Vanessa Ranger · Vanessa Tiffany · Vaneza Narsico · Vannida Kheng · Vannz Puleitu · Vara Nailawe · Vardeep Kaur · Varinder Singh · Varun Dayal · Vasemaca Bulitautini · Vasu Sharma · Veda Kantayapalam · Veena
Prabha · Veer Kaur · Ven Flora · Venice Sayson · Venina Bulileka · Venina Rauma · Venus Conag-Ochea · Vera Go · Vera Karauia · Verna Jacobs Douglas · Verna Mepana · Veronica Basinang · Veronica Freire · Vett Ramos
· Vic Scanlan · Vicki Burt · Vicki Hudson · Vicki Leggett · Vicki McLennan · Vicki Mokalei · Vicki Payne · Vicki Taylor · Vicki Webb · Vicki Young · Vicky Boswell · Vicky Brown · Vicky Lilley · Vicky Sel-Ayen · Vicky Tunnell ·
Vicky Veeran · Vicky Weekley · Vicky Woodgyer · Vicky Bourner · Vicsha Cabanero · Victoria Brevoort · Victoria Nand · Victoria Slade · Vidya Wati · Vijay Gounder · Vijay Khadka · Vijay Lachmi · Vikashni Prasad · Viki
Williamson · Viki Jenkin · Vikki Searle · Vilma Cahis · Vimesha Ramanayake · Vimla Wati · Vin Asalele · Vinita Nand · Vinny Naikau · Vipi Vasu · Virgie Cacho · Virginia Bryan · Virginia Makore · Virpal Kaur Mann · Visal
Varghese · Vishnu Prabhakaran · Vita Furche-Degener · Vittoria Salvatierra · Viv Nixon-Mead · Viv Sayson · Vivien Noel · Vivienne Roberts · Von Banzon · Vrinda Mottammal · Wai Baker-Taumata · Waima Ratana · Wan
Yaemkul · Warren Lee · Wati Saravaki · Wayne Blazey · Wayne Burton · Wayne Ross · Weena Evora · Wei Chen · Wen Wang · Wendy Cawood · Wendy Chinh · Wendy Cockerill · Wendy Gordon · Wendy Hamilton · Wendy
Harris · Wendy Johnstone · Wendy Kaka · Wendy Kappler · Wendy Laurie · Wendy MacDonald · Wendy McCallum · Wendy Miller · Wendy Mutepfa · Wendy Rigarlsford · Wendy Riordan · Wendy Taylor · Wendy Turner ·
Wenna Barrido · Wesi Singh · Wharenikau Hing · Whela King · Wiian Bundalian · Wil Yoro · Wilhelmina Bloem · Will Alejandro · Will Locking · Will Watson · William Geck · William Jones · William See · Wilma Barnard · Win
Win Kyi · Winnie Miguel · Winnie Winstanley · Winston Wiggill · Wyndham Tapsell · Xandi Konigstorfer · Yam Karki · Yamuna De Silva · Yan Wang · Yan Zhang · Yancey Valoria · Yannick Martinoli · Yaowapa Somjitsakul ·
Yashna Prasad · Yasmin Asia · Yeshni Rai · Yi Chen · Yin Huang · Ynys Cadogan · Yok Wongsa · Yolanda Acebedo · Yoshi Donnelly · Yra Diez · Yuki Maeda · Yukie Nakano · Yukiko Falchi · Yvette Brown · Yvette Hammond
· Yvette Pearl · Yvonne Bourassa · Yvonne Carter · Yvonne Na · Yvonne Pascua · Yvonne Rawiri · Yvonne Robinson · Zac Southwick · Zac Wynd · Zandra Soriano · Zara Deans · Zay Garcia · Zenith Cabrera · Zerah Mero ·
Zherwin Gianan · Zia Van Niekerk · Zoe Attrill-Palmer · Zoe Eathorne · Zoe Hekelaar · Zoe Jefferies · Zoe Nyika · Zoe Hunter · Zoey Plew-Smeehuyzen · Zoya Bosquet · Zuzka Erdossyova · Zyra Marana
Retirement villages
Anthony Wilding Retirement Village
5 Corbett Crescent, Aidanfield,
Christchurch
Bert Sutcliffe Retirement Village
2 Rangatira Road, Birkenhead,
Auckland
Bob Owens Retirement Village
112 Carmichael Road, Bethlehem,
Tauranga
Bob Scott Retirement Village
25 Graham Street, Petone,
Lower Hutt
Bruce McLaren Retirement Village
795 Chapel Road, Howick, Auckland
Charles Fleming Retirement Village
112 Parata Street, Waikanae
Charles Upham Retirement Village
24 Charles Upham Drive, Rangiora
Diana Isaac Retirement Village
1 Lady Isaac Way, Mairehau,
Christchurch
Edmund Hillary Retirement Village
221 Abbotts Way, Remuera,
Auckland
Ernest Rutherford Retirement
Village
49 Covent Drive, Stoke, Nelson
Essie Summers Retirement Village
222 Colombo Street, Beckenham,
Christchurch
Evelyn Page Retirement Village
30 Ambassador Glade, Orewa, Auckland
Frances Hodgkins Retirement Village
40 Fenton Crescent, St Clair, Dunedin
Grace Joel Retirement Village
184 St Heliers Bay Road, St Heliers,
Auckland
Hilda Ross Retirement Village
30 Ruakura Road, Hamilton
Jane Mander Retirement Village
262 Fairway Drive, Kamo, Whangarei
Jane Winstone Retirement Village
49 Oakland Avenue, St Johns Hill,
Whanganui
Jean Sandel Retirement Village
71 Barrett Road, New Plymouth
Julia Wallace Retirement Village
28 Dogwood Way, Clearview Park,
Palmerston North
Kiri Te Kanawa Retirement Village
12 Gwyneth Place, Lytton West,
Gisborne
Linda Jones Retirement Village
1775 River Road, Hamilton
Logan Campbell Retirement Village
187 Campbell Road, Greenlane,
Auckland
Malvina Major Retirement Village
134 Burma Road, Khandallah,
Wellington
Margaret Stoddart Retirement Village
23 Bartlett Street, Riccarton,
Christchurch
Murray Halberg Retirement Village
11 Commodore Drive, Lynfield,
Auckland
Nellie Melba Retirement Village
2 Collegium Avenue, Wheelers Hill,
Melbourne
Ngaio Marsh Retirement Village
95 Grants Road, Papanui, Christchurch
Possum Bourne Retirement Village
5 Lisle Farm Drive, Pukekohe
Princess Alexandra Retirement
Village
145 Battery Road, Napier
Rita Angus Retirement Village
66 Coutts Street, Kilbirnie, Wellington
Rowena Jackson Retirement Village
40 O’Byrne Street North, Waikiwi,
Invercargill
Shona McFarlane Retirement Village
66 Mabey Road, Lower Hutt
Weary Dunlop Retirement Village
242 Jells Road, Wheelers Hill,
Melbourne
William Sanders Retirement Village
7 Ngataringa Road, Devonport,
Auckland
Woodcote Retirement Village
29 Woodcote Avenue, Hornby,
Christchurch
Yvette Williams Retirement Village
383 Highgate, Roslyn, Dunedin
Directory
REGISTERED OFFICE
Airport Business Park
92 Russley Road, Christchurch
PO Box 771, Christchurch 8042
New Zealand
RYMAN HEALTHCARE
142
New villages in the pipeline
Aberfeldie
2 Vida Street, Aberfeldie, Melbourne
Burwood East
45 Burwood Highway, Burwood East,
Melbourne
Coburg
81a Bell Street, Coburg, Melbourne
Havelock North
94–148 Te Aute Road,
Havelock North
Highton
157 South Valley Road, Highton,
Victoria
Hobsonville
3 Scott Road, Hobsonville,
Auckland
Karori
26 Donald Street, Karori, Wellington
Kohimarama
223 Kohimarama Road and
7 John Rymer Place, Kohimarama,
Auckland
Lincoln Road
211 Lincoln Road, Henderson
Mt Eliza
70 Kunyung Road, Mt Eliza,
Melbourne
Mt Martha
180 Bentons Road, Mt Martha,
Melbourne
Newtown
192 Adelaide Road, Newtown,
Wellington
Ocean Grove
181–195, Shell Road, Ocean Grove,
Victoria
Park Terrace
78 & 100 Park Terrace, Christchurch
Riccarton Park
Steadman Road, Christchurch
Ringwood East
2–16 Mt Dandenong Road,
Ringwood East, Melbourne
For more information on any of Ryman Healthcare’s retirement villages:
(New Zealand) 0800 588 222
rymanhealthcare.co.nz
(Australia) 1800 922 988
rymanhealthcare.com.au
SHARE REGISTRAR
Link Market Services
PO Box 91976, Auckland 1142
New Zealand
P: +64 9 375 5998
E: enquiries@linkmarketservices.com
MELBOURNE OFFICE
Suite 10.03, Level 10
420 St Kilda Road
Melbourne
PO Box 33119
Melbourne VIC 3004, Australia
AUCKLAND OFFICE
93 Ascot Avenue, Remuera
Auckland 1051, New Zealand
ANNUAL REPORT 2019
143
rymanhealthcare.co.nz
rymanhealthcare.com.au
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.